Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
27 "Epidemiology"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Article
Trends in Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Survey in Korea
Junhyun Kwon, Hanbit Shin, Dae Ho Lee, Eunji Kim
Received July 24, 2025  Accepted October 15, 2025  Published online December 24, 2025  
DOI: https://doi.org/10.3803/EnM.2025.2578    [Epub ahead of print]
  • 329 View
  • 13 Download
AbstractAbstract PDF
Background
The global burden of metabolic dysfunction-associated steatotic liver disease (MASLD), which is associated with higher risks of obesity, type 2 diabetes mellitus, cardiovascular disease, chronic kidney disease, and extrahepatic cancer, is increasing. This study aimed to examine the temporal trends in MASLD prevalence among Korean adults, with a focus on age-stratified patterns and related health conditions.
Methods
This secondary analysis of Korea National Health and Nutrition Examination Survey data included data of 90,912 adults aged ≥19 years from 2007 to 2023. MASLD was defined as having the presence of at least one cardiometabolic risk factor and no heavy alcohol consumption. Temporal trends in MASLD prevalence and associated cardiometabolic risk factors were examined across age groups using weighted prevalence estimates and log-linear regression models.
Results
The overall prevalence of MASLD increased from 25.0% in 2007–2009 to 31.0% in 2022–2023 (annual percent change [APC], 1.36%). The most substantial increase was observed in young adults aged 19–44 years (22.3% to 30.5%; APC=2.09%), particularly among men. Middle-aged (45–64 years) and older (≥65 years) adults showed relatively stable or modest increases over time. Among young adults with MASLD, chronic kidney disease prevalence increased from 2.1% to 5.7%.
Conclusion
This nationwide study revealed a significant and continuous increase in MASLD prevalence among Korean adults, particularly in younger age groups. The disproportionate burden in these populations, along with high rates of metabolic comorbidities, underscores an emerging public health concern that may place considerable strain on future healthcare systems.
Close layer
Review Article
Diabetes, obesity and metabolism
Changes in the Epidemiological Landscape of Diabetes in South Korea: Trends in Prevalence, Incidence, and Healthcare Expenditures
Kyoung Hwa Ha, Dae Jung Kim
Endocrinol Metab. 2024;39(5):669-677.   Published online September 25, 2024
DOI: https://doi.org/10.3803/EnM.2024.2073
  • 14,489 View
  • 276 Download
  • 9 Web of Science
  • 11 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Diabetes is a serious public health concern that significantly contributes to the global burden of disease. In Korea, the prevalence of diabetes is 12.5% among individuals aged 19 and older, and 14.8% among individuals aged 30 and older as of 2022. The total number of people with diabetes among those aged 19 and older is estimated to be 5.4 million. The incidence of diabetes decreased from 8.1 per 1,000 persons in 2006 to 6.3 per 1,000 persons in 2014, before rising again to 7.5 per 1,000 persons in 2019. Meanwhile, the incidence of type 1 diabetes increased significantly, from 1.1 per 100,000 persons in 1995 to 4.8 per 100,000 persons in 2016, with the prevalence reaching 41.0 per 100,000 persons in 2017. Additionally, the prevalence of gestational diabetes saw a substantial rise from 4.1% in 2007 to 22.3% in 2023. These changes have resulted in increases in the total medical costs for diabetes, covering both outpatient and inpatient services. Therefore, effective diabetes prevention strategies are urgently needed.

Citations

Citations to this article as recorded by  
  • Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
    Kyoung Hwa Ha, Soyoung Shin, EunJi Na, Dae Jung Kim
    Journal of Diabetes Investigation.2025; 16(2): 215.     CrossRef
  • Effects of Black Cumin Seed Extract on Pancreatic Islet β-Cell Proliferation and Hypoglycemic Activity in Streptozotocin-Induced Diabetic Rats
    Jongkyu Kim, Yoon-Seok Chun, Namkyu Yoon, Byungkwon Kim, Kiin Choi, Sae-Kwang Ku, Namju Lee
    Antioxidants.2025; 14(2): 174.     CrossRef
  • Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends
    Kyuho Kim, Bongseong Kim, Kyuna Lee, Yu-Bae Ahn, Seung-Hyun Ko, Sung Hee Choi, Kyungdo Han, Jae-Seung Yun
    Diabetes & Metabolism Journal.2025; 49(2): 183.     CrossRef
  • Elevated triglyceride-glucose index is a risk factor for cardiovascular events in adults with type 1 diabetes: a cohort study
    Rosa Oh, Seohyun Kim, Sang Ho Park, Myunghwa Jang, So Hyun Cho, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Association Between Healthy Dietary Patterns and Chronic Kidney Disease in Patients with Diabetes: Findings from Korean National Health and Nutrition Examination Survey 2019–2021
    Minsang Kim, Jung Koh, Jeong Cho, Semin Cho, Soojin Lee, Hyuk Huh, Seong Kim, Sehyun Jung, Eunjeong Kang, Sehoon Park, Jin Paek, Woo Park, Kyubok Jin, Seungyeup Han, Kwon Joo, Kyungdo Han, Dong Kim, Yaerim Kim
    Nutrients.2025; 17(9): 1600.     CrossRef
  • Start Early, Do It Well: Implications of a National Diabetes Care Quality Assessment Program for Life Expectancy
    Kyoung Hwa Ha, Dae Jung Kim
    Diabetes & Metabolism Journal.2025; 49(5): 987.     CrossRef
  • Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes
    Jong Han Choi, Shinae Kang, Soo-Kyung Kim, Won Jun Kim, Ji Min Kim, Jaehyun Bae, Jae-Seung Yun, Eonju Jeon, Young-Eun Kim, Jae Hyun Bae, Hun Jee Choe, Young Min Cho, Seung-Hyun Ko, Sang Yong Kim, Hae Jin Kim, You-Cheol Hwang, Min Kyong Moon, Suk Chon, Seo
    Diabetes & Metabolism Journal.2025; 49(6): 1155.     CrossRef
  • Pharmacoacupuncture for Lowering HbA1c in Korean Adult Patients With Hyperglycemia: A Retrospective Study
    Ju-young Lee, Youngeun Yoo, Sanghun Lee
    Acupuncture & Electro-Therapeutics Research: International Journal of Integrated Medicine.2025; 49(4): 230.     CrossRef
  • Age-stratified comorbidity transitions and interconnected mapping of nine allergic diseases
    Ju Hee Kim, Eun Lee, Jeewon Shin, Eunkyo Ha, Hana Yoo, Soonchul Lee, Man Yong Han
    Allergology International.2025;[Epub]     CrossRef
  • Association of diabetes, obesity, and their co-occurrence with suicide ideation in Korean adults using nationally representative data from 2019 to 2021
    Shiva Raj Acharya, Sudarshan Subedi, Diwash Timilsina
    Scientific Reports.2025;[Epub]     CrossRef
  • Real-World Utility of GWAS-Based Diabetes Mellitus Panel Testing
    In Hwa Jeong, Kyung-Won Hong, Ja-Eun Choi, Bo-Kyung Shine
    International Journal of Molecular Sciences.2025; 27(1): 275.     CrossRef
Close layer
Brief Report
Diabetes, obesity and metabolism
Impact of Diabetes on COVID-19 Susceptibility: A Nationwide Propensity Score Matching Study
Han Na Jang, Sun Joon Moon, Jin Hyung Jung, Kyung-Do Han, Eun-Jung Rhee, Won-Young Lee
Endocrinol Metab. 2024;39(5):813-818.   Published online August 28, 2024
DOI: https://doi.org/10.3803/EnM.2024.2014
  • 2,543 View
  • 48 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Prior research has highlighted poor clinical outcomes in coronavirus disease 2019 (COVID-19)-infected patients with diabetes; however, susceptibility to COVID-19 infection in patients with diabetes has not been extensively studied. Participants aged ≥30 years who underwent COVID-19 testing from December 2019 to April 2020 were analyzed using the National Health Insurance Service data in South Korea. In a cohort comprising 29,433 1:1 propensity score-matched participants, COVID-19 positivity was significantly higher in participants with diabetes than in those without diabetes (512 [3.5%] vs. 395 [2.7%], P<0.001). Logistic regression analysis indicated that diabetes significantly increased the risk of COVID-19 test positivity (odds ratio, 1.307; 95% confidence interval, 1.144 to 1.493; P<0.001). Patients with diabetes exhibited heightened COVID-19 infection rates compared to individuals without diabetes, and diabetes increased the susceptibility to COVID-19, reinforcing the need for heightened preventive measures, particularly considering the poor clinical outcomes in this group.
Close layer
Review Articles
Diabetes, obesity and metabolism
Epidemiology and Trends of Obesity and Bariatric Surgery in Korea
Kyungdo Han, Jin-Hyung Jung, Su-Min Jeong, Mee Kyoung Kim
Endocrinol Metab. 2024;39(5):678-685.   Published online August 2, 2024
DOI: https://doi.org/10.3803/EnM.2024.2056
  • 10,352 View
  • 157 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
The prevalence of obesity in Korea has steadily increased over the past decade, reaching 38.4% in 2021. Notably, the rate of class II– III obesity, defined as a body mass index (BMI) of 30 kg/m2 or higher, exceeded 7% in the same year. Since January 2019, the National Health Insurance Service (NHIS) has provided coverage for bariatric surgery (BS) for eligible patients. Coverage is available for individuals with a BMI of 35 kg/m2 or higher, or those with a BMI of 30 kg/m2 or higher who also have obesity-related comorbidities. Additionally, partial reimbursement is offered for BS in patients with type 2 diabetes mellitus who have BMI values between 27.5 and 30 kg/m2. From 2019 to 2022, the NHIS recorded 9,080 BS procedures, with sleeve gastrectomy being the most commonly performed. The average percentage of weight loss 198±99.7 days post-surgery was 17.9%, with 80.0% of patients losing more than 10% of their body weight. This article presents the trends in obesity and BS in Korea.

Citations

Citations to this article as recorded by  
  • Metabolic and Bariatric Surgery Evolution Over the Past Decades (2009–2024): Insights from the Iranian National Obesity Surgery Database (INOSD)
    Shahab Shahabi Shahmiri, Abdolreza Pazouki, Seyed Amin Setarehdan, Kimia Vakili, Kimia Jazi, Erfan Sheikhbahaei, Fahime Yarigholi, Somayeh Mokhber, Alireza Khalaj, Amir Hossein Davarpanah Jazi, Mohammad Kermansaravi
    Obesity Surgery.2026;[Epub]     CrossRef
  • Impact of caloric restriction on diabetes remission in Korean adults with obesity (CREDO‐K study)
    Mee Kyoung Kim, Jinyoung Kim, Su‐Jeong Park, Yoon‐Ju Song, Hyuk‐Sang Kwon
    Diabetes, Obesity and Metabolism.2025; 27(3): 1609.     CrossRef
  • Diabetes Progression and Its Impact on Kidney Cancer Risk: Insights From a Longitudinal Korean Cohort Study
    Jin Yu, Bongseong Kim, Kyungdo Han, Mee Kyoung Kim
    The Journal of Clinical Endocrinology & Metabolism.2025; 111(1): e125.     CrossRef
  • Long-term exposure to ambient air pollutant mixture and metabolic obesity phenotypes: Results from a nationwide Korean study (2007–2019)
    Seong-Uk Baek, Jin-Ha Yoon
    Journal of Exposure Science & Environmental Epidemiology.2025;[Epub]     CrossRef
  • Early experience with bariatric surgery by an experienced gastric cancer surgeon in a tertiary center
    Jawon Hwang, Shanwen Charleen Yeo, Minah Cho, Yoo Min Kim
    Foregut Surgery.2025; 5(2): 63.     CrossRef
  • A Contemporary Perspective on Long-Term Complications of Bariatric Surgery
    Vladislav Skossyrskiy, Daniil Stepochkin, Ekaterina Zaharova, Rasim Mamedov, Sergey Muraviev, Regina Pakhomova, Elizaveta German, Andrey Nikolaev, Zelimkhan Berikkhanov, Ivan Markov, Andrey Fabrika, Vadim Razumovsky
    Obesity Surgery.2025;[Epub]     CrossRef
Close layer
Diabetes, obesity and metabolism
Young-Onset Diabetes in East Asians: From Epidemiology to Precision Medicine
Juliana C.N. Chan, Chun-Kwan O, Andrea O.Y. Luk
Endocrinol Metab. 2024;39(2):239-254.   Published online April 16, 2024
DOI: https://doi.org/10.3803/EnM.2024.1968
  • 9,638 View
  • 315 Download
  • 10 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   ePub   
Precision diagnosis is the keystone of clinical medicine. In East Asians, classical type 1 diabetes is uncommon in patients with youngonset diabetes diagnosed before age of 40, in whom a family history, obesity, and beta-cell and kidney dysfunction are key features. Young-onset diabetes affects one in five Asian adults with diabetes in clinic settings; however, it is often misclassified, resulting in delayed or non-targeted treatment. Complex aetiologies, long disease duration, aggressive clinical course, and a lack of evidence-based guidelines have contributed to variable care standards and premature death in these young patients. The high burden of comorbidities, notably mental illness, highlights the numerous knowledge gaps related to this silent killer. The majority of adult patients with youngonset diabetes are managed as part of a heterogeneous population of patients with various ages of diagnosis. A multidisciplinary care team led by physicians with special interest in young-onset diabetes will help improve the precision of diagnosis and address their physical, mental, and behavioral health. To this end, payors, planners, and providers need to align and re-design the practice environment to gather data systematically during routine practice to elucidate the multicausality of young-onset diabetes, treat to multiple targets, and improve outcomes in these vulnerable individuals.

Citations

Citations to this article as recorded by  
  • Type 2 diabetes: a contemporary view from the Asian lens
    Jeyakantha Ratnasingam, Quan Hziung Lim, Siew Pheng Chan
    Current Opinion in Endocrinology, Diabetes & Obesity.2025; 32(1): 20.     CrossRef
  • Diabetes Fact Sheets in Korea 2024
    Se Eun Park, Seung-Hyun Ko, Ji Yoon Kim, Kyuho Kim, Joon Ho Moon, Nam Hoon Kim, Kyung Do Han, Sung Hee Choi, Bong Soo Cha
    Diabetes & Metabolism Journal.2025; 49(1): 24.     CrossRef
  • Development and Validation of the Patient-Level Chinese Diabetes Outcome Model on Long-term Complications in Type 2 Diabetes: An Application of the Hong Kong Diabetes Register
    Eric S.H. Lau, Andrea O.Y. Luk, Lee-Ling Lim, Hongjiang Wu, Aimin Yang, Alice P.S. Kong, Ronald C.W. Ma, Risa Ozaki, Elaine Y.K. Chow, Chiu-Chi Tsang, Chun-Kwun O, Amy Fu, Edward W. Gregg, Philip Clarke, Wing-Yee So, Juliana N.M. Lui, Juliana C.N. Chan
    Diabetes Care.2025; 48(4): 579.     CrossRef
  • Young‐onset type 2 diabetes—Epidemiology, pathophysiology, and management
    Andrea O.Y. Luk, Hongjiang Wu, Yingnan Fan, Baoqi Fan, Chun Kwan O, Juliana C.N. Chan
    Journal of Diabetes Investigation.2025; 16(7): 1157.     CrossRef
  • Understanding the drivers and consequences of early-onset type 2 diabetes
    Lee-Ling Lim, Sophie Jones, Justin Cirhuza Cikomola, Marie-France Hivert, Shivani Misra
    The Lancet.2025; 405(10497): 2327.     CrossRef
  • Global Burden of Type 1 Diabetes Mellitus Related Chronic Kidney Disease among Adolescents and Young Adults, and Projections to 2035: Results from the Global Burden of Disease Study 2021
    Xiaoli Qu, Chongbin Liu, Lin Sun, Zhifeng Sheng
    Diabetes & Metabolism Journal.2025; 49(4): 812.     CrossRef
  • Development of a Chinese‐Specific Clinical Model to Predict Maturity‐Onset Diabetes of the Young
    Sandra T. F. Tsoi, Cadmon K. P. Lim, Ronald C. W. Ma, Eric S. H. Lau, Baoqi Fan, Chun Kwan O, Yingnan Fan, Elaine Chow, Alice P. S. Kong, Wing‐Yee So, Juliana C. N. Chan, Andrea O. Y. Luk
    Diabetes/Metabolism Research and Reviews.2025;[Epub]     CrossRef
  • Environmental exposure to toxic and essential metals and glucose homeostasis in adolescents: A cross-sectional analysis of the Hong Kong School Children Cohort
    Jiazhou Yu, Aimin Yang, Elaine Chow, Mai Shi, Yincong Xue, Claudia HT Tam, Natural HS Chu, Stephanie HM Cheung, Eric SH Lau, Hongjiang Wu, Juliana NM Lui, Ronald CW Ma, Alice PS Kong, Andrea OY Luk, Jones CM Chan, Iris HS Chan, Michael HM Chan, Juliana CN
    Ecotoxicology and Environmental Safety.2025; 305: 119179.     CrossRef
  • Beta-Cell Function, Insulin Sensitivity, and Metabolic Characteristics in Young-Onset Type 2 Diabetes Mellitus: Findings from Anam Diabetes Observational Study
    Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim
    Diabetes & Metabolism Journal.2025; 49(6): 1287.     CrossRef
  • Differences in cardiovascular disease incidence according to changes in obesity status in young diabetic patients
    Do Kyeong Song, Yeon-Ah Sung, Young Sun Hong, Min-ho Kim, Hyejin Lee
    Cardiovascular Diabetology – Endocrinology Reports.2025;[Epub]     CrossRef
  • Genetic Predisposition to Prediabetes in the Kazakh Population
    Gulnara Svyatova, Galina Berezina, Alexandra Murtazaliyeva, Altay Dyussupov, Tatyana Belyayeva, Raida Faizova, Azhar Dyussupova
    Current Issues in Molecular Biology.2024; 46(10): 10913.     CrossRef
Close layer
Original Articles
Thyroid
Big Data Articles (National Health Insurance Service Database)
Prevalence, Treatment Status, and Comorbidities of Hyperthyroidism in Korea from 2003 to 2018: A Nationwide Population Study
Hwa Young Ahn, Sun Wook Cho, Mi Young Lee, Young Joo Park, Bon Seok Koo, Hang-Seok Chang, Ka Hee Yi
Endocrinol Metab. 2023;38(4):436-444.   Published online July 12, 2023
DOI: https://doi.org/10.3803/EnM.2023.1684
  • 8,164 View
  • 221 Download
  • 11 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study aimed to investigate the changes of incidence and treatment of choice for hyperthyroidism from 2003 to 2018 and explore the treatment-related complications and concomitant comorbidities in South Korea using data from the National Health Insurance Service.
Methods
This is a retrospective observational study. Hyperthyroidism was defined as a case having two or more diagnostic codes of thyrotoxicosis, with antithyroid drug intake for more than 6 months.
Results
The average age-standardized incidence of hyperthyroidism from 2003 to 2018 was 42.23 and 105.13 per 100,000 men and women, respectively. In 2003 to 2004, hyperthyroidism was most often diagnosed in patients in their 50s, but in 2017 to 2018, people were most often diagnosed in their 60s. During the entire period, about 93.7% of hyperthyroidism patients were prescribed with antithyroid drugs, and meanwhile, the annual rates of ablation therapy decrease from 7.68% in 2008 to 4.56% in 2018. Antithyroid drug-related adverse events, mainly agranulocytosis and acute hepatitis, as well as complications of hyperthyroidism such as atrial fibrillation or flutter, osteoporosis, and fractures, occurred more often in younger patients.
Conclusion
In Korea, hyperthyroidism occurred about 2.5 times more in women than in men, and antithyroid drugs were most preferred as the first-line treatment. Compared to the general population, hyperthyroid patients may have a higher risk of atrial fibrillation or flutter, osteoporosis, and fractures at a younger age.

Citations

Citations to this article as recorded by  
  • Effect of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients
    Sungho Bea, Hwa Young Ahn, Jieun Woo, Ju-Young Shin, Sun Wook Cho
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(9): e3109.     CrossRef
  • Unveiling Risk Factors for Treatment Failure in Patients with Graves’ Disease: A Nationwide Cohort Study in Korea
    Jung A Kim, Kyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim
    Endocrinology and Metabolism.2025; 40(1): 125.     CrossRef
  • 2025 Korean Thyroid Association Management Guidelines for Radioactive Iodine Therapy in Patients with Hyperthyroidism
    Kyeong Jin Kim, Eyun Song, Mijin Kim, Hyemi Kwon, Eu Jeong Ku, Hyun Woo Kwon, Jee Hee Yoon, Eun Kyung Lee, Won Woo Lee, Young Joo Park, Dong-Jun Lim, Sun Wook Kim, Ho-Cheol Kang, Jae Hoon Chung, Tae Yong Kim, Sin Gon Kim, Dong Gyu Na, Jee Soo Kim
    International Journal of Thyroidology.2025; 18(1): 65.     CrossRef
  • 2025 Korean Thyroid Association Management Guidelines for Radioactive Iodine Therapy in Patients with Hyperthyroidism
    Kyeong Jin Kim, Eyun Song, Mijin Kim, Hyemi Kwon, Eu Jeong Ku, Hyun Woo Kwon, Jee Hee Yoon, Eun Kyung Lee, Won Woo Lee, Young Joo Park, Dong-Jun Lim, Sun Wook Kim, Ho-Cheol Kang, Jae Hoon Chung, Tae Yong Kim, Sin Gon Kim, Dong Gyu Na, Jee Soo Kim
    Endocrinology and Metabolism.2025; 40(3): 342.     CrossRef
  • A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
    Jung Hyun Kim, Jaeyong Shin, Man S Kim, Jae Hoon Moon
    JMIR mHealth and uHealth.2025; 13: e56738.     CrossRef
  • Long-term Effect of Thyrotropin-binding Inhibitor Immunoglobulin on Atrial Fibrillation in Euthyroid Patients
    Jung-Chi Hsu, Kang-Chih Fan, Ting-Chuan Wang, Shu-Lin Chuang, Ying-Ting Chao, Ting-Tse Lin, Kuan-Chih Huang, Lian-Yu Lin, Lung-Chun Lin
    Endocrine Practice.2024; 30(6): 537.     CrossRef
  • Treatment Patterns and Preferences for Graves’ Disease in Korea: Insights from a Nationwide Cohort Study
    Kyeong Jin Kim, Jimi Choi, Soo Myoung Shin, Jung A Kim, Kyoung Jin Kim, Sin Gon Kim
    Endocrinology and Metabolism.2024; 39(4): 659.     CrossRef
  • Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration
    Meihua Jin, Chae A Kim, Min Ji Jeon, Won Bae Kim, Tae Yong Kim, Won Gu Kim
    Endocrinology and Metabolism.2024; 39(4): 579.     CrossRef
  • The Current Status of Hyperthyroidism in Korea
    Hyemi Kwon
    Endocrinology and Metabolism.2023; 38(4): 392.     CrossRef
  • Is Thyroid Dysfunction Associated with Unruptured Intracranial Aneurysms? A Population-Based, Nested Case–Control Study from Korea
    Hyeree Park, Sun Wook Cho, Sung Ho Lee, Kangmin Kim, Hyun-Seung Kang, Jeong Eun Kim, Aesun Shin, Won-Sang Cho
    Thyroid®.2023; 33(12): 1483.     CrossRef
Close layer
Thyroid
Big Data Articles (National Health Insurance Service Database)
Recent Changes in the Incidence of Thyroid Cancer in Korea between 2005 and 2018: Analysis of Korean National Data
Yun Mi Choi, Jiwoo Lee, Mi Kyung Kwak, Min Ji Jeon, Tae Yong Kim, Eun-Gyoung Hong, Won Bae Kim, Won Gu Kim
Endocrinol Metab. 2022;37(5):791-799.   Published online October 11, 2022
DOI: https://doi.org/10.3803/EnM.2022.1533
  • 7,931 View
  • 242 Download
  • 19 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
In this study, we evaluated the recent changes in the standardized, age-specific, stage-specific incidence rates (IRs) of thyroid cancer in Korea and compared them with the incidence data reported by the Surveillance, Epidemiology, and End Results Program.
Methods
The analysis was conducted using the incidence data (2005 to 2018) from the Statistics Korea and Korea Central Cancer Registry.
Results
The age-standardized IR (SIR) of thyroid cancer increased from 24.09 per 100,000 in 2005 to 74.83 in 2012 (annual percent change [APC], 14.5). From 2012 to 2015, the SIR decreased to 42.52 (APC, –17.9) and then remained stable until 2018 (APC, 2.1). This trend was similar in both men and women. Regarding age-specific IRs, the IRs for ages of 30 years and older showed a trend similar to that of the SIR; however, for ages below 30 years, no significant reduction was observed from the vertex of IR in 2015. Regarding stage-specific IRs, the increase was more prominent in those with regional disease (APC, 17.4) than in those with localized disease until 2012; then, the IR decreased until 2015 (APC, –16.1). The average APC from 2005 to 2018 increased in men, those under the age of 30 years, and those with regional disease.
Conclusion
The SIR in Korea peaked in 2012 and decreased until 2015 and then remained stable until 2018. However, in young individuals under the age of 30 years, the IR did not significantly decrease but tended to increase again. In terms of stage-specific IRs, the sharpest increase was seen among those with regional disease.

Citations

Citations to this article as recorded by  
  • Deep Learning Technology for Classification of Thyroid Nodules Using Multi-View Ultrasound Images: Potential Benefits and Challenges in Clinical Application
    Jinyoung Kim, Min-Hee Kim, Dong-Jun Lim, Hankyeol Lee, Jae Jun Lee, Hyuk-Sang Kwon, Mee Kyoung Kim, Ki-Ho Song, Tae-Jung Kim, So Lyung Jung, Yong Oh Lee, Ki-Hyun Baek
    Endocrinology and Metabolism.2025; 40(2): 216.     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shin Je Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyo
    International Journal of Thyroidology.2025; 18(1): 30.     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shinje Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyon
    Endocrinology and Metabolism.2025; 40(3): 307.     CrossRef
  • Hybrid Transoral Endoscopic Thyroidectomy Submental Access (H-TOETSA) Versus Conventional and Bilateral-Axillo Breast Approach (BABA) Thyroidectomy: A Comparative Study of Feasibility and Safety
    Myungyup Hyun, Junwon Min, Euitae Kim
    Journal of Endocrine Surgery.2025; 25(4): 139.     CrossRef
  • Comparison of postoperative pain between transoral and conventional thyroidectomy: a propensity score-matched analysis
    Min Kyu Park, Van Cuong Nguyen, Eugene Kim, Chang Myeon Song, Yong Bae Ji, Jin Hyeok Jeong, Kyung Tae
    Surgical Endoscopy.2024; 38(3): 1512.     CrossRef
  • Contents analysis of thyroid cancer-related information uploaded to YouTube by physicians in Korea: endorsing thyroid cancer screening, potentially leading to overdiagnosis
    EunKyo Kang, HyoRim Ju, Soojeong Kim, Juyoung Choi
    BMC Public Health.2024;[Epub]     CrossRef
  • Bilateral axillo-breast approach robotic total thyroidectomy without isthmectomy: a case report
    Hyeji Kim, Hyeonuk Hwang, Hyungju Kwon
    The Ewha Medical Journal.2024;[Epub]     CrossRef
  • Association between Consumption of Iodine-Rich Foods and Thyroid Cancer Prevalence: Findings from a Large Population-Based Study
    Yu-Jin Kwon, Hye-Sun Lee, Sang-Wook Kang, Ji-Won Lee
    Nutrients.2024; 16(7): 1041.     CrossRef
  • Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid Cancer: A Retrospective Study on a Korean Population
    Han-Sang Baek, Jeonghoon Ha, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Sungju Kim, Dong-Jun Lim, Chul-Min Kim
    Endocrinology and Metabolism.2024; 39(2): 310.     CrossRef
  • Thyroid Cancer Incidence Among Korean Individuals: A Comparison of South Korea and the United States
    Dohun Kim, Guan Li, Peter K. Moon, Yifei Ma, Soohyun Sim, Sung Y. Park, Minkyung Oh, Uchechukwu C. Megwalu
    The Laryngoscope.2024; 134(9): 4156.     CrossRef
  • Thyroid cancer-specific mortality during 2005–2018 in Korea, aftermath of the overdiagnosis issue: a nationwide population-based cohort study
    Kyeong Jin Kim, Jimi Choi, Sue K. Park, Young Joo Park, Sin Gon Kim
    International Journal of Surgery.2024; 110(9): 5489.     CrossRef
  • Trends in Thyroid Cancer Mortality Rates in Korea: Insights from National Health Database
    Won Gu Kim
    Endocrinology and Metabolism.2024; 39(6): 853.     CrossRef
  • Cancer and Mortality Risks of Graves’ Disease in South Korea Based on National Data from 2010 to 2019
    Young Ju Choi, Kyungdo Han, Won Kyoung Cho, Min Ho Jung, Byung-Kyu Suh
    Clinical Epidemiology.2023; Volume 15: 535.     CrossRef
  • Survival Comparison of Incidentally Found versus Clinically Detected Thyroid Cancers: An Analysis of a Nationwide Cohort Study
    Shinje Moon, Eun Kyung Lee, Hoonsung Choi, Sue K. Park, Young Joo Park
    Endocrinology and Metabolism.2023; 38(1): 81.     CrossRef
  • Cumulative exposure to metabolic syndrome increases thyroid cancer risk in young adults: a population-based cohort study
    Jinyoung Kim, Kyungdo Han, Mee Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
    The Korean Journal of Internal Medicine.2023; 38(4): 526.     CrossRef
  • Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population
    Han-Sang Baek, Jeonghoon Ha, Kwangsoon Kim, Jaseong Bae, Jeong Soo Kim, Sungju Kim, Dong-Jun Lim, Chulmin Kim
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Long-Term Changes in the Mortality Rates of Thyroid Cancer in Korea: Analysis of Korean National Data from 1985 to 2020
    Yun Mi Choi, Min-Ju Kim, Jiwoo Lee, Mi Kyung Kwak, Min Ji Jeon, Tae Yong Kim, Eun-Gyoung Hong, Won Bae Kim, Won Gu Kim
    Endocrinology and Metabolism.2023; 38(5): 588.     CrossRef
  • Age and Post-Lobectomy Recurrence after Endoscopic or Robotic Thyroid Surgery: A Retrospective Cohort Study of 2348 Papillary Thyroid Carcinoma Patients
    Jin-Seong Cho, Yong-Min Na, Hee Kyung Kim
    Cancers.2023; 15(23): 5506.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Big Data Articles (National Health Insurance Service Database)
Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
Endocrinol Metab. 2022;37(3):466-474.   Published online June 29, 2022
DOI: https://doi.org/10.3803/EnM.2022.1440
  • 8,366 View
  • 186 Download
  • 9 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Diabetes is a leading cause of death that is responsible for 1.6 million annual deaths worldwide. However, the life expectancy and age at death of people with diabetes have been a matter of debate.
Methods
The National Health Insurance Service claims database, merged with death records from the National Statistical Information Service in Korea from 2006 to 2018, was analyzed.
Results
In total, 1,432,567 deaths were collected. The overall age at death increased by 0.44 and 0.26 year/year in the diabetes and control populations, respectively. The disparity in the mean age at death between the diabetes and control populations narrowed from 5.2 years in 2006 to 3.0 years in 2018 (p<0.001). In a subgroup analysis according to the presence of comorbid diseases, the number and proportion of deaths remained steady in the group with diabetes only, but steadily increased in the groups with diabetes combined with dyslipidemia and/or hypertension. Compared to the control population, the increase in the mean death age was higher in the population with diabetes. This trend was more prominent in the groups with dyslipidemia and/or hypertension than in the diabetes only group. Deaths from vascular disease and diabetes decreased, whereas deaths from cancer and pneumonia increased. The decline in the proportion of deaths from vascular disease was greater in the diabetes groups with hypertension and/or dyslipidemia than in the control population.
Conclusion
The age at death in the population with diabetes increased more steeply and reached a comparable level to those without diabetes.

Citations

Citations to this article as recorded by  
  • Association between the number of glucose-lowering drugs in use, diet quality, and nutrient intake among adults with type 2 diabetes mellitus
    Renata Maksoud Bussuan, Ângela Cristine Bersch-Ferreira, Aline Marcadenti
    Nutrition and Health.2025; 31(4): 1553.     CrossRef
  • Effects of Pancreatitis and Type 2 Diabetes Mellitus on the Development of Pancreatic Cancer: A Nationwide Nested Case-Control Study
    Young-eun Kim, Min Heui Yu, Chung Mo Nam, Eun Seok Kang
    Diabetes & Metabolism Journal.2025; 49(2): 252.     CrossRef
  • Imeglimin Inhibits Macrophage Foam Cell Formation and Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-Deficient Mice
    Ji Yeon Lee, Yup Kang, Ja Young Jeon, Seung Jin Han
    Cells.2025; 14(7): 472.     CrossRef
  • Impact of Type 2 Diabetes Mellitus on Age at Death in the Hemodialysis Population: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Ji Hong You, Kang Ju Son, Kyoung Sook Park, Byung-Wan Lee, Sun Ok Song
    Diabetology.2025; 6(12): 145.     CrossRef
  • Islet transplantation in Korea
    Joonyub Lee, Kun‐Ho Yoon
    Journal of Diabetes Investigation.2024; 15(9): 1165.     CrossRef
  • A Retrospective Herb-Drug Interaction Study of Oryeong-san (Wuling-san) Co-administration in Type 2 Diabetes Patients Receiving Hypoglycemic Treatment
    Mee-ryoung Song, Woo-nyoung Jung, Yeon-joo Yoo, Min-seong Lee, Young-min Ahn, Se-young Ahn, Byung-cheol Lee
    The Journal of Internal Korean Medicine.2024; 45(4): 602.     CrossRef
  • Analysis of Cause-of-Death Mortality in Children and Young Adults with Diabetes: A Nationwide 10-Year Follow-Up Cohort Study
    Iee-Ho Choi, Sang-Woo Yeom, Sun-Young Kim, Jihye You, Jong-Seung Kim, Minsun Kim
    Children.2023; 10(2): 358.     CrossRef
  • Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Sun Ok Song, Eugene Han, Kang Ju Son, Bong-Soo Cha, Byung-Wan Lee
    Journal of Clinical Medicine.2023; 12(9): 3160.     CrossRef
  • Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study
    Joonyub Lee, Hun-Sung Kim, Kee-Ho Song, Soon Jib Yoo, Kyungdo Han, Seung-Hwan Lee
    Endocrinology and Metabolism.2023; 38(5): 525.     CrossRef
  • Long-Term Cumulative Exposure to High γ-Glutamyl Transferase Levels and the Risk of Cardiovascular Disease: A Nationwide Population-Based Cohort Study
    Han-Sang Baek, Bongseong Kim, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Sang-Ah Chang, Kyungdo Han, Jae-Seung Yun
    Endocrinology and Metabolism.2023; 38(6): 770.     CrossRef
Close layer
Thyroid
Big Data Articles (National Health Insurance Service Database)
Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
Yoon Young Cho, Bongseong Kim, Dong Wook Shin, Hye Ryoun Jang, Bo-Yeon Kim, Chan-Hee Jung, Jae Hyeon Kim, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han, Tae Hyuk Kim
Endocrinol Metab. 2022;37(2):281-289.   Published online April 6, 2022
DOI: https://doi.org/10.3803/EnM.2021.1333
  • 9,884 View
  • 164 Download
  • 6 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Hyperthyroidism is associated with an increased glomerular filtration rate (GFR) in the hyperdynamic state, which is reversible after restoring euthyroidism. However, long-term follow-up of renal dysfunction in patients with hyperthyroidism has not been performed.
Methods
This was a retrospective cohort study using the Korean National Health Insurance database and biannual health checkup data. We included 41,778 Graves’ disease (GD) patients and 41,778 healthy controls, matched by age and sex. The incidences of end-stage renal disease (ESRD) were calculated in GD patients and controls. The cumulative dose and duration of antithyroid drugs (ATDs) were calculated for each patient and categorized into the highest, middle, and lowest tertiles.
Results
Among 41,778 GD patients, 55 ESRD cases occurred during 268,552 person-years of follow-up. Relative to the controls, regardless of smoking, drinking, or comorbidities, including chronic kidney disease, GD patients had a 47% lower risk of developing ESRD (hazard ratio [HR], 0.53; 95% confidence interval [CI], 0.37 to 0.76). In particular, GD patients with a higher baseline GFR (≥90 mL/min/1.73 m2; HR, 0.33; 95% CI, 0.11 to 0.99), longer treatment duration (>33 months; HR, 0.31; 95% CI, 0.17 to 0.58) or higher cumulative dose (>16,463 mg; HR, 0.29; 95% CI, 0.15 to 0.57) of ATDs had a significantly reduced risk of ESRD.
Conclusion
This was the first epidemiological study on the effect of GD on ESRD, and we demonstrated that GD population had a reduced risk for developing ESRD.

Citations

Citations to this article as recorded by  
  • Chronic Kidney Disease and Thyroid Hormones
    Yuan Cheng, Haofei Hu, Wangyang Li, Sheng Nie, Shiyu Zhou, Yuna Chen, Tao Cao, Hong Xu, Bicheng Liu, Chunbo Chen, Huafeng Liu, Qiongqiong Yang, Hua Li, Yaozhong Kong, Guisen Li, Yan Zha, Ying Hu, Gang Xu, Yongjun Shi, Yilun Zhou, Guobin Su, Ying Tang, Men
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(8): e2446.     CrossRef
  • Significance of pathological changes and chemokine expression in various organs in a Graves’ disease animal model
    Yang Yang, Chen Hui
    Journal of Molecular Histology.2025;[Epub]     CrossRef
  • Kidney diseases and the thyroid: interactions and consequences
    Gabriela Brenta
    Nature Reviews Endocrinology.2025;[Epub]     CrossRef
  • Renal function changes in patients with subclinical hyperthyroidism: a novel postulated mechanism
    Magdy Mohamed Allam, Hanaa Tarek El-Zawawy, Tarek Hussein El-Zawawy
    Endocrine.2023; 82(1): 78.     CrossRef
  • Effect of Hyperthyroidism on Preventing Renal Insufficiency
    Tae Yong Kim
    Endocrinology and Metabolism.2022; 37(2): 220.     CrossRef
  • Effects and Clinical Value of Peritoneal Dialysis on Water and Water Balance, Adverse Reactions, Quality of Life, and Clinical Prognosis in Patients with Decompensated Chronic Nephropathy: A Systematic Review and Meta-Analysis
    Xichao Wang, Miaomiao Zhang, Na Sun, Wenxiu Chang, Gang Chen
    Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
Close layer
Adrenal Gland
Big Data Articles (National Health Insurance Service Database)
Epidemiology and Long-Term Adverse Outcomes in Korean Patients with Congenital Adrenal Hyperplasia: A Nationwide Study
Jung Hee Kim, Sunkyu Choi, Young Ah Lee, Juneyoung Lee, Sin Gon Kim
Endocrinol Metab. 2022;37(1):138-147.   Published online February 28, 2022
DOI: https://doi.org/10.3803/EnM.2021.1328
  • 8,410 View
  • 206 Download
  • 22 Web of Science
  • 23 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Previous studies on the epidemiology and complications of congenital adrenal hyperplasia (CAH) were conducted in Western countries and in children/adolescents. We aimed to explore the epidemiology of CAH, as well as the risk of comorbidities and mortality, in a Korean nationwide case-control study.
Methods
CAH patients (n=2,840) were included between 2002 and 2017 from the National Health Insurance Service database and the Rare Intractable Disease program. CAH patients were compared, at a 1:10 ratio, with age-, sex-, and index year-matched controls (n=28,400).
Results
The point prevalence of CAH patients in Korea was 1 in 18,745 persons in 2017. The annual incidence rate declined between 2003 and 2017 from 3.25 to 0.41 per 100,000 persons. CAH patients were at elevated risk for cardiovascular disease (odds ratio [OR], 1.6; 95% confidence interval [CI], 1.4 to 1.9), stroke (OR, 1.7; 95% CI, 1.3 to 2.0), diabetes mellitus (OR, 2.8; 95% CI, 2.6 to 3.1), dyslipidemia (OR, 2.4; 95% CI, 2.2 to 2.6), and psychiatric disorders (OR, 1.5; 95% CI, 1.3 to 1.6). Fracture risk increased in CAH patients aged over 40 years (OR, 1.4; 95% CI, 1.1 to 1.7). CAH patients were at higher risk of mortality than controls (hazard ratio, 1.6; 95% CI, 1.3 to 2.0).
Conclusion
Our nationwide study showed a recent decline in the incidence of CAH and an elevated risk for cardiovascular, metabolic, skeletal, and psychiatric disorders in CAH patients. Lifelong management for comorbidity risk is a crucial component of treating CAH patients.

Citations

Citations to this article as recorded by  
  • Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
    Robert Krysiak, Hedi L Claahsen-van der Grinten, Nicole Reisch, Philippe Touraine, Henrik Falhammar
    Endocrine Reviews.2025; 46(1): 80.     CrossRef
  • Prevalence of Psychiatric Comorbidities in Females With Classic Congenital Adrenal Hyperplasia
    Behzad Sorouri Khorashad, Oumaima Kaabi, Melissa D Gardner, Darios Getahun, Michael Goodman, Timothy L Lash, Peter A Lee, Joshua May, Courtney McCracken, Maria Muzik, Suma Vupputuri, Rami Yacoub, David E Sandberg
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(8): e2562.     CrossRef
  • Glucocorticoid therapy in classic congenital adrenal hyperplasia: traditional and new treatment paradigms
    Irina Bancos, Hyunwoo Kim, Henry K. Cheng, Mariam Rodriguez-Lee, Helen Coope, Samantha Cicero, Hannah Goldsmith, Vivian H. Lin, George S. Jeha
    Expert Review of Endocrinology & Metabolism.2025; 20(1): 33.     CrossRef
  • Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
    Hedvig Engberg, Anna Nordenström, Angelica Lindén Hirschberg
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(Supplement): S37.     CrossRef
  • Metabolic Syndrome Spectrum in Children with Classic Congenital Adrenal Hyperplasia—A Comprehensive Review
    Sanja Panic Zaric, Tatjana Milenkovic, Sladjana Todorovic, Katarina Mitrovic, Dimitrije Cvetkovic, Maja Cehic, Jelena Vekic, Katja Dumic, Rade Vukovic
    Metabolites.2025; 15(2): 89.     CrossRef
  • Long-term outcomes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a retrospective study from a tertiary care center in Saudi Arabia
    Haneen Aldalaan, Afaf Alsagheir, Nujud Alghamdi, Raghad Alhuthil, Maha Almslam, Mohamed H. Al-Hamed
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The epidemiology of disorders of sex development
    Agnethe Berglund, Simon Chang, Marie Lind-Holst, Kirstine Stochholm, Claus Højbjerg Gravholt
    Best Practice & Research Clinical Endocrinology & Metabolism.2025; 39(4): 102002.     CrossRef
  • Causal associations between congenital adrenal hyperplasia and neuropsychiatric conditions- a Mendelian Randomization Study
    Yang Liu, Xiaokun Gang, Yuan Gao, Guixia Wang
    Endocrine.2025; 89(1): 291.     CrossRef
  • Epidemiology and clinical outcomes of clinically suspected multiple endocrine neoplasia type 1 in South Korea: a nationwide cohort study
    Kyoung Jin Kim, Min Heui Yu, Yoon-a Hwang, Shinje Moon, Namki Hong, Yumie Rhee
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment
    Paola Loli, Sara Menotti, Luigi di Filippo, Andrea Giustina
    Endocrine.2025; 90(1): 1.     CrossRef
  • Increased mortality in primary adrenal insufficiency: a systematic review and meta-analysis
    Konstantinos Dalakas, Francesca Allosso, Christian Basile, Ragnhildur Bergthorsdottir, Dimitrios Chantzichristos, Eva Hessman, Bright I Nwaru, Emanuele Bobbio, Daniela Pasquali, Gudmundur Johannsson, Daniela Esposito
    European Journal of Endocrinology.2025; 193(4): S53.     CrossRef
  • Exploration of the potential of genomic editing in the treatment of congenital adrenal hyperplasia
    Lara E. Graves, Sharntie Christina, Kathryn L. Mullany, Ian E. Alexander, Henrik Falhammar
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Long‐term health consequences of congenital adrenal hyperplasia
    Riccardo Pofi, Xiaochen Ji, Nils P. Krone, Jeremy W. Tomlinson
    Clinical Endocrinology.2024; 101(4): 318.     CrossRef
  • Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
    Angelica Lindén Hirschberg
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(5): 1202.     CrossRef
  • Predictors of Cardiovascular Morbidities in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
    Suranut Charoensri, Richard J Auchus
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1133.     CrossRef
  • Case report: Development of central precocious puberty in a girl with late-diagnosed simple virilizing congenital adrenal hyperplasia complicated with Williams syndrome
    Eun Young Joo, Myung Ji Yoo, Su Jin Kim, Woori Jang, Ji-Eun Lee
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Proof of concept for a superior therapeutic index of corticosterone compared with hydrocortisone in patients with congenital adrenal hyperplasia
    Catriona J Kyle, Luke D Boyle, Mark Nixon, Natalie Z M Homer, Joanna P Simpson, Alison Rutter, Lynne E Ramage, Alexandra Kelman, Ellen Marie Freel, Ruth Andrew, Brian R Walker, Roland H Stimson
    European Journal of Endocrinology.2024; 191(6): 535.     CrossRef
  • Анализ распространенности и заболеваемости надпочечниковой недостаточностью в мире
    М. Ю. Юкина, Н. Ф. Нуралиева, Е. А. Трошина
    Ateroscleroz.2023; 18(4): 426.     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
    Beatrice Righi, Salma R. Ali, Jillian Bryce, Jeremy W. Tomlinson, Walter Bonfig, Federico Baronio, Eduardo C. Costa, Guilherme Guaragna-Filho, Guy T’Sjoen, Martine Cools, Renata Markosyan, Tania A. S. S. Bachega, Mirela C. Miranda, Violeta Iotova, Henrik
    Endocrine.2023; 80(3): 630.     CrossRef
  • Serum steroid profile captures metabolic phenotypes in adults with classic congenital adrenal hyperplasia
    Chang Ho Ahn, Jaeyoon Shim, Han Na Jang, Young Ah Lee, Sang-Won Lee, Man Ho Choi, Jung Hee Kim
    The Journal of Steroid Biochemistry and Molecular Biology.2023; 234: 106374.     CrossRef
  • Multiplexed Serum Steroid Profiling Reveals Metabolic Signatures of Subtypes in Congenital Adrenal Hyperplasia
    Jaeyoon Shim, Chang Ho Ahn, Seung Shin Park, Jongsung Noh, Chaelin Lee, Sang Won Lee, Jung Hee Kim, Man Ho Choi
    Journal of the Endocrine Society.2023;[Epub]     CrossRef
  • Long-Term Outcomes of Congenital Adrenal Hyperplasia
    Anna Nordenström, Svetlana Lajic, Henrik Falhammar
    Endocrinology and Metabolism.2022; 37(4): 587.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Lower High-Density Lipoprotein Cholesterol Concentration Is Independently Associated with Greater Future Accumulation of Intra-Abdominal Fat
Sun Ok Song, You-Cheol Hwang, Han Uk Ryu, Steven E. Kahn, Donna L. Leonetti, Wilfred Y. Fujimoto, Edward J. Boyko
Endocrinol Metab. 2021;36(4):835-844.   Published online August 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.1130
  • 9,099 View
  • 132 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Both intra-abdominal fat (IAF) and high-density lipoprotein cholesterol (HDL-C) are known to be associated with cardiometabolic health. We evaluated whether the accumulation of computed tomography (CT)-measured IAF over 5 years was related to baseline HDL-C concentration in a prospective cohort study.
Methods
All participants were Japanese-Americans between the ages of 34 and 74 years. Plasma HDL-C concentration and CT measurements of IAF, abdominal subcutaneous fat (SCF), and thigh SCF cross-sectional areas were assessed at baseline and at 5-year follow-up visits.
Results
A total of 397 subjects without diabetes were included. The mean±standard deviation HDL-C concentration was 51.6±13.0 mg/dL in men and 66.0±17.0 mg/dL in women, and the IAF was 91.9±48.4 cm2 in men and 63.1±39.5 cm2 in women. The baseline plasma concentration of HDL-C was inversely associated with the change in IAF over 5 years using multivariable regression analysis with adjustment for age, sex, family history of diabetes, weight change over 5 years, and baseline measurements of body mass index, IAF, abdominal SCF, abdominal circumference, thigh SCF, and homeostatic model assessment for insulin resistance.
Conclusion
These results demonstrate that HDL-C concentration significantly predicts future accumulation of IAF over 5 years independent of age, sex, insulin sensitivity, and body composition in Japanese-American men and women without diabetes.

Citations

Citations to this article as recorded by  
  • HDL-C and visceral adipose tissue as combined predictors of visceral fat changes following laparoscopic sleeve gastrectomy
    Yilan Sun, Liang Wang, Guangyi Zhu, Xiyuan Chen, Dongbo Lian, Nengwei Zhang, Guangzhong Xu
    BMC Surgery.2025;[Epub]     CrossRef
  • Visceral Fat Area and Subcutaneous Fat Area Increase in Hyperthyroidism Patients After Treatment—A Single-Group Repeated-Measures Trial
    Mengnan Li, Xifeng Yang, Ru Li, Baofeng Wu, Jinxuan Hao, Yijie Qi, Tao Bai, Luyang Yang, Yi Zhang, Yunfeng Liu
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2165.     CrossRef
  • Subcutaneous Fat Thickness with HDL and LDL Levels in Overweight Female Student
    Amilia Yuni Damayanti, Fatimah Fatimah, Lulu’ Luthfiya, Afina Deni Kusumadiastuti
    Amerta Nutrition.2023; 7(2SP): 13.     CrossRef
  • Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
    Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
    Metabolism.2022; 137: 155327.     CrossRef
  • The associations between lipid profiles and visceral obesity among gastrointestinal cancer patients: a cross-sectional study
    Bo Gao, Xiangrui Li, Wenqing Chen, Shu’an Wang, Jian He, Yu Liu, Chao Ding, Xiaotian Chen
    Lipids in Health and Disease.2022;[Epub]     CrossRef
Close layer
Hypothalamus and Pituitary Gland
Big Data Articles (National Health Insurance Service Database)
Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing’s Disease in Korea
Jin Sun Park, Soo Jin Yun, Jung Kuk Lee, So Young Park, Sang Ouk Chin
Endocrinol Metab. 2021;36(3):688-696.   Published online June 28, 2021
DOI: https://doi.org/10.3803/EnM.2021.1000
  • 8,500 View
  • 194 Download
  • 9 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies. This study was designed to evaluate the epidemiology of prolactinoma and Cushing’s disease and their survival analysis according to treatment.
Methods
The nationwide, population-based study evaluated incidence and prevalence of prolactinoma and Cushing’s disease using de-identified claims data in The Korean Health Insurance Review and Assessment Service database between 2013 and 2017. The survival analysis investigated regarding treatment over a period of 6 years. A log-rank test and Cox proportional hazard regression analysis were used.
Results
The 6,056 patients with newly diagnosed prolactinoma and 584 patients with Cushing’s disease were recorded between 2013 and 2017. The annual incidence of prolactinoma was 23.5 cases per million, and its prevalence was 82.5 cases per million, and 2.3 cases per million/year and 9.8 cases per million for Cushing’s disease. The survival benefit was insignificant in prolactinoma according to treatment, but treatment of Cushing’s disease ameliorated the survival rate significantly.
Conclusion
Overall, the incidence of prolactinoma and Cushing’s disease was similar with those found previously, but the prevalence of two diseases were inconsistent when compared with the early studies. The present study also proposed necessity of treatment in Cushing’s disease for improving the survival rate.

Citations

Citations to this article as recorded by  
  • The 24-Hour Urinary Cortisol/Urinary Creatinine Ratio Helps Differentiate Cushing's Syndrome From Simple Obesity
    Meng Wang, Xueting Sun, Shiwei Li, Xin Li, Jingqiu Cui
    Endocrine Practice.2025; 31(2): 140.     CrossRef
  • 68Ga-DOTATOC PET/CT in the Localization of Pituitary Tumors in Cushing’s Disease
    Kyungwon Kim, Dongwoo Kim, Min-Ho Lee, Yae Won Park, Sung Soo Ahn, Ju Hyung Moon, Eui Hyun Kim, Sun Ho Kim, Cheol Ryong Ku, Eun Jig Lee
    Endocrinology and Metabolism.2025; 40(4): 637.     CrossRef
  • Rising burden of PRL-PitNETs: patterns across tumour sizes and incidentalomas
    Frederik Østergaard Klit, Sara Faartoft Nørgård, Anna-Sofie Dam Berrett, Christian Rosendal, Amar Nikontovic, Peter Vestergaard, Jesper Krogh, Kirstine Stochholm, Jakob Dal
    European Journal of Endocrinology.2025; 193(6): 745.     CrossRef
  • For the Forthcoming Winning Shot in the Battle against Cushing Disease
    Sang Ouk Chin
    Endocrinology and Metabolism.2024; 39(4): 573.     CrossRef
  • Reframing the Paradigm: A Nuanced Approach to Prolactinoma Management
    Jung Hee Kim
    Endocrinology and Metabolism.2024; 39(6): 850.     CrossRef
  • Elucidating Clinical Queries for Tailored Therapy in Patients with Prolactinoma
    Min-Ho Lee, Jae Won Hong, Kyungwon Kim, Cheol Ryong Ku, Eun Jig Lee
    Endocrinology and Metabolism.2024; 39(6): 819.     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Cushing Syndrome
    Martin Reincke, Maria Fleseriu
    JAMA.2023; 330(2): 170.     CrossRef
  • Clinical Biology of the Pituitary Adenoma
    Shlomo Melmed, Ursula B Kaiser, M Beatriz Lopes, Jerome Bertherat, Luis V Syro, Gerald Raverot, Martin Reincke, Gudmundur Johannsson, Albert Beckers, Maria Fleseriu, Andrea Giustina, John A H Wass, Ken K Y Ho
    Endocrine Reviews.2022; 43(6): 1003.     CrossRef
Close layer
Clinical Study
Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea
Ji Hong You, Sang Ah Lee, Sung-Youn Chun, Sun Ok Song, Byung-Wan Lee, Dae Jung Kim, Edward J. Boyko
Endocrinol Metab. 2020;35(4):901-908.   Published online December 10, 2020
DOI: https://doi.org/10.3803/EnM.2020.787
  • 10,388 View
  • 246 Download
  • 22 Web of Science
  • 25 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The aim of this study was to evaluate clinical outcomes in coronavirus disease 2019 (COVID-19) positive patients with type 2 diabetes compared to those without diabetes in Korea.
Methods
We extracted claims data for patients diagnosed with COVID-19 from the National Health Insurance Service database in Korea from January 20, 2020 to March 31, 2020. We followed up this cohort until death from COVID-19 or discharge from hospital.
Results
A total of 5,473 patients diagnosed with COVID-19 were analyzed, including 495 with type 2 diabetes and 4,978 without diabetes. Patients with type 2 diabetes were more likely to be treated in the intensive care unit (ICU) (P<0.0001). The incidence of inhospital mortality was higher in patients with type 2 diabetes (P<0.0001). After adjustment for age, sex, insurance status, and comorbidities, odds of ICU admission (adjusted odds ratio [OR], 1.59; 95% confidence interval [CI], 1.02 to 2.49; P=0.0416) and in-hospital mortality (adjusted OR, 1.90; 95% CI, 1.13 to 3.21; P=0.0161) among patients with COVID-19 infection were significantly higher in those with type 2 diabetes. However, there was no significant difference between patients with and without type 2 diabetes in ventilator, oxygen therapy, antibiotics, antiviral drugs, antipyretics, and the incidence of pneumonia after adjustment.
Conclusion
COVID-19 positive patients with type 2 diabetes had poorer clinical outcomes with higher risk of ICU admission and in-hospital mortality than those without diabetes. Therefore, medical providers need to consider this more serious clinical course when planning and delivering care to type 2 diabetes patients with COVID-19 infection.

Citations

Citations to this article as recorded by  
  • The clinical features and outcomes of diabetes patients infected with COVID-19: a systematic review and meta-analysis comprising 192,693 patients
    Kai Liu, Shu Liu, Ting-ting Xu, Hong Qiao
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Relationship between periodontitis, type 2 diabetes mellitus and COVID-19 disease: a narrative review
    José Luis Muñoz-Carrillo, Paulo Israel Palomeque-Molina, Marcelo Stalin Villacis-Valencia, Oscar Gutiérrez-Coronado, Francisca Chávez-Ruvalcaba, Silverio Jafet Vázquez-Alcaraz, Paola Trinidad Villalobos-Gutiérrez, Josue Palomeque-Molina
    Frontiers in Cellular and Infection Microbiology.2025;[Epub]     CrossRef
  • Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 — a systematic review and meta-analyses
    Babatunde Fatoke, Amrit Lal Hui, Muhammad Saqib, Mrinal Vashisth, Stephen Olaide Aremu, Dorcas Oluwakemi Aremu, Deborah Bukola Aremu
    BMC Infectious Diseases.2025;[Epub]     CrossRef
  • Reasons for Hospitalization Among Australians With Type 1 or Type 2 Diabetes and COVID-19
    Dunya Tomic, Jonathan E. Shaw, Dianna J. Magliano
    Canadian Journal of Diabetes.2024; 48(1): 53.     CrossRef
  • Factors Associated with Length of Hospitalization in Patients with Diabetes and Mild COVID-19: Experiences from a Tertiary University Center in Serbia
    Vojislav M. Ciric, Natasa Krsto Rancic, Milica M. Pesic, Danijela B. Radojkovic, Nikola Milenkovic
    Medicina.2024; 60(5): 788.     CrossRef
  • Predictors of COVID-19 outcome in type 2 diabetes mellitus: a hospital-based study
    Amira M. Elsayed, Mohamad S. Elsayed, Ahmed E. Mansour, Ahmed W. Mahedy, Eman M. Araby, Maha H. Morsy, Rasha O. Abd Elmoniem
    The Egyptian Journal of Internal Medicine.2024;[Epub]     CrossRef
  • Diabetes Mellitus and Pneumococcal Pneumonia
    Catia Cilloniz, Antoni Torres
    Diagnostics.2024; 14(8): 859.     CrossRef
  • Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study
    Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Olena Budarna, Iryna Halabitska, Pavlo Petakh, Oleksandr Kamyshnyi
    Frontiers in Genetics.2024;[Epub]     CrossRef
  • Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
    Jong Han Choi, Kyoung Min Kim, Keeho Song, Gi Hyeon Seo
    Endocrinology and Metabolism.2023; 38(2): 245.     CrossRef
  • The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
    Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, Nataliia Zavidniuk, Aleksandr Kamyshnyi
    Viruses.2023; 15(5): 1072.     CrossRef
  • Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
    Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, Philipp Linnerz, Kalliopi Pafili, Oliver Kuss, Christian Herder, Manuela Neuenschwander, Janett Barbaresko, Michael Roden
    Diabetologia.2023; 66(8): 1395.     CrossRef
  • Diabetes and deaths of COVID-19 patients: Systematic review of meta-analyses
    Aakriti Garg, Mahesh Kumar Posa, Anoop Kumar
    Health Sciences Review.2023; 7: 100099.     CrossRef
  • Cardiometabolic Risk Factors and COVID-19 Outcomes in the Asia-Pacific Region: A Systematic Review, Meta-analysis and Meta-regression of 84,011 Patients
    Ru Ying Fong, Annie Lee, Fei Gao, Jonathan Jiunn Liang Yap, Khung Keong Yeo
    Journal of Asian Pacific Society of Cardiology.2023;[Epub]     CrossRef
  • Pituitary Diseases and COVID-19 Outcomes in South Korea: A Nationwide Cohort Study
    Jeonghoon Ha, Kyoung Min Kim, Dong-Jun Lim, Keeho Song, Gi Hyeon Seo
    Journal of Clinical Medicine.2023; 12(14): 4799.     CrossRef
  • Factors influencing the severity of COVID-19 course for patients with diabetes mellitus in tashkent: a retrospective cohort study
    A. V. Alieva, A. A. Djalilov, F. A. Khaydarova, A. V. Alimov, D. Z. Khalilova, V. A. Talenova, N. U. Alimova, M. D. Aripova, A. S. Sadikova
    Obesity and metabolism.2023; 20(2): 92.     CrossRef
  • Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
    Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Sandor G. Vari, Aleksandr Kamyshnyi
    Viruses.2023; 15(8): 1724.     CrossRef
  • Anti-SARS-CoV-2 antibody levels predict outcome in COVID-19 patients with type 2 diabetes: a prospective cohort study
    Sylvia Mink, Christoph H. Saely, Andreas Leiherer, Matthias Frick, Thomas Plattner, Heinz Drexel, Peter Fraunberger
    Scientific Reports.2023;[Epub]     CrossRef
  • Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
    Waqar Ahmad, Khadija Shabbiri
    The Egyptian Journal of Internal Medicine.2022;[Epub]     CrossRef
  • Baseline haemoglobin A1c and the risk of COVID‐19 hospitalization among patients with diabetes in the INSIGHT Clinical Research Network
    Jea Young Min, Nicholas Williams, Will Simmons, Samprit Banerjee, Fei Wang, Yongkang Zhang, April B. Reese, Alvin I. Mushlin, James H. Flory
    Diabetic Medicine.2022;[Epub]     CrossRef
  • The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course—A Narrative Review
    Evangelia Tzeravini, Eleftherios Stratigakos, Chris Siafarikas, Anastasios Tentolouris, Nikolaos Tentolouris
    Frontiers in Clinical Diabetes and Healthcare.2022;[Epub]     CrossRef
  • Impact of Type 2 Diabetes Mellitus on the Incidence and Outcomes of COVID-19 Needing Hospital Admission According to Sex: Retrospective Cohort Study Using Hospital Discharge Data in Spain, Year 2020
    Jose M. de Miguel-Yanes, Rodrigo Jimenez-Garcia, Javier de Miguel-Diez, Valentin Hernández-Barrera, David Carabantes-Alarcon, Jose J. Zamorano-Leon, Ricardo Omaña-Palanco, Ana Lopez-de-Andres
    Journal of Clinical Medicine.2022; 11(9): 2654.     CrossRef
  • The burden and risks of emerging complications of diabetes mellitus
    Dunya Tomic, Jonathan E. Shaw, Dianna J. Magliano
    Nature Reviews Endocrinology.2022; 18(9): 525.     CrossRef
  • A Comprehensive Analysis of Chinese, Japanese, Korean, US-PIMA Indian, and Trinidadian Screening Scores for Diabetes Risk Assessment and Prediction
    Norma Latif Fitriyani, Muhammad Syafrudin, Siti Maghfirotul Ulyah, Ganjar Alfian, Syifa Latif Qolbiyani, Muhammad Anshari
    Mathematics.2022; 10(21): 4027.     CrossRef
  • New-Onset Diabetes Mellitus Presenting As Diabetic Ketoacidosis in Patients With COVID-19: A Case Series
    Aysha Sarwani, Mahmood Al Saeed, Husain Taha, Rawdha M Al Fardan
    Cureus.2021;[Epub]     CrossRef
  • The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?
    Leszek Czupryniak, Dror Dicker, Roger Lehmann, Martin Prázný, Guntram Schernthaner
    Cardiovascular Diabetology.2021;[Epub]     CrossRef
Close layer
Clinical Study
Trends in the Diagnosis and Treatment of Patients with Medullary Thyroid Carcinoma in Korea
Hwa Young Ahn, Jae Eun Chae, Hyemi Moon, Junghyun Noh, Young Joo Park, Sin Gon Kim
Endocrinol Metab. 2020;35(4):811-819.   Published online November 20, 2020
DOI: https://doi.org/10.3803/EnM.2020.709
  • 11,293 View
  • 218 Download
  • 19 Web of Science
  • 19 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Thyroid cancer is becoming increasingly common worldwide, but little is known about the epidemiology of medullary thyroid carcinoma (MTC). This study investigated the current status of the incidence and treatment of MTC using Korean National Health Insurance Service (NHIS) data for the entire Korean population from 2004 to 2016.
Methods
This study included 1,790 MTC patients identified from the NHIS database.
Results
The age-standardized incidence rate showed a slightly decreasing or stationary trend during the period, from 0.25 per 100,000 persons in 2004 to 0.19 in 2016. The average proportion of MTC among all thyroid cancers was 0.5%. For initial surgical treatment, 65.4% of patients underwent total thyroidectomy. After surgery, external-beam radiation therapy (EBRT) was performed in 10% of patients, a proportion that increased from 6.7% in 2004 to 11.0% in 2016. Reoperations were performed in 2.7% of patients (n=49) at a median of 1.9 years of follow-up (interquartile range, 1.2 to 3.4). Since November 2015, 25 (1.4%) patients with MTC were prescribed vandetanib by December 2016.
Conclusion
The incidence of MTC decreased slightly with time, and the proportion of patients who underwent total thyroidectomy was about 65%. EBRT, reoperation, and tyrosine kinase inhibitor therapy are additional treatments after initial surgery for advanced MTC in Korea.

Citations

Citations to this article as recorded by  
  • Digital Phenotyping of Rare Endocrine Diseases Across International Data Networks and the Effect of Granularity of Original Vocabulary
    Seunghyun Lee, Namki Hong, Gyu Seop Kim, Jing Li, Xiaoyu Lin, Sarah Seager, Sungjae Shin, Kyoung Jin Kim, Jae Hyun Bae, Seng Chan You, Yumie Rhee, Sin Gon Kim
    Yonsei Medical Journal.2025; 66(3): 187.     CrossRef
  • Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
    Mijin Kim, Seung Chan Kim, Jinmi Kim, Bo Hyun Kim
    Diabetes & Metabolism Journal.2025; 49(1): 49.     CrossRef
  • Preoperative controlling nutritional status score for patients with medullary thyroid cancer
    Mijin Kim, Hee Kyung Kim, Chae A. Kim, Meihua Jin, Min Ji Jeon, Ho-Cheol Kang, Dong Jun Lim, Eun Sook Kim, Byeong-Cheol Ahn, Won Gu Kim, Bo Hyun Kim
    Endocrine.2025; 89(2): 476.     CrossRef
  • Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single center
    Bin Liu, Ying Peng, Yanjun Su, Chang Diao, Ruochuan Cheng
    Endocrine.2024; 86(3): 1081.     CrossRef
  • Management of Giant Thyroid Tumors in Patients with Multiple Comorbidities in a Tertiary Head and Neck Surgery Center
    Daniela Vrinceanu, Mihai Dumitru, Andreea Marinescu, Crenguta Serboiu, Gabriela Musat, Mihai Radulescu, Matei Popa-Cherecheanu, Catalina Ciornei, Felicia Manole
    Biomedicines.2024; 12(10): 2204.     CrossRef
  • MicroRNAs in thyroid cancer with focus on medullary thyroid carcinoma: potential therapeutic targets and diagnostic/prognostic markers and web based tools
    ELHAM SHAKIBA, SETI BOROOMAND, SIMA KHERADMAND KIA, MEHDI HEDAYATI
    Oncology Research.2024; 32(6): 1011.     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma
    Chan Kwon Jung, Shipra Agarwal, Jen-Fan Hang, Dong-Jun Lim, Andrey Bychkov, Ozgur Mete
    Endocrine Pathology.2023; 34(1): 1.     CrossRef
  • Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates
    Hye Choi, Kwangsoon Kim
    International Journal of Molecular Sciences.2023; 24(13): 11138.     CrossRef
  • Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective study
    Guiming Fu, Xiaoyi Li, Fengli Guo, Xianhui Ruan, Wei Zhang, Weijing Zhang, Yaping Zhang, Yibo Chen, Chunhua Li, Jin Chen, Xiangqian Zheng, Zhaohui Wang, Ming Gao
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Association of Socioeconomic Status With Long-Term Outcome in Survivors After Out-of-Hospital Cardiac Arrest: Nationwide Population-Based Longitudinal Study
    Kyung Hun Yoo, Yongil Cho, Jaehoon Oh, Juncheol Lee, Byuk Sung Ko, Hyunggoo Kang, Tae Ho Lim, Sang Hwan Lee
    JMIR Public Health and Surveillance.2023; 9: e47156.     CrossRef
  • Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy
    Hyunju Park, Hyun Jin Ryu, Jung Heo, Man Ki Chung, Young Ik Son, Jung-Han Kim, Soo Yeon Hahn, Jung Hee Shin, Young Lyun Oh, Sun Wook Kim, Jae Hoon Chung, Jee Soo Kim, Tae Hyuk Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study
    Xin Wu, Binglu Li, Chaoji Zheng
    Technology in Cancer Research & Treatment.2022;[Epub]     CrossRef
  • Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research
    Dae-Sung Kyoung, Hun-Sung Kim
    Journal of Lipid and Atherosclerosis.2022; 11(2): 103.     CrossRef
  • Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
    Daqi Zhang, Carla Colombo, Hui Sun, Hoon Yub Kim, Antonella Pino, Simone De Leo, Giacomo Gazzano, Luca Persani, Gianlorenzo Dionigi, Laura Fugazzola
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: A propensity-matched survival analysis
    Weili Liang, Jinyuan Shi, Hui Zhang, Guixu Lv, Tiantian Wang, Yong Wang, Bin Lv, Luchuan Li, Qingdong Zeng, Lei Sheng
    Surgery.2022; 172(5): 1385.     CrossRef
  • Constitutive Cytomorphologic Features of Medullary Thyroid Carcinoma Using Different Staining Methods
    Chih-Yi Liu, Chien-Chin Chen, Andrey Bychkov, Shipra Agarwal, Yun Zhu, Jen-Fan Hang, Chiung-Ru Lai, Hee Young Na, So Yeon Park, Weiwei Li, Zhiyan Liu, Deepali Jain, Ayana Suzuki, Mitsuyoshi Hirokawa, Noel Chia, Min En Nga, Tikamporn Jitpasutham, Somboon K
    Diagnostics.2021; 11(8): 1396.     CrossRef
  • Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer
    Jinyoung Kim, Jun Park, Hyunju Park, Min Sun Choi, Hye Won Jang, Tae Hyuk Kim, Sun Wook Kim, Jae Hoon Chung
    Cancers.2021; 13(22): 5842.     CrossRef
  • A High Frequency of Lobectomy Instead of Total Thyroidectomy to Treat Medullary Thyroid Cancer in Korea: Data from the Korean National Health Insurance Service
    Sun Wook Cho
    Endocrinology and Metabolism.2020; 35(4): 784.     CrossRef
Close layer
Clinical Study
The Prevalence and Risk of Type 2 Diabetes in Adults with Disabilities in Korea
Inha Jung, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Eun-Jung Rhee, Won-Young Lee
Endocrinol Metab. 2020;35(3):552-561.   Published online July 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.653
  • 11,648 View
  • 219 Download
  • 18 Web of Science
  • 22 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
People with disabilities are at risk of secondary conditions such as diabetes. The aim of this study was to evaluate the prevalence and risk of type 2 diabetes in South Korea, especially among people with all types of disabilities.
Methods
We conducted a cross-sectional study using data from the Korean National Health Insurance Service, with two disabilityfree controls matched for each participant with disabilities by age and sex. Information regarding the type, severity and grade of disabilities was obtained based on the National Disability Registry. Diagnosis of type 2 diabetes was defined according to the following criteria: presence of International Classification of Diseases, Tenth Revision, Clinical Modification codes E11, E12, E13, or E14 and claims for at least one oral anti-diabetic agent or insulin at baseline, or fasting glucose level ≥126 mg/dL.
Results
We included 1,297,806 participants with disabilities and 2,943,719 control. Out of 4,241,525 participants, 841,990 (19.9%) were diagnosed with diabetes. The prevalence of diabetes was higher in the disability group compared with individuals without disabilities (23.1% vs. 18.4%). The odds of having diabetes was higher in the disability group compared with the control group (adjusted odds ratio, 1.34; 95% confidence interval, 1.33 to 1.34). The results showed higher prevalence of diabetes in the mildly disabled group (23.2%) than in the severely disabled group (22.7%).
Conclusion
The prevalence and risk of diabetes were higher in people with disabilities compared with the general population. Physicians and public health authorities should focus on people with disabilities for proper diabetes management.

Citations

Citations to this article as recorded by  
  • Association of disability with cardiovascular mortality in the community-dwelling Spanish adult population
    Roberto Pastor-Barriuso, Alicia Padrón-Monedero, Fernando J. García López, Javier Almazán-Isla, Jesús de Pedro-Cuesta, Javier Damián
    Revista Española de Cardiología (English Edition).2026; 79(1): 3.     CrossRef
  • Asociación de la discapacidad con la mortalidad cardiovascular en la población adulta española no institucionalizada
    Roberto Pastor-Barriuso, Alicia Padrón-Monedero, Fernando J. García López, Javier Almazán-Isla, Jesús de Pedro-Cuesta, Javier Damián
    Revista Española de Cardiología.2026; 79(1): 3.     CrossRef
  • Intellectual disabilities and risk of cardiovascular diseases: A population-based cohort study
    In Young Cho, Hye Yeon Koo, Yoo Jin Um, Yong-Moon Mark Park, Kyung Mee Kim, Chung Eun Lee, Kyungdo Han
    Disability and Health Journal.2025; 18(2): 101754.     CrossRef
  • Impact of acupuncture on mortality in patients with disabilities and newly diagnosed heart failure: a nationwide cohort study
    Hyungsun Jun, Dasol Park, Jae-Uk Sul, Moon Joo Cheong, Haerim Kim, Inae Youn, Jungtae Leem
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Risk of Diabetes Mellitus in Adults with Intellectual Disabilities: A Nationwide Cohort Study
    Hye Yeon Koo, In Young Cho, Yoo Jin Um, Yong-Moon Mark Park, Kyung Mee Kim, Chung Eun Lee, Kyungdo Han
    Endocrinology and Metabolism.2025; 40(1): 103.     CrossRef
  • The Role of Physical Activity in Determining the Association between Metabolic Syndrome and Type-2 Diabetes in Older People with Disabilities
    Minjeong Kang, Hyunsik Kang
    Journal of The Korean Society of Living Environmental System.2025; 32(2): 135.     CrossRef
  • Cardiometabolic Diseases and Mental Health Disorders in Korean Adults With Disabilities: A 3-Year Retrospective Analysis and Risk Comparison
    Shiva Raj Acharya, NamKwen Kim, Navin Ray, Diwash Timilsina
    American Journal of Preventive Medicine.2025; 69(3): 107938.     CrossRef
  • Short-Term and Long-Term Risk of Diabetes Mellitus among Patients with Spinal Cord Injury: A Nationwide Retrospective Cohort Study
    Seonghye Kim, Kyung-Do Han, Bongseong Kim, Ju-Hong Min, Won Hyuk Chang, In Young Cho, Dong Wook Shin
    Healthcare.2024; 12(18): 1859.     CrossRef
  • Widening disparities in the national prevalence of diabetes mellitus for people with disabilities in South Korea
    I. Hwang, S.Y. Kim, Y.Y. Kim, J.H. Park
    Public Health.2024; 226: 173.     CrossRef
  • Bipolar disorder and the risk of cardiometabolic diseases, heart failure, and all-cause mortality: a population-based matched cohort study in South Korea
    You-Bin Lee, Hyewon Kim, Jungkuk Lee, Dongwoo Kang, Gyuri Kim, Sang-Man Jin, Jae Hyeon Kim, Hong Jin Jeon, Kyu Yeon Hur
    Scientific Reports.2024;[Epub]     CrossRef
  • Psychotic Disorders and the Risk of Type 2 Diabetes Mellitus, Atherosclerotic Cardiovascular Diseases, and All-Cause Mortality: A Population-Based Matched Cohort Study
    You-Bin Lee, Hyewon Kim, Jungkuk Lee, Dongwoo Kang, Gyuri Kim, Sang-Man Jin, Jae Hyeon Kim, Hong Jin Jeon, Kyu Yeon Hur
    Diabetes & Metabolism Journal.2024; 48(1): 122.     CrossRef
  • Pathways linking health literacy to self-care in diabetic patients with physical disabilities: A moderated mediation model
    Hye Jin Nam, Ju Young Yoon, Wen-Jun Tu
    PLOS ONE.2024; 19(3): e0299971.     CrossRef
  • Cross-Sectional Analysis of Difficulties Using Usual Source of Care for People with Disability
    Jane Ko, Jae-Hyun Park
    INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2024;[Epub]     CrossRef
  • The First Use of the Washington Group Short Set in a National Survey of Japan: Characteristics of the New Disability Measure in Comparison to an Existing Disability Measure
    Takashi Saito, Kumiko Imahashi, Chikako Yamaki
    International Journal of Environmental Research and Public Health.2024; 21(12): 1643.     CrossRef
  • Dysphagia Requiring Medical Attention in Parkinson’s Disease: A Korean Population-Based Study
    Seungwoo Cha, Won Kee Chang, Hee-Mun Cho, Kyungdo Han, Nam-Jong Paik, Sohyun Kwon, Won-Seok Kim
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Disparities in diabetes-related avoidable hospitalization among diabetes patients with disability using a nationwide cohort study
    Hin Moi Youn, Dong-Woo Choi, Sung-In Jang, Eun-Cheol Park
    Scientific Reports.2022;[Epub]     CrossRef
  • Disability type–specific mortality patterns and life expectancy among disabled people in South Korea using 10-year combined data between 2008 and 2017
    Jinwook Bahk, Hee-Yeon Kang, Young-Ho Khang
    Preventive Medicine Reports.2022; 29: 101958.     CrossRef
  • Cholecystectomy reduces the risk of myocardial and cerebral infarction in patients with gallstone-related infection
    Seon Mee Park, Hyun Jung Kim, Tae Uk Kang, Heather Swan, Hyeong Sik Ahn
    Scientific Reports.2022;[Epub]     CrossRef
  • Nationwide trends in the incidence of tuberculosis among people with disabilities in Korea: a nationwide serial cross-sectional study
    Jinsoo Min, So Young Kim, Jong Eun Park, Yeon Yong Kim, Jong Hyock Park
    Epidemiology and Health.2022; 44: e2022098.     CrossRef
  • Prevalence of Type 2 Diabetes among Persons with Disabilities in the South-East Asian Region
    Rajeswaran Thiagesan, Vijayaprasad Gopichandran, Sudharshini Subramaniam, Hilaria Soundari, Kalpana Kosalram
    Current Medical Issues.2022; 20(3): 161.     CrossRef
  • Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus
    Mee Kyoung Kim, Kyungdo Han, Eun Sil Koh, Oak-Kee Hong, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
    Diabetes Research and Clinical Practice.2021; 175: 108799.     CrossRef
  • Diabetes in People with Disabilities: a Call for Action
    Inha Jung, Eun-Jung Rhee, Won-Young Lee
    Cardiovascular Prevention and Pharmacotherapy.2021; 3(4): 82.     CrossRef
Close layer
Clinical Study
Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity
Seung Jin Han, Wilfred Y. Fujimoto, Steven E. Kahn, Donna L. Leonetti, Edward J. Boyko
Endocrinol Metab. 2020;35(2):351-358.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.351
  • 10,818 View
  • 146 Download
  • 11 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
High plasma apolipoprotein B (apoB) levels have been shown to be associated with hypertension, central obesity, and insulin resistance in cross-sectional research. However, it is unclear whether apoB levels predict future hypertension independent of body composition and insulin sensitivity. Therefore, we prospectively investigated whether plasma apoB concentrations independently predicted the risk of hypertension in a cohort of Japanese Americans.
Methods
A total of 233 normotensive Japanese Americans (77 men, 156 women; mean age, 46.4±11.0 years) were followed over 10 years to monitor them for the development of hypertension. Fasting plasma concentrations of apoB, glucose, and insulin were measured at baseline. Insulin sensitivity was estimated using the homeostasis model assessment of insulin resistance (HOMA-IR). The abdominal visceral and subcutaneous fat areas were measured at baseline using computed tomography. Logistic regression analysis was used to estimate the association between apoB concentrations and the odds of incident hypertension.
Results
The 10-year cumulative incidence of hypertension was 21.5%. The baseline apoB level was found to be positively associated with the odds of incident hypertension over 10 years after adjustment for age, sex, body mass index, systolic blood pressure, abdominal visceral fat area, abdominal subcutaneous fat area, total plasma cholesterol concentration, diabetes status, and HOMA-IR at baseline (odds ratio and 95% confidence interval for a 1-standard deviation increase, 1.89 [1.06 to 3.37]; P=0.030).
Conclusion
Higher apoB concentrations predicted greater risks of future hypertension independent of abdominal visceral fat area and insulin sensitivity in Japanese Americans.

Citations

Citations to this article as recorded by  
  • Effect of age and systemic inflammation on the association between severity of periodontitis and blood pressure in periodontitis patients
    Hongjia Yang, Yixuan Qin, Jiaqi Geng, Jinyue Qu, Qian Cheng, Kuibao Li, Dongxue Zhang
    BMC Oral Health.2025;[Epub]     CrossRef
  • Clinical Research Progress of Apolipoprotein B/Apolipoprotein A1
    小红 李
    Advances in Clinical Medicine.2025; 15(03): 253.     CrossRef
  • The monomer of resveratrol butyrate ester ameliorates obesity and gut microbiota in high-fat diet rats
    Yu-Wei Chen, Rou-Yun Liu, Ming-Kuei Shih, Wen-Wei Lin, Chiu-Min Cheng, Chang-Wei Hsieh, Chih-Yao Hou, Shin-Yu Chen
    Journal of Functional Foods.2024; 118: 106260.     CrossRef
  • Manipulation of Serum Protein Adsorption by Nanoengineered Biomaterials Influences Subsequent Immune Responses
    Richard Bright, Rahul M. Visalakshan, Johanna Simon, Anne Mari Rokstad, Arthur Ghazaryan, Svenja Morsbach, Andrew Hayles, Volker Mailänder, Katharina Landfester, Krasimir Vasilev
    ACS Biomaterials Science & Engineering.2024; 10(10): 6230.     CrossRef
  • Correlation between Central Obesity and Liver Function in Young Adults—A Cross-Sectional Study
    John Alvin, Damodara Gowda KM
    Journal of Health and Allied Sciences NU.2023; 13(02): 273.     CrossRef
  • Serum amyloid A in children and adolescents: association with overweight and carotid intima-media thickness
    Maria Vitória Mareschi Barbosa, João Carlos Pina Faria, Stephanie Ramos Coelho, Fernando Luiz Affonso Fonseca, Andrea Paula Kafejian Haddad, Fabíola Isabel Suano de Souza, Roseli Oselka Saccardo Sarni
    einstein (São Paulo).2023;[Epub]     CrossRef
  • The association of the apolipoprotein B/A1 ratio and the metabolic syndrome in children and adolescents: a systematic review and meta-analysis
    Kayhan Dinpanah, Toba Kazemi, Sameep Shetty, Saeede Khosravi Bizhaem, Ali Fanoodi, Seyed Mohammad Riahi
    Journal of Diabetes & Metabolic Disorders.2023; 23(1): 1.     CrossRef
  • Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome
    Lăcramioara Ionela Butnariu, Eusebiu Vlad Gorduza, Elena Țarcă, Monica-Cristina Pânzaru, Setalia Popa, Simona Stoleriu, Vasile Valeriu Lupu, Ancuta Lupu, Elena Cojocaru, Laura Mihaela Trandafir, Ștefana Maria Moisă, Andreea Florea, Laura Stătescu, Minerva
    Diagnostics.2023; 13(14): 2348.     CrossRef
  • Sex-Based Differences and Risk Factors for Comorbid Nonalcoholic Fatty Liver Disease in Patients with Bipolar Disorder: A Cross-Sectional Retrospective Study
    Ying Wang, Yiyi Liu, Xun Zhang, Qing Wu
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 3533.     CrossRef
  • Apolipoprotein B Displays Superior Predictive Value Than Other Lipids for Long-Term Prognosis in Coronary Atherosclerosis Patients and Particular Subpopulations: A Retrospective Study
    Chunyan Zhang, Jingwei Ni, Zhenyue Chen
    Clinical Therapeutics.2022; 44(8): 1071.     CrossRef
  • Genetics of Cholesterol-Related Genes in Metabolic Syndrome: A Review of Current Evidence
    Sok Kuan Wong, Fitri Fareez Ramli, Adli Ali, Nurul ‘Izzah Ibrahim
    Biomedicines.2022; 10(12): 3239.     CrossRef
Close layer
Review Article
Hypothalamus and Pituitary gland
Epidemiology of Functioning Pituitary Adenomas
Sang Ouk Chin
Endocrinol Metab. 2020;35(2):237-242.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.237
  • 14,988 View
  • 350 Download
  • 20 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   ePub   
Pituitary adenomas (PAs) are defined as benign monoclonal tumors in the pituitary gland that cause symptoms due to either hormonal hypersecretion or a space-occupying effect, and are classified as functioning or non-functioning. Because of their rarity and slow-growing with symptomless nature in most cases, it has been challenging to investigate the epidemiology of PAs. Considering their public health impact and association with increased morbidity and mortality, however, it is essential to understand the prevalence and incidence of PAs in order to improve patient outcomes and to minimize the resultant burden on the health care system. Fortunately, developments in imaging modalities and easier access to large-scale population data have enabled investigators to analyze the epidemiology of PAs more accurately. This review summarizes previously reported epidemiologic data on functioning PAs in Korea and other countries.

Citations

Citations to this article as recorded by  
  • The Diagnostic Value of Conventional MRI Combined With Diffusion‐Weighted Imaging in Microprolactinomas
    Min‐Yang Wang, Ying Yu, Yu Han, Yang Yang, Wan Jiang, Jin Liu, Lin‐Feng Yan, Guang‐Bin Cui
    Journal of Magnetic Resonance Imaging.2025; 61(3): 1155.     CrossRef
  • Non-recurrent mutations and copy number changes predominate pituitary adenoma genomes
    Dipika R Mohan, Ticiana Paes, Jacobo Buelvas Mebarak, David M Meredith, Beatriz Soares, Victor Vaz, Rona S Carroll, Ursula B Kaiser, Timothy R Smith, Wenya L Bi, Antonio M Lerario, Ana Paula Abreu
    European Journal of Endocrinology.2025; 192(5): 590.     CrossRef
  • Spherical type of amyloidogenic pituitary prolactinoma in a 50 year old male
    Madhala Divya, Balasubramanian Archana, Lawrence D Cruze, D. Balasubramanian
    Interdisciplinary Neurosurgery.2024; 36: 101957.     CrossRef
  • Clinical aspects of the plurihormonal pituitary adenoma formation
    I. A. Khripun, S. V. Vorobyev, N. A. Kuzmenko, E. S. Engibaryan, V. O. Perevalova
    South Russian Journal of Therapeutic Practice.2024; 5(2): 98.     CrossRef
  • Anaesthesia for pituitary surgery
    K. Raveendran, S. Kwok, L. Glancz
    BJA Education.2024; 24(12): 433.     CrossRef
  • Manifestations of Endocrine Disease in the Lower Extremities: Beyond the Diabetic Foot
    Kleoniki I. Athanasiadou, Christothea A. Tsiridis, Ioanna A. Paschou, Stavroula A. Paschou, Nikolaos Papanas
    The International Journal of Lower Extremity Wounds.2024;[Epub]     CrossRef
  • Predicting Tumor Type and Residual Status of Suprasellar Lesions Using Indian Discharge Summaries
    Priyanka C. Nair, Deepa Gupta, Bhagavatula Indira Devi, Vani Kanjirangat, P. Deepak
    IEEE Access.2024; 12: 134379.     CrossRef
  • Spontaneous Cerebrospinal Fluid Rhinorrhea in Pre-operative Pituitary Adenoma: A Report of Two Cases
    Jessica E Eisold, Dace Dimante, Jonathan Pollock, Alireza Shoakazemi, Nemanja Stojanovic
    Cureus.2024;[Epub]     CrossRef
  • Surgical effect of the medial wall resection of the cavernous sinus for functional pituitary adenomas
    Xiao Liang, Zhuoqun Li, Mengyang Xing, Wenbo Gao, Pengfei Liu
    Frontiers in Surgery.2024;[Epub]     CrossRef
  • Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
    Rihards Saksis, Olesja Rogoza, Helvijs Niedra, Kaspars Megnis, Ilona Mandrika, Inga Balcere, Liva Steina, Janis Stukens, Austra Breiksa, Jurijs Nazarovs, Jelizaveta Sokolovska, Ilze Konrade, Raitis Peculis, Vita Rovite
    Cancer Cell International.2023;[Epub]     CrossRef
  • Prognostic Models in Growth-Hormone- and Prolactin-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review
    Roxana-Ioana Dumitriu-Stan, Iulia-Florentina Burcea, Teodor Salmen, Catalina Poiana
    Diagnostics.2023; 13(12): 2118.     CrossRef
  • Salivary microbiome profiles for different clinical phenotypes of pituitary adenomas by single-molecular long-read sequencing
    Xuefei Ji, Pingping Li, Qinglong Guo, Liao Guan, Peng Gao, Bingshan Wu, Hongwei Cheng, Jin Xiao, Lei Ye, Justin R. Kaspar
    Microbiology Spectrum.2023;[Epub]     CrossRef
  • Endoscopic endonasal surgical management of giant pituitary adenomas with extension into ventricle system
    Mykola O. Guk, Oleksii V. Ukrainets
    Ukrainian Neurosurgical Journal.2023; 29(4): 13.     CrossRef
  • Uso de resonancia magnética nuclear intraoperatoria en la resección transesfenoidal de adenomas hipofisiarios: ¿qué resultados se han obtenido?
    María Laura Boschetti Saer, Levino Roberto Boschetti, Jose Pastor Linarez Veloz, Michael Ortega-Sierra
    Archivos de Neurociencias.2023;[Epub]     CrossRef
  • Single Cell Metabolic Landscape of Pituitary Neuroendocrine Tumor Subgroups and Lineages
    Sai Batchu, Michael Joseph Diaz, Keldon Lin, Namrata Arya, Karan Patel, Brandon Lucke-Wold
    OBM Neurobiology.2023; 07(01): 1.     CrossRef
  • Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification
    Luz E. Castellanos, Catherine Gutierrez, Timothy Smith, Edward R. Laws, J. Bryan Iorgulescu
    Pituitary.2022; 25(1): 201.     CrossRef
  • The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages
    Keiko Taniguchi-Ponciano, Lesly A. Portocarrero-Ortiz, Gerardo Guinto, Sergio Moreno-Jimenez, Erick Gomez-Apo, Laura Chavez-Macias, Eduardo Peña-Martínez, Gloria Silva-Román, Sandra Vela-Patiño, Jesús Ordoñez-García, Sergio Andonegui-Elguera, Aldo Ferreir
    BMC Medical Genomics.2022;[Epub]     CrossRef
  • IL-10 Gene Rs1800871, Rs1800872, and Rs1800896 Polymorphisms and IL-10 Serum Levels Association with Pituitary Adenoma
    Migle Palivonaite, Greta Gedvilaite, Brigita Glebauskiene, Loresa Kriauciuniene, Vita Rovite, Rasa Liutkeviciene
    Biomedicines.2022; 10(8): 1921.     CrossRef
  • Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients’ plasma
    Helvijs Niedra, Raitis Peculis, Helena Daiga Litvina, Kaspars Megnis, Ilona Mandrika, Inga Balcere, Mihails Romanovs, Liva Steina, Janis Stukens, Austra Breiksa, Jurijs Nazarovs, Jelizaveta Sokolovska, Rasa Liutkeviciene, Alvita Vilkevicute, Ilze Konrade,
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Identification of mutant K-RAS in pituitary macroadenoma
    Veronica Aran, Manoela Heringer, Paulo Jose da Mata, Leandro Kasuki, Renan Lyra Miranda, Felipe Andreiuolo, Leila Chimelli, Paulo Niemeyer Filho, Monica Roberto Gadelha, Vivaldo Moura Neto
    Pituitary.2021; 24(5): 746.     CrossRef
  • Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas
    Ji Yong Park, Wonsuk Choi, A Ram Hong, Jee Hee Yoon, Hee Kyung Kim, Woo-Youl Jang, Shin Jung, Ho-Cheol Kang
    Pituitary.2021; 24(6): 955.     CrossRef
Close layer
Original Articles
Clinical Study
Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
Jung Hee Kim, Hyemi Moon, Junghyun Noh, Juneyoung Lee, Sin Gon Kim
Endocrinol Metab. 2020;35(1):157-164.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.157
  • 12,298 View
  • 225 Download
  • 37 Web of Science
  • 34 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Pheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors originating from chromaffin cells. PPGLs are associated with a high mortality rate and several complications. To date, no epidemiological studies have been conducted on PPGLs in Asia. This study aimed to investigate the epidemiology and prognosis of PPGLs in Korea using nationwide data.

Methods

Using the National Health Insurance Service Database, subjects with a principal diagnosis of PPGLs on two or more occasions between 2003 and 2014 who satisfied the operational definition of PPGLs were included. Incidence, prevalence, complications, metastasis, and mortality were investigated.

Results

In total, 1048 subjects with a mean age of 47.6±16.1 years were included. There was no sex preponderance. The overall prevalence of PPGLs was 2.13 per 100,000 persons, and the overall age-standardized incidence rate was 0.18 per 100,000 person-years. Malignant PPGLs accounted for 17.7% (185 of 1,048) of cases, and 94 subjects exhibited metastasis at the time of diagnosis. Among initially non-metastatic PPGLs, 9.5% (nine of 954) eventually metastasized after a mean duration of 78.1±41.4 months. The 5-year survival rates for non-metastatic and metastatic PPGLs at diagnosis were 97% and 84%, respectively. Multivariable Cox regression models adjusted for covariates showed that metastatic PPGLs were associated with a 2.40-fold higher risk of mortality than non-metastatic PPGLs (95% confidence interval, 1.38 to 4.17; P=0.002).

Conclusion

PPGLs are rare in Korea, and the prognosis of these endocrine tumors varies depending on whether they are benign or malignant. This epidemiological study paves the way for further research on PPGLs.

Citations

Citations to this article as recorded by  
  • Digital Phenotyping of Rare Endocrine Diseases Across International Data Networks and the Effect of Granularity of Original Vocabulary
    Seunghyun Lee, Namki Hong, Gyu Seop Kim, Jing Li, Xiaoyu Lin, Sarah Seager, Sungjae Shin, Kyoung Jin Kim, Jae Hyun Bae, Seng Chan You, Yumie Rhee, Sin Gon Kim
    Yonsei Medical Journal.2025; 66(3): 187.     CrossRef
  • Prediction of postoperative myocardial injury in patients undergoing laparoscopic pheochromocytoma/paraganglioma resection: protocol for an ambispective cohort study
    Ling Lan, Ye Ma, Yifei Zhao, Yaohan Li, Yi Zhang, Le Shen, Yuelun Zhang, Yuguang Huang
    BMJ Open.2025; 15(2): e091975.     CrossRef
  • Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study
    Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim
    Endocrinology and Metabolism.2025; 40(1): 82.     CrossRef
  • Differences in Clinical Presentation Between Pheochromocytomas and Paragangliomas
    Vincent E. D. Pihlblad, Jan Calissendorff, Henrik Falhammar
    Clinical Endocrinology.2025; 103(5): 651.     CrossRef
  • The effect of primary tumor resection on overall survival in metastatic pheochromocytoma and paraganglioma: A population-based study
    Hexiang Bai, Zhihong Liu, Xu Liu, Yige Jia, Yuchun Zhu, Xiang Li, Kan Wu
    Surgery.2025; 187: 109637.     CrossRef
  • Pheochromocytoma-Induced Leukocytosis With Concurrent Severe Eosinophilia: A Case Report
    Nouf Alnaqeeb, Mohamed M Abd Elhamid, Ihab AImagdub, Randa Ali
    Cureus.2025;[Epub]     CrossRef
  • Analysis of the clinical characteristics of bone metastases after pheochromocytoma/paraganglioma surgery
    Longmin Li, Hongbo Gao, Yujun Shao, Xiayang Zhu
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study
    Seung Shin Park, Chang Ho Ahn, Seunghoo Lee, Woochang Lee, Won Woong Kim, Yu‐Mi Lee, Su Jin Kim, Tae‐Yon Sung, Kyu Eun Lee, Jung Hee Kim, Seung Hun Lee, Jung‐Min Koh
    Journal of Internal Medicine.2024; 296(1): 68.     CrossRef
  • Seventy years of pheochromocytomas and paragangliomas in Argentina. The FRENAR database
    V.C. de Miguel, L.S. Aparicio, G. Sansó, A.L. Paissan, S.N. Lupi, S.H. Belli, J. Tkatch, M.J. Marín, M.B. Barontini
    Hipertensión y Riesgo Vascular.2024; 41(3): 170.     CrossRef
  • Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients
    Wolfgang Raber, Raphael Schendl, Melisa Arikan, Andreas Scheuba, Peter Mazal, Valerie Stadlmann, Reinhard Lehner, Petra Zeitlhofer, Sabina Baumgartner-Parzer, Cornelia Gabler, Harald Esterbauer
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician
    Sona Sharma, Lauren Fishbein
    Endocrine Practice.2023; 29(12): 999.     CrossRef
  • Pheochromocytoma: a changing perspective and current concepts
    Andreas Kiriakopoulos, Periklis Giannakis, Evangelos Menenakos
    Therapeutic Advances in Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
    Gildas Gabiache, Charline Zadro, Laura Rozenblum, Delphine Vezzosi, Céline Mouly, Matthieu Thoulouzan, Rosine Guimbaud, Philippe Otal, Lawrence Dierickx, Hervé Rousseau, Christopher Trepanier, Laurent Dercle, Fatima-Zohra Mokrane
    Cancers.2023; 15(18): 4666.     CrossRef
  • Trends in the incidence of adrenocortical carcinoma and pheochromocytoma/paraganglioma in Taiwan
    Chung-Hsin Tsai, Tun-Sung Huang, Shih-Ping Cheng
    Formosan Journal of Surgery.2023; 56(5): 147.     CrossRef
  • An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma
    Anri Inaki, Tohru Shiga, Yoshito Tsushima, Megumi Jinguji, Hiroshi Wakabayashi, Daiki Kayano, Norihito Akatani, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Tomo Hiromasa, Hiroshi Mori, Kenji Hirata, Shiro Watanabe, Tetsuya Higuchi, Hiroyasu Tomonaga, S
    Annals of Nuclear Medicine.2022; 36(3): 267.     CrossRef
  • Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance
    Jan Calissendorff, Carl Christofer Juhlin, Irina Bancos, Henrik Falhammar
    Cancers.2022; 14(4): 917.     CrossRef
  • Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients
    Jung Hee Kim, Hyung-Chul Lee, Su-jin Kim, Kyu Eun Lee, Kyeong Cheon Jung
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Change of Computed Tomography-Based Body Composition after Adrenalectomy in Patients with Pheochromocytoma
    Yousun Ko, Heeryoel Jeong, Seungwoo Khang, Jeongjin Lee, Kyung Won Kim, Beom-Jun Kim
    Cancers.2022; 14(8): 1967.     CrossRef
  • Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years
    Abdul Rahman Al Subhi, Veronica Boyle, Marianne S Elston
    Journal of the Endocrine Society.2022;[Epub]     CrossRef
  • Incidence and risk factors for myocardial injury after laparoscopic adrenalectomy for pheochromocytoma: A retrospective cohort study
    Ling Lan, Qian Shu, Chunhua Yu, Lijian Pei, Yuelun Zhang, Li Xu, Yuguang Huang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • The Clinical Characteristics of Pheochromocytomas and Paragangliomas with Negative Catecholamines
    Lin Zhao, Xiaoran Zhang, Xu Meng, Ting Zhang, Hua Fan, Qiongyu Zhang, Yecheng Liu, Xianliang Zhou, Huadong Zhu
    Journal of Clinical Medicine.2022; 11(19): 5583.     CrossRef
  • A midline ectopic paraganglioma
    Christina SANT FOURNIER, Matthias FARRUGIA, Kimberley PACE, Christian CAMENZULI, Alexander R. ATTARD
    Chirurgia.2022;[Epub]     CrossRef
  • Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Ana
    Yang Yang, Jie Zhang, Liqun Fang, Xue Jia, Wensheng Zhang
    Drug Design, Development and Therapy.2022; Volume 16: 3599.     CrossRef
  • Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study
    Andreas Ebbehoj, Kirstine Stochholm, Sarah Forslund Jacobsen, Christian Trolle, Peter Jepsen, Maciej Grzegorz Robaczyk, Åse Krogh Rasmussen, Ulla Feldt-Rasmussen, Reimar Wernich Thomsen, Esben Søndergaard, Per Løgstrup Poulsen
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(5): e2251.     CrossRef
  • Determinants of anxiety and depression among pheochromocytoma patients
    Siming Jia, Chengbai Li, Zhuqing Lei, Qiang Xia, Yuqing Jiang
    Medicine.2021; 100(3): e24335.     CrossRef
  • Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases
    Akiyuki Kawashima, Masakatsu Sone, Nobuya Inagaki, Kentaro Okamoto, Mika Tsuiki, Shoichiro Izawa, Michio Otsuki, Shintaro Okamura, Takamasa Ichijo, Takuyuki Katabami, Yoshiyu Takeda, Takanobu Yoshimoto, Mitsuhide Naruse, Akiyo Tanabe
    Endocrine.2021; 74(1): 155.     CrossRef
  • Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
    Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan
    Endocrinology and Metabolism.2021; 36(2): 322.     CrossRef
  • Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A 4-Decade Experience
    Thomas Uslar, Ignacio F San Francisco, Roberto Olmos, Stefano Macchiavelo, Alvaro Zuñiga, Pablo Rojas, Marcelo Garrido, Alvaro Huete, Gonzalo P Mendez, Ignacio Cortinez, José Tomás Zemelman, Joaquín Cifuentes, Fernando Castro, Daniela Olivari, José Miguel
    Journal of the Endocrine Society.2021;[Epub]     CrossRef
  • Pheochromocytoma
    Zhonghua Liu, Junsheng Ma, Camilo Jimenez, Miao Zhang
    American Journal of Surgical Pathology.2021; 45(9): 1155.     CrossRef
  • Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients
    Jung Hee Kim, Hyung-Chul Lee, Su-jin Kim, Soo Bin Yoon, Sung Hye Kong, Hyeong Won Yu, Young Jun Chai, June Young Choi, Kyu Eun Lee, Kwang-Woong Lee, Seung-Kee Min, Chan Soo Shin, Kyu Joo Park
    Scientific Reports.2021;[Epub]     CrossRef
  • Changes in the Nociception Level Index During Surgical Resection of Paragangliomas: A Case Report
    Rita Saynhalath, Umar H. Khan, Gijo Alex, Joseph T. Murphy, Peter Szmuk
    A&A Practice.2021; 15(11): e01542.     CrossRef
  • Hypertension Cure and Reducing Pill Burden after Adrenalectomy for Endocrine Hypertension of Adrenal Origin: A Comparative Study from an Asian and UK Cohort
    Kee Y Ngiam, Ciaran Durand, Titus C Vasciuc, Chia H Tai, Raluca Orpean, Fiona Eatock, Mehak Mahipal, Tan W Boon
    World Journal of Endocrine Surgery.2021; 13(1): 9.     CrossRef
  • A Brief Overview of the Epidemiology of Pheochromocytoma and Paraganglioma in Korea
    Yun Mi Choi
    Endocrinology and Metabolism.2020; 35(1): 95.     CrossRef
Close layer
Clinical Study
Association between Serum Gamma-Glutamyltransferase and Prevalence of Metabolic Syndrome Using Data from the Korean Genome and Epidemiology Study
Mi Young Lee, Dae Sung Hyon, Ji Hye Huh, Hae Kyung Kim, Sul Ki Han, Jang Young Kim, Sang Baek Koh
Endocrinol Metab. 2019;34(4):390-397.   Published online December 23, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.4.390
  • 10,251 View
  • 137 Download
  • 17 Web of Science
  • 17 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The aim of this study was to determine whether there is a positive correlation between gamma-glutamyltransferase (GGT) levels and the prevalence of metabolic syndrome and whether GGT can be used as an easily checkable metabolic index using data from the large-scale Korean Genome and Epidemiology Study (KoGES).

Methods

We obtained data of 211,725 participants of the KoGES. The collected data included age, sex, height, weight, waist circumference, and various biochemical characteristics, including serum GGT levels. The data of study participants who ingested more than 40 g/day of alcohol and who were diagnosed with metabolic syndrome at baseline was excluded. We analyzed the prevalence of metabolic syndrome according to GGT quartiles in both genders.

Results

The GGT level was significantly higher in subjects with metabolic syndrome compared to normal subjects (37.92±48.20 mg/dL vs. 25.62±33.56 mg/dL). The prevalence of metabolic syndrome showed a stepwise increase with GGT quartiles in both male and female subjects. Compared to the lowest GGT quartile, the odds ratio was 1.534 (95% confidence interval [CI], 1.432 to 1.643), 1.939 (95% CI, 1.811 to 2.076), and 2.754 (95% CI, 2.572 to 2.948) in men and 1.155 (95% CI, 1.094 to 1.218), 1.528 (95% CI, 1.451 to 1.609), and 2.022 (95% CI, 1.921 to 2.218) in women with increasing GGT quartile. The cutoff value of GGT predicting risk of metabolic syndrome was 27 IU/L in men and 17 IU/L in women.

Conclusion

We suggested that GGT could be an easily checkable marker for the prediction of metabolic syndrome.

Citations

Citations to this article as recorded by  
  • Serum γ-glutamyl transferase as a novel risk indicator for lung cancer: insights from four million Koreans
    Chiwook Chung, Kyu Na Lee, Dong Wook Shin, Sei Won Lee, Kyungdo Han
    Respiratory Research.2025;[Epub]     CrossRef
  • Inflammatory markers CRP and WBC as predictors of liver function impairment in multiple injury trauma patients: a repeated measures analysis
    Gang Wang, Cui Tang, Rui Wang, Chundao Xu, Tugang Shen, Gaokai Li
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Associating Liver Enzymes and Their Interactions with Metabolic Syndrome Prevalence in a Japanese Working Population
    Aziz Jamal, Akira Babazono, Ning Liu, Rieko Yamao, Takako Fujita, Sung-a Kim, Yunfei Li
    Metabolic Syndrome and Related Disorders.2024; 22(1): 27.     CrossRef
  • Association between gamma glutamyl transpeptidase to HDL-Cholesterol (GGT/HDL-C) ratio and metabolic syndrome resolution after sleeve gastrectomy
    Melanni L. Lizarbe-Lezama, Jhoel E. Rodriguez-Macedo, Daniel Fernandez-Guzman, Ana L. Alcantara-Diaz, Gustavo Salinas-Sedo, Carlos J. Toro-Huamanchumo
    Diabetes and Vascular Disease Research.2024;[Epub]     CrossRef
  • Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice
    Rosanna Villani, Grazia Pia Magnati, Giulia Tuccari, Moris Sangineto, Antonino Davide Romano, Tommaso Cassano, Gaetano Serviddio
    Ultrasound.2023; 31(3): 177.     CrossRef
  • Serum γ-glutamyltransferase level and incidence risk of metabolic syndrome in community dwelling adults: longitudinal findings over 12 years
    Jiwon Kwak, In-Ho Seo, Yong-Jae Lee
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Gamma-Glutamyl Transferase as a Diagnostic Marker of Metabolic Syndrome
    Bobbili Tarun Kesava Naidu, Kakarlapudi Santosh Raju, Janapareddi V BhaskaraRao, Nallapati Sunil Kumar
    Cureus.2023;[Epub]     CrossRef
  • Metabolic syndrome and transaminases: systematic review and meta-analysis
    Elena Raya-Cano, Rafael Molina-Luque, Manuel Vaquero-Abellán, Guillermo Molina-Recio, Rocío Jiménez-Mérida, Manuel Romero-Saldaña
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Association between Serum Gamma-glutamyl Transferase and Metabolic Syndrome: A Case–control Study
    Akshay Shelar, Nalini Humaney, Akshay Chhajed, Krunal Domki, Ajay Narwade
    Journal of Datta Meghe Institute of Medical Sciences University.2023; 18(4): 651.     CrossRef
  • “Big Data” Approaches for Prevention of the Metabolic Syndrome
    Xinping Jiang, Zhang Yang, Shuai Wang, Shuanglin Deng
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Can Gamma-glutamyl Transferase Predict Unhealthy Metabolic Phenotypes Among Healthcare Workers in Azar Cohort Study?
    Mohammadhossein Somi, Seyed Sina Zakavi, Alireza Ostadrahimi, Negin Frounchi, Neda Gilani, Sarvin Sanaie, Elnaz Faramarzi
    Hepatitis Monthly.2022;[Epub]     CrossRef
  • Association between liver enzymes and metabolic syndrome in Canadian adults: results from the Canadian health measures survey - cycles 3 &4
    Luan Manh Chu, Chandima Karunanayake, Palok Aich, Markus Hecker, Punam Pahwa
    Journal of Diabetes & Metabolic Disorders.2022; 21(2): 1699.     CrossRef
  • Repeatedly elevated γ-glutamyltransferase levels are associated with an increased incidence of digestive cancers: A population-based cohort study
    Chang-Hoon Lee, Kyungdo Han, Da Hye Kim, Min-Sun Kwak
    World Journal of Gastroenterology.2021; 27(2): 176.     CrossRef
  • Index of Cardiac Age Index and Cardiometabolic Biomarkers in Adults with Metabolic Syndrome
    Eun Jung Choi, Sang Yeoup Lee
    Metabolic Syndrome and Related Disorders.2021; 19(5): 288.     CrossRef
  • Simple metabolic markers associated with tophaceous gout
    Wei Liu, Hui Song, Siliang Man, Hongchao Li, Siming Gao
    Clinical Rheumatology.2021; 40(12): 5047.     CrossRef
  • Expression Status and Prognostic Significance of Gamma-Glutamyl Transpeptidase Family Genes in Hepatocellular Carcinoma
    Shan Tian, Jiao Li, Yingyun Guo, Weiguo Dong, Xin Zheng
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
    Sang Youn You, Kyungdo Han, Seung-Hawn Lee, Mee Kyoung Kim
    Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
Close layer
Clinical Study
Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data
Ji Hong You, Sun Ok Song, Se Hee Park, Kyoung Hye Park, Joo Young Nam, Dong Wook Kim, Hyun Min Kim, Dong-Jun Kim, Yong-ho Lee, Byung-Wan Lee
Endocrinol Metab. 2019;34(3):275-281.   Published online September 26, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.3.275
  • 10,758 View
  • 118 Download
  • 11 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Hyperglycemic crisis is a metabolic emergency associated with diabetes mellitus. However, accurate epidemiologic information on cases of hyperglycemic crisis in Korea remains scarce. We evaluated trends in hyperglycemic crisis hospitalizations and in- and out-of-hospital mortality in Korea. We also predicted future trends.

Methods

We extracted claims data with hyperglycemic crisis as the principal diagnosis from the National Health Insurance Service database in Korea from January 2004 to December 2013. We investigated the numbers of claims with hyperglycemic crisis and identified trends in hyperglycemic crisis based on those claims data. We predicted future trends by statistical estimation.

Results

The total annual number of claims of hyperglycemic crisis increased from 2,674 in 2004 to 5,540 in 2013. Statistical analysis revealed an increasing trend in hyperglycemic crisis hospitalizations (P for trend <0.01). In contrast, the hospitalization rate per 1,000 diabetes cases showed a decreasing trend (P for trend <0.01) during this period. The mortality rate per 1,000 diabetes cases also showed a decreasing trend (P for trend <0.0001). However, no distinct linear trend in the case-related fatality rate at <60 days over the last decade was observed. The predicted number of annual claims of hyperglycemic crisis will increase by 2030.

Conclusion

The number of hyperglycemic crisis hospitalizations in Korea increased in the last decade, although the hospitalization rate per 1,000 diabetes cases and mortality rate decreased. Also, the predicted number of annual claims will increase in the future. Thus, it is necessary to establish long-term healthcare policies to prevent hyperglycemic crisis.

Citations

Citations to this article as recorded by  
  • Trends in admissions for hyperglycaemic emergencies and associated clinical factors in adults with type 2 diabetes in Singapore, 2013–2022
    Gerald Gui Ren Sng, Gek Hsiang Lim, Kristy Jia Yi Tian, Yong Mong Bee, Ming Ming Teh
    Diabetic Medicine.2025;[Epub]     CrossRef
  • Enhancing outcome prediction by applying the 2019 WHO DM classification to adults with hyperglycemic crises: A single-center cohort in Thailand
    Chatchon Kaewkrasaesin, Weerapat Kositanurit, Phawinpon Chotwanvirat, Nitchakarn Laichuthai
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(4): 103012.     CrossRef
  • Prevalence of hyperglycaemic crisis among diabetes mellitus patients in Ethiopia, systematic review and meta-analysis
    A Getie, T Ayenew, G Yilak, M Gedfew, BT Amlak, A Wondmieneh, M Bimerew
    Journal of Endocrinology, Metabolism and Diabetes of South Africa.2024; 29(2): 61.     CrossRef
  • Obesity and 30-day case fatality after hyperglycemic crisis hospitalizations in Korea: a national cohort study
    Hojun Yoon, Hyun Ho Choi, Giwoong Choi, Sun Ok Song, Kyoung Hwa Ha, Dae Jung Kim
    Cardiovascular Prevention and Pharmacotherapy.2023; 5(3): 74.     CrossRef
  • Interpreting global trends in type 2 diabetes complications and mortality
    Mohammed K. Ali, Jonathan Pearson-Stuttard, Elizabeth Selvin, Edward W. Gregg
    Diabetologia.2022; 65(1): 3.     CrossRef
  • Comparison of the clinical characteristics and outcomes of pediatric patients with and without diabetic ketoacidosis at the time of type 1 diabetes diagnosis
    Young-Jun Seo, Chang Dae Kum, Jung Gi Rho, Young Suk Shim, Hae Sang Lee, Jin Soon Hwang
    Annals of Pediatric Endocrinology & Metabolism.2022; 27(2): 126.     CrossRef
  • Clinical characteristics and outcomes of care in patients hospitalized with diabetic ketoacidosis
    Mohsen S. Eledrisi, Haifaa Alkabbani, Malk Aboawon, Aya Ali, Imad Alabdulrazzak, Maab Elhaj, Ashraf Ahmed, Hazim Alqahwachi, Joanne Daghfal, Salem A. Beshyah, Rayaz A. Malik
    Diabetes Research and Clinical Practice.2022; 192: 110041.     CrossRef
  • Hyperglycemic Crisis Characteristics and Outcome of Care in Adult Patients without and with a History of Diabetes in Tigrai, Ethiopia: Comparative Study
    Getachew Gebremedhin, Fikre Enqueselassie, Helen Yifter, Negussie Deyessa
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 547.     CrossRef
  • Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea
    Min Jeong Han, Jun Ho Heo
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 783.     CrossRef
  • Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports
    Na-young Kim, Eunyeong Ha, Jun Sung Moon, Yong-Hoon Lee, Eun Young Choi
    Diabetes & Metabolism Journal.2020; 44(2): 349.     CrossRef
  • Letter: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
    Jang Won Son
    Endocrinology and Metabolism.2019; 34(4): 422.     CrossRef
  • Response: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
    Ji Hong You, Sun Ok Song
    Endocrinology and Metabolism.2019; 34(4): 424.     CrossRef
Close layer
Review Articles
Obesity and Metabolism
Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
Eun-Jung Rhee
Endocrinol Metab. 2019;34(3):226-233.   Published online September 26, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.3.226
  • 16,153 View
  • 366 Download
  • 82 Web of Science
  • 86 Crossref
AbstractAbstract PDFPubReader   ePub   

Nonalcoholic fatty liver disease (NAFLD) is thought to stem from the body's inability to store excess energy in adipocytes; as such, it is commonly viewed as the hepatic manifestation of metabolic syndrome. The pathogenesis of NAFLD involves ectopic fat accumulation, which also takes place in the liver, muscle and visceral fat. NAFLD is rapidly becoming more widespread in Korea, with an estimated prevalence of 30% in adults. Type 2 diabetes mellitus (T2DM) and NAFLD share insulin resistance as a common pathophysiological mechanism, and each of these two diseases affects the development of the other. Recent studies have suggested that NAFLD is often present as a comorbidity in T2DM patients. The mutual interrelationship between these conditions is shown by findings suggesting that T2DM can exacerbate NAFLD by promoting progression to nonalcoholic hepatosteatosis or fibrosis, while NAFLD causes the natural course of diabetic complications to worsen in T2DM patients. It remains unknown whether one disease is the cause of the other or vice versa. In this review, I would like to discuss current epidemiological data on the associations between NAFLD and T2DM, and how each disease affects the course of the other.

Citations

Citations to this article as recorded by  
  • Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 Diabetes
    Farooq Khan, Stafny Dsouza, Amar Hassan Khamis, Fatima Abdul, Muhammad Hamed Farooqi, Fatima Sulaiman, Fahad Mulla, Fatheya Al Awadi, Mohammed Hassanein, Riad Bayoumi
    Journal of General Internal Medicine.2025; 40(10): 2309.     CrossRef
  • Association between diabetes prevalence and weekend warrior activity patterns
    Zihao Chen, Junqiang Jia, Jiayuan Tu, Yuehui Zhao, Xiaoming Li
    Public Health.2025; 240: 97.     CrossRef
  • Antiobesity medications in adult and pediatric obesity and metabolic dysfunction–associated steatotic liver disease
    Natalie Rodriguez, Phillipp Hartmann
    Pharmacological Reviews.2025; 77(4): 100058.     CrossRef
  • Navigating New Frontiers: Approaches to Diabetes Care Through Perimenopause and Menopause
    Brian Burroughs, Angie Clinton, Laura Knudsen
    ADCES in Practice.2025;[Epub]     CrossRef
  • Association between perceived stress and MAFLD partially mediated by smoking and drinking
    Yan Gong, Shengshu Wang, Jianan Jiang, Qiang Zeng, Weimin Wang, Yansong Zheng, Wenping Lv
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • The relationship between tobacco and non-alcoholic fatty liver disease incidence: a systematic review and meta-analysis of observational studies
    Jianxiang Jin, Yuping Zhang, Yiping Huang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Sugar-sweetened beverage consumption predicts metabolic associated fatty liver disease in patients with type 2 diabetes mellitus
    Zhenjun Yu, Mengdie Chen, Shicheng Gu, Chaohui Wang, Ping Feng, Gang Lin
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Quantitative evaluation of myocardial work in patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver by noninvasive pressure-strain loop
    Min Tian, Xuanning Hou, Zihan Wang, Xiuxiu Cui, Meng Jing, Xingxiang Ren, Weiwei Ping, Kefeng LI, Xiaoyan Wang
    BMC Cardiovascular Disorders.2025;[Epub]     CrossRef
  • Recent advances and potentiality of postbiotics in the food industry: Composition, inactivation methods, current applications in metabolic syndrome, and future trends
    Yujie Zhong, Tao Wang, Ruilin Luo, Jiayu Liu, Ruyi Jin, Xiaoli Peng
    Critical Reviews in Food Science and Nutrition.2024; 64(17): 5768.     CrossRef
  • Effect of exercise intervention on clinical parameters in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Yu Zeng, Xuemei Zhang, Wenling Luo, Yunjian Sheng
    European Journal of Gastroenterology & Hepatology.2024; 36(1): 1.     CrossRef
  • Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction–associated steatohepatitis
    Sven M. Francque, Alexander Hodge, Jerome Boursier, Ziad H. Younes, Gerardo Rodriguez-Araujo, Grace S. Park, Naim Alkhouri, Manal F. Abdelmalek
    Hepatology Communications.2024;[Epub]     CrossRef
  • Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients
    Young-Hwan Park, Minji Sohn, So Yeon Lee, Soo Lim
    Diabetes & Metabolism Journal.2024; 48(2): 253.     CrossRef
  • Research Progress of Traditional Chinese Medicine and Western Medicine on Non-Alcoholic Fatty Liver Disease
    强江 郭
    Advances in Clinical Medicine.2024; 14(03): 561.     CrossRef
  • Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe
    Maria Eleni Chondrogianni, Ioannis Kyrou, Theodoros Androutsakos, Christina-Maria Flessa, Evangelos Menenakos, Kamaljit Kaur Chatha, Yekaterina Aranan, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Obeticholic Acid and Insulin Sensitivity in Overweight Patients with Prediabetes
    H. Amer, M. Nesim, H. Mansour, E. Nasr, N. Ahmed
    Obesity and metabolism.2024; 21(2): 161.     CrossRef
  • Multiple Definitions of Fatty Liver Disease: Which One Most Accurately Predicts Diabetes?
    Eun-Jung Rhee
    Endocrinology and Metabolism.2024; 39(2): 397.     CrossRef
  • The Efficacy of Empagliflozin in Combination with Pioglitazone on the Improvement of Fatty Liver Disease in Patients with Type 2 Diabetes
    Morteza Aghajanpoor, Mehrzad Gholampourdehaki, Reza Mosaed, Iraj Mirzaii-Dizgah, Afsaneh Vosughi
    Annals of Military and Health Sciences Research.2024;[Epub]     CrossRef
  • Higher habitual intakes of flavonoids and flavonoid-rich foods are associated with a lower incidence of type 2 diabetes in the UK Biobank cohort
    Alysha S. Thompson, Amy Jennings, Nicola P. Bondonno, Anna Tresserra-Rimbau, Benjamin H. Parmenter, Claire Hill, Aurora Perez-Cornago, Tilman Kühn, Aedín Cassidy
    Nutrition & Diabetes.2024;[Epub]     CrossRef
  • Associations of sex-related and thyroid-related hormones with risk of metabolic dysfunction-associated fatty liver disease in T2DM patients
    Weihong Lu, Shangjian Li, Yuhua Li, Jingqi Zhou, Kai Wang, Ning Chen, Zhibin Li
    BMC Endocrine Disorders.2024;[Epub]     CrossRef
  • Diagnostic role of SPP1 and collagen IV in a rat model of type 2 diabetes mellitus with MASLD
    Shan Xiao, Xiao Bei Wang, Ye Yang, Qin Wang
    Scientific Reports.2024;[Epub]     CrossRef
  • Impact of dietary fiber intake on non-alcoholic fatty liver disease risk in Korean patients with obesity and type 2 diabetes mellitus
    Ji-Sook Park, Hina Akbar, Young-Seol Kim, Jung-Eun Yim
    Journal of Nutrition and Health.2024; 57(3): 282.     CrossRef
  • Clinical cohort of nonalcoholic fatty liver disease in a primary care setting
    Julia R. Gips, Lisa Yanek, Jiajun Wu, James P. Hamilton, Tinsay A. Woreta, Jeanne M. Clark
    Journal of Family Medicine and Primary Care.2024; 13(8): 2958.     CrossRef
  • Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review
    Sultan Alfawaz, Abdulhadi Burzangi , Ahmed Esmat
    Cureus.2024;[Epub]     CrossRef
  • Povara bolii ficatului steatozic
    Felicia Darii, Olga Tagadiuc
    Akademos.2024; (2(73)): 91.     CrossRef
  • Honey preparation in complex therapy of metabolically associated fatty liver disease
    V. P. Gomonova, A. Yu. Baranovsky, I. S. Sakeian
    Experimental and Clinical Gastroenterology.2024; (10): 195.     CrossRef
  • Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People
    Naoya Otsubo, Tatsuya Fukuda, Genhin Cho, Fumiaki Ishibashi, Tetsuya Yamada, Koshiro Monzen
    Internal Medicine.2023; 62(16): 2307.     CrossRef
  • Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease: A systematic review and meta-analysis of 16 RCTs
    Yan Zhao, Wenli Zhao, Huaien Bu, Maeda Toshiyoshi, Ye Zhao
    Medicine.2023; 102(6): e32892.     CrossRef
  • Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
    Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
    Diabetes & Metabolism Journal.2023; 47(2): 220.     CrossRef
  • Metabolomics analysis reveals serum biomarkers in patients with diabetic sarcopenia
    Yuwei Tan, Xiaosong Liu, Yinping Yang, Baoying Li, Fei Yu, Wenqian Zhao, Chunli Fu, Xin Yu, Zhenxia Han, Mei Cheng
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Antagonizing apolipoprotein J chaperone promotes proteasomal degradation of mTOR and relieves hepatic lipid deposition
    Shuangdi Duan, Nong Qin, Jiayi Pi, Pei Sun, Yating Gao, Lamei Liu, Zenghui Li, Ya Li, Liyang Shi, Qiang Gao, Ye Qiu, Songqing Tang, Chun-Hsiang Wang, Tzu-Ying Chen, Sin-Tian Wang, Kung-Chia Young, Hung-Yu Sun
    Hepatology.2023; 78(4): 1182.     CrossRef
  • The Influence of Metabolic Factors in Patients with Chronic Viral Hepatitis C Who Received Oral Antiviral Treatment
    Oana Irina Gavril, Radu Sebastian Gavril, Florin Mitu, Otilia Gavrilescu, Iolanda Valentina Popa, Diana Tatarciuc, Andrei Drugescu, Andrei Catalin Oprescu, Andreea Gherasim, Laura Mihalache, Irina Mihaela Esanu
    Metabolites.2023; 13(4): 571.     CrossRef
  • The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study
    Minzhen Wang, Yanan Zhao, Yingqian He, Lulu Zhang, Jing Liu, Shan Zheng, Yana Bai
    Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(8): 1521.     CrossRef
  • Visceral fat: A key mediator of NAFLD development and progression
    Savita Bansal, Meenakshi Vachher, Taruna Arora, Bhupender Kumar, Archana Burman
    Human Nutrition & Metabolism.2023; 33: 200210.     CrossRef
  • Greater Severity of Steatosis Is Associated with a Higher Risk of Incident Diabetes: A Retrospective Longitudinal Study
    Ji Min Han, Jung Hwan Cho, Hye In Kim, Sunghwan Suh, Yu-Ji Lee, Jung Won Lee, Kwang Min Kim, Ji Cheol Bae
    Endocrinology and Metabolism.2023; 38(4): 418.     CrossRef
  • The role of TRIM family in metabolic associated fatty liver disease
    Jingyue Zhang, Yingming Zhang, Ze Ren, Dongmei Yan, Guiying Li
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Non-alcoholic fatty liver disease and diabetic retinopathy: Is there an association?
    Mathew Jacob, Mary Joseph, Jyothi Idiculla
    Journal of Family Medicine and Primary Care.2023; 12(9): 2028.     CrossRef
  • Camel whey protein improves diabetic liver injury by targeting ACMSD and promoting de novo NAD+ synthesis
    Zhihua Dou, Huaibin Yao, Yutong Xie, Ying Liu, Yang Gao, Jie Yang
    Journal of Functional Foods.2023; 110: 105835.     CrossRef
  • Gut microbiota and nonalcoholic fatty liver disease
    Boyeon Kim, Bukyung Kim
    Kosin Medical Journal.2023; 38(3): 169.     CrossRef
  • Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
    E.G. Mankieva, E.I. Kukhareva
    Russian Journal of Evidence-Based Gastroenterology.2023; 12(4): 103.     CrossRef
  • Body Fat Distribution, Glucose Metabolism, and Diabetes Status Among Older Adults: The Multiethnic Cohort Adiposity Phenotype Study
    Gertraud Maskarinec, Phyllis Raquinio, Bruce S. Kristal, Adrian A. Franke, Steven D. Buchthal, Thomas M. Ernst, Kristine R. Monroe, John A. Shepherd, Yurii B. Shvetsov, Loïc Le Marchand, Unhee Lim
    Journal of Epidemiology.2022; 32(7): 314.     CrossRef
  • Evaluation of the reciprocal interaction between hepatic steatosis and type 2 diabetes: a comparative analysis with respect to anti-diabetic treatment, glycemic control, renal and hepatic function
    Teslime Ayaz, Hatice Beyazal Polat, Bilgesah Kilictas
    International Journal of Diabetes in Developing Countries.2022; 42(3): 421.     CrossRef
  • Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease
    Diego García-Compeán, Emanuela Orsi, Tsutomu Nishida, Ramesh Kumar
    Annals of Hepatology.2022; 27(1): 100648.     CrossRef
  • Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999–2016
    Pegah Golabi, James M. Paik, Michael Harring, Elena Younossi, Khaled Kabbara, Zobair M. Younossi
    Clinical Gastroenterology and Hepatology.2022; 20(12): 2838.     CrossRef
  • The Influence of Obesity and Metabolic Health on Vascular Health
    Eun-Jung Rhee
    Endocrinology and Metabolism.2022; 37(1): 1.     CrossRef
  • Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials
    Xiaojuan Peng, Juan Li, Hailiang Zhao, Junlong Lai, Junqin Lin, Shaohui Tang
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018
    Ji Cheol Bae, Lauren A. Beste, Kristina M. Utzschneider
    Endocrinology and Metabolism.2022; 37(3): 455.     CrossRef
  • Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
    Eun-Jung Rhee
    Endocrinology and Metabolism.2022; 37(3): 415.     CrossRef
  • Structurally‐engineered fatty acid 1024 (SEFA‐1024) improves diet‐induced obesity, insulin resistance, and fatty liver disease
    Jordon D. Secor, Bennet S. Cho, Lumeng J. Yu, Amy Pan, Victoria H. Ko, Duy T. Dao, Michael Feigh, Lorenzo Anez‐Bustillos, Gillian L. Fell, David A. Fraser, Kathleen M. Gura, Mark Puder
    Lipids.2022; 57(4-5): 241.     CrossRef
  • Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study
    Ángel Arturo López-González, Bárbara Altisench Jané, Luis Masmiquel Comas, Sebastiana Arroyo Bote, Hilda María González San Miguel, José Ignacio Ramírez Manent
    Nutrients.2022; 14(14): 2795.     CrossRef
  • Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33
    Tina Ghaffari, Nariman Moradi, Elham Chamani, Zahra Ebadi, Reza Fadaei, Shahin Alizadeh-Fanalou, Sahar Yarahmadi, Soudabeh Fallah
    Current Pharmaceutical Design.2022; 28(16): 1367.     CrossRef
  • Elevated serum γ-glutamyl transferase is associated with low muscle function in adults independent of muscle mass
    Seunghyun Lee, Dawon Song, Sungjae Shin, Namki Hong, Yumie Rhee
    Nutrition.2022; 103-104: 111813.     CrossRef
  • Cross-sectional association between prolactin levels and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a retrospective analysis of patients from a single hospital in China
    Yuanyuan Zhang, Huaizhen Liu
    BMJ Open.2022; 12(10): e062252.     CrossRef
  • Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?
    Q Binet, A Loumaye, V Preumont, J-P Thissen, M.P. Hermans, N Lanthier
    Acta Gastro Enterologica Belgica.2022; 85(2): 346.     CrossRef
  • Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats
    Yujie Zhong, Zhiman Li, Ruyi Jin, Yanpeng Yao, Silan He, Min Lei, Xin Wang, Chao Shi, Li Gao, Xiaoli Peng
    Nutrients.2022; 14(23): 4994.     CrossRef
  • Correlation between Component Factors of Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Nurses: An Observational and Cross-Sectional Study
    Wen-Pei Chang, Yu-Pei Chang
    International Journal of Environmental Research and Public Health.2022; 19(23): 16294.     CrossRef
  • Holistic analysis of hepatosteatosis literature: a scientometric study of global hepatosteatosis publications between 1980 and 2019
    Fatih ESKİN, Engin ŞENEL
    Journal of Medicine and Palliative Care.2022; 3(4): 300.     CrossRef
  • Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
    Pengyu Yao, Yajuan Liu
    Molecules.2022; 28(1): 272.     CrossRef
  • Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study
    Zahra Heidari, Zahra Sharafi
    Iranian South Medical Journal.2022; 25(1): 30.     CrossRef
  • Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
    Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen
    Nutrients.2022; 14(21): 4556.     CrossRef
  • MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy
    Ying-Xin Xian, Jian-Ping Weng, Fen Xu
    Chinese Medical Journal.2021; 134(1): 8.     CrossRef
  • Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study
    Matthias Claus, Christoph Antoni, Bernd Hofmann
    BMC Gastroenterology.2021;[Epub]     CrossRef
  • Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model
    P. Comeglio, E. Sarchielli, S. Filippi, I. Cellai, G. Guarnieri, A. Morelli, G. Rastrelli, E. Maseroli, S. Cipriani, T. Mello, A. Galli, B. J. Bruno, K. Kim, K. Vangara, K. Papangkorn, N. Chidambaram, M. V. Patel, M. Maggi, L. Vignozzi
    Journal of Endocrinological Investigation.2021; 44(10): 2175.     CrossRef
  • Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis
    Chien-Yu Lin, Pratik Adhikary, Kun Cheng
    Advanced Drug Delivery Reviews.2021; 174: 127.     CrossRef
  • Trend for Clinical Use of Metabolic Associated Fatty Liver Disease (MAFLD)
    Hiroshi Bando
    Asploro Journal of Biomedical and Clinical Case Reports.2021; 4(2): 99.     CrossRef
  • Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems
    Ye-Na Kweon, Hae-Jin Ko, A-Sol Kim, Hye-In Choi, Ji-Eun Song, Ji-Yeon Park, Sung-Min Kim, Hee-Eun Hong, Kyung-Jin Min
    Healthcare.2021; 9(7): 899.     CrossRef
  • Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice
    Yongxiang Yu, Dongru Chen, Yuhua Zhao, Jianjun Zhu, Xiaohui Dong
    International Journal of Immunopathology and Pharmacology.2021;[Epub]     CrossRef
  • Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
    Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles
    Cureus.2021;[Epub]     CrossRef
  • Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
    Sang Youn You, Kyungdo Han, Seung-Hawn Lee, Mee Kyoung Kim
    Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
  • Serum syndecan‐4 is associated with nonalcoholic fatty liver disease
    Shu Jing Xia, Li Zhong Tang, Wen Hua Li, Zhao Shan Xu, Li Li Zhang, Feng Gan Cheng, Hong Xia Chen, Zi Hua Wang, Yu Cheng Luo, An Na Dai, Jian Gao Fan
    Journal of Digestive Diseases.2021; 22(9): 536.     CrossRef
  • Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
    Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang
    Endocrinology and Metabolism.2021; 36(4): 823.     CrossRef
  • Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice
    Tehila Daniel, Michaella Ben-Shachar, Elyashiv Drori, Sharleen Hamad, Anna Permyakova, Elad Ben-Cnaan, Joseph Tam, Zohar Kerem, Tovit Rosenzweig
    The Journal of Nutritional Biochemistry.2021; 98: 108867.     CrossRef
  • The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
    Sylwia Ziolkowska, Agata Binienda, Maciej Jabłkowski, Janusz Szemraj, Piotr Czarny
    International Journal of Molecular Sciences.2021; 22(20): 11128.     CrossRef
  • The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
    Hyun Min Kim, Yong-ho Lee
    Endocrinology and Metabolism.2021; 36(6): 1232.     CrossRef
  • Tip 2 Diyabet Modeli Ratların Karaciğer Dokularında Kodlanan Genlerin İfade Düzeyleri
    Lütfiye ÖZPAK, Ayfer PAZARBAŞI
    Ankara Sağlık Bilimleri Dergisi.2021; 10(1): 25.     CrossRef
  • Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
    Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G. Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément
    Nature Reviews Gastroenterology & Hepatology.2020; 17(5): 279.     CrossRef
  • Non-alcoholic fatty liver disease and primary care physicians
    Ludovico Abenavoli, Anna C. Procopio, Milica Medić-Stojanoska, Francesco Luzza
    Minerva Gastroenterologica e Dietologica.2020;[Epub]     CrossRef
  • The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
    Hideki Fujii, Norifumi Kawada
    International Journal of Molecular Sciences.2020; 21(11): 3863.     CrossRef
  • Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway
    Yuanyuan Liu, Mengjie Wang, Wei Xu, Hongman Zhang, Weihe Qian, Xiang Li, Xingbo Cheng
    Life Sciences.2020; 241: 117086.     CrossRef
  • Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease
    Inha Jung, Hyemi Kwon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
    Atherosclerosis.2020; 308: 1.     CrossRef
  • The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Xueyang Zhang, Ran Bai, Yong Jia, Junwei Zong, Yongbo Wang, Yanan Dong
    International Journal of Diabetes in Developing Countries.2020; 40(4): 491.     CrossRef
  • Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients
    Bin Huang, Shengju Yang, Shandong Ye
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • The Absence of NLRP3-inflammasome Modulates Hepatic Fibrosis Progression, Lipid Metabolism, and Inflammation in KO NLRP3 Mice during Aging
    Paloma Gallego, Beatriz Castejón-Vega, José A. del Campo, Mario D. Cordero
    Cells.2020; 9(10): 2148.     CrossRef
  • Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
    Cassyano J. Correr, Wendel Coura-Vital, Josélia C. Q. P. Frade, Renata C. R. M. Nascimento, Lúbia G. Nascimento, Eliete B. Pinheiro, Wesley M. Ferreira, Janice S. Reis, Karla F. S. Melo, Roberto Pontarolo, Mônica S. A. Lenzi, José V. Almeida, Hermelinda C
    Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
  • Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
    Kyung-Soo Kim, Byung-Wan Lee
    Clinical and Molecular Hepatology.2020; 26(4): 430.     CrossRef
  • Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case–Control Study


    Chenyi Wang, Qianglong Niu, Haihong Lv, Qian Li, Yuping Ma, Jiaojiao Tan, Chunhua Liu
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4369.     CrossRef
  • Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice
    Ayala Wollman, Tehila Daniel, Tovit Rosenzweig
    Nutrients.2019; 11(12): 3044.     CrossRef
Close layer
Miscellaneous
Evidence of the Possible Harm of Endocrine-Disrupting Chemicals in Humans: Ongoing Debates and Key Issues
Duk-Hee Lee
Endocrinol Metab. 2018;33(1):44-52.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.44
  • 16,219 View
  • 182 Download
  • 49 Web of Science
  • 54 Crossref
AbstractAbstract PDFPubReader   ePub   

Evidence has emerged that endocrine-disrupting chemicals (EDCs) can produce adverse effects, even at low doses that are assumed safe. However, systemic reviews and meta-analyses focusing on human studies, especially of EDCs with short half-lives, have demonstrated inconsistent results. Epidemiological studies have insuperable methodological limitations, including the unpredictable net effects of mixtures, non-monotonic dose-response relationships, the non-existence of unexposed groups, and the low reliability of exposure assessment. Thus, despite increases in EDC-linked diseases, traditional epidemiological studies based on individual measurements of EDCs in bio-specimens may fail to provide consistent results. The exposome has been suggested as a promising approach to address the uncertainties surrounding human studies, but it is never free from these methodological issues. Although exposure to EDCs during critical developmental periods is a major concern, continuous exposure to EDCs during non-critical periods is also harmful. Indeed, the evolutionary aspects of epigenetic programming triggered by EDCs during development should be considered because it is a key mechanism for developmental plasticity. Presently, living without EDCs is impossible due to their omnipresence. Importantly, there are lifestyles which can increase the excretion of EDCs or mitigate their harmful effects through the activation of mitohormesis or xenohormesis. Effectiveness of lifestyle interventions should be evaluated as practical ways against EDCs in the real world.

Citations

Citations to this article as recorded by  
  • Consequences and Functional Alterations of Endocrine Disruptors on Women's Health
    Diksha Mishra, Rohit Singh, Nandakumar U.P., Rajesh Pradhan, Sharad Chand
    Current Women s Health Reviews.2026;[Epub]     CrossRef
  • Cadmium exposure and thyroid hormone disruption: a systematic review and meta-analysis
    Seung Min Chung, Min Cheol Chang
    Reviews on Environmental Health.2025; 40(1): 37.     CrossRef
  • Microplastics pollution in Australia: Sources, impacts, and mitigation strategies
    Rumana Hossain, Anirban Ghose, Veena Sahajwalla
    Case Studies in Chemical and Environmental Engineering.2025; 11: 101036.     CrossRef
  • A review on optimizing photocatalytic performance for effective removal of emerging pollutants: Approaches and applications
    R. Kamalesh, A. Saravanan, Y.P. Ragini, A.S. Vickram
    Journal of Water Process Engineering.2025; 69: 106883.     CrossRef
  • Are (bio)electrochemical techniques sustainable solutions to combat micro- and nano-plastic pollution?
    Almeenu Rasheed, Yasser Bashir, Sovik Das
    Current Opinion in Chemical Engineering.2025; 47: 101091.     CrossRef
  • Premature thelarche and pesticide exposure: A case-control study in an intensive agricultural area
    Lucia Coppola, Enrica Fabbrizi, Giovanni Angelozzi, Chiara Laura Battistelli, Alice Catena, Lorella Ciferri, Annamaria Iannetta, Sabrina Tait, Monia Perugini, Cinzia La Rocca
    International Journal of Hygiene and Environmental Health.2025; 264: 114524.     CrossRef
  • Prenatal exposure to Bisphenol-A as a risk factor for infant neurodevelopment
    Ivan Hazel Bello-Cortes, Jose Antonio García-García, Manuel Gutiérrez-Aguilar, Daniela Araiza-Olivera, Celia Sánchez-Pérez, Gabriela García-Cerón, Sofia Morán-Ramos, Hugo Tovar, Andrea Bonilla-Brunner, Roeb García-Arrazola
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Joint and interactive effects of metal mixtures on liver damage: Epidemiological evidence from repeated-measures study
    Guohuan Yin, Shuanzheng Zhao, Meiduo Zhao, Jing Xu, Xiaoyu Ge, Jingtao Wu, Yifan Zhou, Xiaolin Liu, Lanping Wei, Qun Xu
    Ecotoxicology and Environmental Safety.2024; 274: 116178.     CrossRef
  • Thyroid under siege: Unravelling the toxic impact of real-life metal mixture exposures in Wistar rats
    Đurđica Marić, Katarina Baralić, Dragana Vukelić, Ivan Milošević, Anja Nikolić, Biljana Antonijević, Danijela Đukić-Ćosić, Zorica Bulat, Michael Aschner, Aleksandra Buha Djordjevic
    Chemosphere.2024; 360: 142441.     CrossRef
  • Mitigation Strategies of Emerging Pollutants from Cosmetic Industry Effluent: A Review
    Bishal Das, Sayanee Sarkar, Sourav Paul, Ayesha Zafar, Deepika Biswas, Jigisha Roy Panda, Tamalika Chakraborty
    European Journal of Theoretical and Applied Sciences.2024; 2(3): 886.     CrossRef
  • Endocrine-Disrupting Compounds in Urban Soils of Malaysia: Occurrence, Contamination, and Impacts on Health and the Environment
    Michael Lie, Joseph Kasongo, Elias Mtui, Rubiyatno, Jovale Vincent Tongco
    Tropical Aquatic and Soil Pollution.2024;[Epub]     CrossRef
  • Reconsidering “low‐dose”—Impacts of oral estrogen exposure during preimplantation embryo development
    Meret Schmidhauser, Anna‐Katharina Hankele, Susanne E. Ulbrich
    Molecular Reproduction and Development.2023; 90(7): 445.     CrossRef
  • Simultaneous estimation of methyl paraben, propyl paraben, and Bisphenol A in the plasma of Indian pregnant women using liquid chromatography–tandem mass spectrometry
    Rajesh Pradhan, Diksha Mishra, Sunil Kumar Dubey, Rajesh Khadgawat, Garima Kachhawa, Tarang Gupta, Rajeev Taliyan
    SEPARATION SCIENCE PLUS.2023;[Epub]     CrossRef
  • Influences of key factors on river water quality in urban and rural areas: A review
    Nguyen Tuan Anh, Le Duy Can, Nguyen Thi Nhan, Britta Schmalz, Tran Le Luu
    Case Studies in Chemical and Environmental Engineering.2023; 8: 100424.     CrossRef
  • Human health risk assessment for consumption of microplastics and plasticizing substances through marine species
    Virginia Montero, Yarenis Chinchilla, Luis Gómez, Adrián Flores, Alejandro Medaglia, Rossy Guillén, Ernesto Montero
    Environmental Research.2023; 237: 116843.     CrossRef
  • Effects of postnatal exposure to phthalate, bisphenol a, triclosan, parabens, and per- and poly-fluoroalkyl substances on maternal postpartum depression and infant neurodevelopment: a korean mother-infant pair cohort study
    Ju Hee Kim, Nalae Moon, Eunsun Ji, Hyo-Bang Moon
    Environmental Science and Pollution Research.2023; 30(42): 96384.     CrossRef
  • Systematic review of prenatal exposure to endocrine disrupting chemicals and autism spectrum disorder in offspring
    Salvador Marí-Bauset, Isabel Peraita-Costa, Carolina Donat-Vargas, Agustín Llopis-González, Amelia Marí-Sanchis, Juan Llopis-Morales, María Morales Suárez-Varela
    Autism.2022; 26(1): 6.     CrossRef
  • Elucidation of xenoestrogen metabolism by non-targeted, stable isotope-assisted mass spectrometry in breast cancer cells
    Mira Flasch, Christoph Bueschl, Giorgia Del Favero, Gerhard Adam, Rainer Schuhmacher, Doris Marko, Benedikt Warth
    Environment International.2022; 158: 106940.     CrossRef
  • Fetoplacental vasculature as a model to study human cardiovascular endocrine disruption
    Margarida Lorigo, Elisa Cairrao
    Molecular Aspects of Medicine.2022; 87: 101054.     CrossRef
  • UV-B Filter Octylmethoxycinnamate Is a Modulator of the Serotonin and Histamine Receptors in Human Umbilical Arteries
    Margarida Lorigo, Carla Quintaneiro, Luiza Breitenfeld, Elisa Cairrao
    Biomedicines.2022; 10(5): 1054.     CrossRef
  • Microbiota analysis for risk assessment: evaluation of hazardous dietary substances and its potential role on the gut microbiome variability and dysbiosis
    Klara Cerk, Margarita Aguilera‐Gómez
    EFSA Journal.2022;[Epub]     CrossRef
  • Human adrenocortical carcinoma cell line (NCI-H295R): An in vitro screening model for the assessment of endocrine disruptors’ actions on steroidogenesis with an emphasis on cell ultrastructural features
    Hana Duranova, Veronika Fialkova, Veronika Valkova, Jana Bilcikova, Lucia Olexikova, Norbert Lukac, Peter Massanyi, Zuzana Knazicka
    Acta Histochemica.2022; 124(5): 151912.     CrossRef
  • Endocrine Disrupting Compounds (Nonylphenol and Bisphenol A)–Sources, Harmfulness and Laccase-Assisted Degradation in the Aquatic Environment
    Agnieszka Gałązka, Urszula Jankiewicz
    Microorganisms.2022; 10(11): 2236.     CrossRef
  • Subacute exposure to lead promotes disruption in the thyroid gland function in male and female rats
    Niedson Correia de Lima Junior, Juliana Franco Camilo, Pâmella Rodrigues do Carmo, Marcelle Novaes de Andrade, Bernardo Ferreira Braz, Ricardo Erthal Santelli, Lycia de Brito Gitirana, Andrea Claudia Freitas Ferreira, Denise Pires de Carvalho, Leandro Mir
    Environmental Pollution.2021; 274: 115889.     CrossRef
  • Plasticenta: First evidence of microplastics in human placenta
    Antonio Ragusa, Alessandro Svelato, Criselda Santacroce, Piera Catalano, Valentina Notarstefano, Oliana Carnevali, Fabrizio Papa, Mauro Ciro Antonio Rongioletti, Federico Baiocco, Simonetta Draghi, Elisabetta D'Amore, Denise Rinaldo, Maria Matta, Elisabet
    Environment International.2021; 146: 106274.     CrossRef
  • Impact of endocrine-disrupting chemicals on steroidogenesis and consequences on testicular function
    Casandra Walker, Samuel Garza, Vassilios Papadopoulos, Martine Culty
    Molecular and Cellular Endocrinology.2021; 527: 111215.     CrossRef
  • Best Achievements in Translational and Basic Thyroidology in 2020
    Sun Wook Cho, Young Joo Park
    Endocrinology and Metabolism.2021; 36(1): 36.     CrossRef
  • Endocrine disrupting chemicals in the pathogenesis of hypospadias; developmental and toxicological perspectives
    Deidre M. Mattiske, Andrew J. Pask
    Current Research in Toxicology.2021; 2: 179.     CrossRef
  • Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?
    Pheruza Tarapore, Bin Ouyang
    International Journal of Environmental Research and Public Health.2021; 18(7): 3794.     CrossRef
  • Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
    Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez
    International Journal of Molecular Sciences.2021; 22(9): 4807.     CrossRef
  • Microplastics in aquatic environment: Challenges and perspectives
    Aashlesha Chekkala Vivekanand, Sanjeeb Mohapatra, Vinay Kumar Tyagi
    Chemosphere.2021; 282: 131151.     CrossRef
  • A Review on Emerging Pollutants in the Water Environment: Existences, Health Effects and Treatment Processes
    Nor Zaiha Arman, Salmiati Salmiati, Azmi Aris, Mohd Razman Salim, Tasnia Hassan Nazifa, Mimi Suliza Muhamad, Marpongahtun Marpongahtun
    Water.2021; 13(22): 3258.     CrossRef
  • Effects of different influent C/N ratios on microbial community and selected estrogens removal in a sequencing batch reactor
    Bingchen Zhao, Jie Lan, Dong Chen, Linlin Li
    Desalination and Water Treatment.2021; 223: 128.     CrossRef
  • Urban-level environmental factors related to pediatric asthma
    Inês Paciência, João Cavaleiro Rufo
    Porto Biomedical Journal.2020; 5(1): e57.     CrossRef
  • Mechanisms of Testicular Disruption from Exposure to Bisphenol A and Phtalates
    Francesco Pallotti, Marianna Pelloni, Daniele Gianfrilli, Andrea Lenzi, Francesco Lombardo, Donatella Paoli
    Journal of Clinical Medicine.2020; 9(2): 471.     CrossRef
  • Developmental instability is associated with estrogenic endocrine disruption in the Chilean native fish species, Trichomycterus areolatus
    Angéline Bertin, Gautier Damiens, Daniela Castillo, Ricardo Figueroa, Christophe Minier, Nicolas Gouin
    Science of The Total Environment.2020; 714: 136638.     CrossRef
  • Tyrosinase nanocapsule based nano-biosensor for ultrasensitive and rapid detection of bisphenol A with excellent stability in different application scenarios
    Lingxia Wu, Xianbo Lu, Kai Niu, Dhanjai, Jiping Chen
    Biosensors and Bioelectronics.2020; 165: 112407.     CrossRef
  • The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study
    Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Journal of Trace Elements in Medicine and Biology.2020; 62: 126601.     CrossRef
  • Diet: A Source of Endocrine Disruptors
    Hina Rashid, Saad S. Alqahtani, Saeed Alshahrani
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2020; 20(5): 633.     CrossRef
  • Aryl-hydrocarbon receptor binding and the incidence of type 2 diabetes: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
    Bruce B. Duncan, Cristina D. Castilhos, Paula A. Bracco, Maria I. Schmidt, Sora Kang, Suyeol Im, Hong-Kyu Lee, Álvaro Vigo, Youngmi K. Pak
    Environmental Health.2020;[Epub]     CrossRef
  • Endocrinology and Metabolism Has Been Indexed in MEDLINE: A Major Achievement
    Won-Young Lee
    Endocrinology and Metabolism.2019; 34(2): 138.     CrossRef
  • Endocrine-disrupting chemicals: Effects on neuroendocrine systems and the neurobiology of social behavior
    Andrea C. Gore, Krittika Krishnan, Michael P. Reilly
    Hormones and Behavior.2019; 111: 7.     CrossRef
  • Removal of Pharmaceutical Contaminants in Wastewater Using Nanomaterials: A Comprehensive Review
    Anjali Chauhan, Devendra Sillu, Shekhar Agnihotri
    Current Drug Metabolism.2019; 20(6): 483.     CrossRef
  • Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease
    Olga Papalou, Eleni A. Kandaraki, George Papadakis, Evanthia Diamanti-Kandarakis
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Adverse Effect of Nonylphenol on the Reproductive System in F2 Male Mice : A Qualitative Change?
    Yong-Bin Kim, Yong-Pil Cheon, Donchan Choi, Sung-Ho Lee
    Development & Reproduction.2019; 23(3): 255.     CrossRef
  • Association of serum levels of p,p’- Dichlorodiphenyldichloroethylene (DDE) with type 2 diabetes in African American and Caucasian adult men from agricultural (Delta) and non-agricultural (non-Delta) regions of Mississippi
    Edward C. Meek, Dana Dale Jones, J. Allen Crow, Robert W. Wills, William H. Cooke, Janice E. Chambers
    Journal of Toxicology and Environmental Health, Part A.2019; 82(6): 387.     CrossRef
  • UV-B Filter Octylmethoxycinnamate Induces Vasorelaxation by Ca2+ Channel Inhibition and Guanylyl Cyclase Activation in Human Umbilical Arteries
    Margarida Lorigo, Carla Quintaneiro, Manuel C. Lemos, José Martinez-de-Oliveira, Luiza Breitenfeld, Elisa Cairrao
    International Journal of Molecular Sciences.2019; 20(6): 1376.     CrossRef
  • Transgenerational effects of BPA on female reproduction
    Stefania Santangeli, Claudia Consales, Francesca Pacchierotti, Hamid R. Habibi, Oliana Carnevali
    Science of The Total Environment.2019; 685: 1294.     CrossRef
  • Exposure to polybrominated biphenyl and stochastic epigenetic mutations: application of a novel epigenetic approach to environmental exposure in the Michigan polybrominated biphenyl registry
    Sarah W. Curtis, Dawayland O. Cobb, Varun Kilaru, Metrecia L. Terrell, M. Elizabeth Marder, Dana Boyd Barr, Carmen J. Marsit, Michele Marcus, Karen N. Conneely, Alicia K. Smith
    Epigenetics.2019; 14(10): 1003.     CrossRef
  • Determining the endocrine disruption potential of industrial chemicals using an integrative approach: Public databases, in vitro exposure, and modeling receptor interactions
    Olubusayo Alofe, Edwina Kisanga, Salmaan H. Inayat-Hussain, Masao Fukumura, Rolando Garcia-Milian, Lalith Perera, Vasilis Vasiliou, Shannon Whirledge
    Environment International.2019; 131: 104969.     CrossRef
  • 4-Nonylphenol-Enhanced EZH2 and RNF2 Expression, H3K27me3 and H2AK119ub1 Marks Resulting in Silencing of p21 CDKN1A  
    Krishna Ghosh, Biji Chatterjee, Uma Maheswari, Mariyam Athifa, Santosh R Kanade
    Epigenomics.2019; 11(8): 899.     CrossRef
  • Sex-specific effects of blood cadmium on thyroid hormones and thyroid function status: Korean nationwide cross-sectional study
    Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Journal of Trace Elements in Medicine and Biology.2019; 53: 55.     CrossRef
  • Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance
    Laura Escrivá, Annika Hanberg, Johanna Zilliacus, Anna Beronius
    EFSA Journal.2019;[Epub]     CrossRef
  • Comparative assessment of endocrine disrupting compounds removal in heterotrophic and enriched nitrifying biomass
    Elissavet Kassotaki, Maite Pijuan, Ignasi Rodriguez-Roda, Gianluigi Buttiglieri
    Chemosphere.2019; 217: 659.     CrossRef
Close layer
Obesity and Metabolism
The Diabetes Epidemic in Korea
Junghyun Noh
Endocrinol Metab. 2016;31(3):349-353.   Published online August 26, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.3.349
  • 10,677 View
  • 60 Download
  • 53 Web of Science
  • 55 Crossref
AbstractAbstract PDFPubReader   

Diabetes is one of the foremost public health issues worldwide that can lead to complications in many organ systems, and has become a significant cause of morbidity and mortality in Korea. According to data from the National Health Insurance Service (NHIS), about 2.7 million Koreans (8.0%) aged 30 years or older had type 2 diabetes mellitus (T2DM) in 2013. The prevalence of T2DM increased with age and rose from 5.6% in 2006 to 8.0% in 2013. Using data based on The Health Screening Service of the NHIS, 25% of Korean adults were reported to have prediabetes in 2013. The prevalence of an impaired fasting glucose tended to increase over time from 21.5% in 2006 to 25.0% in 2013. Even though nationwide health screening has been regularly conducted as a public service, the proportion of undiagnosed cases of diabetes was still reported to be on the higher side in the latest study. Based on the results of these epidemic studies, further actions will be needed to effectively implement lifestyle changes on a social level and increase measures for the early detection of diabetes to stem the tide of the epidemic.

Citations

Citations to this article as recorded by  
  • A Nationwide Population‐Based Study for the Recurrence and Comorbidities in Sudden Sensorineural Hearing Loss
    Hye Yeon Ko, Hae Jeong Nam, Min Hee Kim
    The Laryngoscope.2024; 134(3): 1417.     CrossRef
  • Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
    Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
    Advances in Therapy.2024; 41(5): 1967.     CrossRef
  • Cancer risk according to fasting blood glucose trajectories: a population-based cohort study
    Thi Minh Thu Khong, Thi Tra Bui, Hee-Yeon Kang, Jinhee Lee, Eunjung Park, Jin-Kyoung Oh
    BMJ Open Diabetes Research & Care.2024; 12(1): e003696.     CrossRef
  • Cost-effectiveness of open versus laparoscopic pancreatectomy: A nationwide, population-based study
    Jun Suh Lee, Ha Lynn Oh, Yoo-Seok Yoon, Ho-Seong Han, Jai Young Cho, Hae-Won Lee, Boram Lee, MeeYoung Kang, Yeshong Park, Jinju Kim
    Surgery.2024; 176(2): 427.     CrossRef
  • Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy
    Huiyul Park, Eileen L. Yoon, Mimi Kim, Seon Cho, Eun-Hee Nah, Dae Won Jun
    Clinical Gastroenterology and Hepatology.2023; 21(4): 1041.     CrossRef
  • Efficacy of Polydeoxyribonucleotide in Promoting the Healing of Diabetic Wounds in a Murine Model of Streptozotocin-Induced Diabetes: A Pilot Experiment
    Jiyoung Yun, SaeGwang Park, Ha Young Park, Kyung Ah Lee
    International Journal of Molecular Sciences.2023; 24(3): 1932.     CrossRef
  • Influence of Fasting Glucose Level on Gastric Cancer Incidence in a Prospective Cohort Study
    Tao Thi Tran, Jeonghee Lee, Madhawa Gunathilake, Hyunsoon Cho, Jeongseon Kim
    Cancer Epidemiology, Biomarkers & Prevention.2022; 31(1): 254.     CrossRef
  • A Comparative analysis of type 2 diabetes management quality indicators in cancer survivors
    Eun J. Ko, Su J. Lee
    Asia-Pacific Journal of Oncology Nursing.2022; 9(11): 100116.     CrossRef
  • Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
    Seung Eun Lee, Hyewon Nam, Han Seok Choi, Hoseob Kim, Dae-Sung Kyoung, Kyoung-Ah Kim
    Diabetes & Metabolism Journal.2022; 46(4): 567.     CrossRef
  • Prevalence and diagnosis experience of osteoporosis in postmenopausal women over 50: Focusing on socioeconomic factors
    Min Hyeok Choi, Ji Hee Yang, Jae Seung Seo, Yoon-ji Kim, Suk-Woong Kang, Jose M. Moran
    PLOS ONE.2021; 16(3): e0248020.     CrossRef
  • Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
    Da Hea Seo, Kyoung Hwa Ha, So Hun Kim, Dae Jung Kim
    Endocrinology and Metabolism.2021; 36(1): 70.     CrossRef
  • A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea
    Ka-Won Kang, Ji Eun Song, Byung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Yong Park, Byung Soo Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver
    Huiyul Park, Eileen L. Yoon, Mimi Kim, Jung-Hwan Kim, Seon Cho, Dae Won Jun, Eun-Hee Nah
    Journal of Clinical Medicine.2021; 10(19): 4625.     CrossRef
  • The Effects of Glucose Lowering Agents on the Secondary Prevention of Coronary Artery Disease in Patients with Type 2 Diabetes
    Inha Jung, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Eun-Jung Rhee, Won-Young Lee
    Endocrinology and Metabolism.2021; 36(5): 977.     CrossRef
  • Decreased Vagal Activity and Deviation in Sympathetic Activity Precedes Development of Diabetes
    Da Young Lee, Mi Yeon Lee, Jung Hwan Cho, Hyemi Kwon, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Won-Young Lee, Sung-Woo Park, Seungho Ryu, Se Eun Park
    Diabetes Care.2020; 43(6): 1336.     CrossRef
  • Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus
    Jie Liu, Shrita Patel, Nilo B. Cater, Larry Wu, Susan Huyck, Steven G. Terra, Anne Hickman, Amanda Darekar, Annpey Pong, Ira Gantz
    Diabetes, Obesity and Metabolism.2020; 22(4): 574.     CrossRef
  • Outcomes for Inappropriate Renal Dose Adjustment of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus: Population-Based Study
    Sangmo Hong, Kyungdo Han, Cheol-Young Park
    Mayo Clinic Proceedings.2020; 95(1): 101.     CrossRef
  • Longitudinal Study of Diabetic Differences between International Migrants and Natives among the Asian Population
    Heng Piao, Jae Moon Yun, Aesun Shin, Belong Cho
    Biomolecules & Therapeutics.2020; 28(1): 110.     CrossRef
  • Risk of active tuberculosis development in contacts exposed to infectious tuberculosis in congregate settings in Korea
    Shin Young Park, Sunmi Han, Young-Man Kim, Jieun Kim, Sodam Lee, Jiyeon Yang, Un-Na Kim, Mi-sun Park
    Scientific Reports.2020;[Epub]     CrossRef
  • The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study
    Hyung Jung Oh, Hye Ah Lee, Chang Mo Moon, Dong-Ryeol Ryu
    Yonsei Medical Journal.2020; 61(6): 506.     CrossRef
  • Coffee Consumption, Genetic Polymorphisms, and the Risk of Type 2 Diabetes Mellitus: A Pooled Analysis of Four Prospective Cohort Studies
    An Na Kim, Hyun Jeong Cho, Jiyoung Youn, Taiyue Jin, Moonil Kang, Joohon Sung, Jung Eun Lee
    International Journal of Environmental Research and Public Health.2020; 17(15): 5379.     CrossRef
  • Current findings of kidney biopsy including nephropathy associated with hypertension and diabetes mellitus in Korea
    Kipyo Kim, Sang Ho Lee, Sung Woo Lee, Jung Pyo Lee, Ho Jun Chin
    The Korean Journal of Internal Medicine.2020; 35(5): 1173.     CrossRef
  • A Diabetes-Related Dietary Pattern Is Associated with Incident Diabetes in Obese Men in the Korean Genome Epidemiology Study
    Hye Ah Lee, NaYeong Son, Won Kyung Lee, Hyesook Park
    The Journal of Nutrition.2019; 149(2): 323.     CrossRef
  • Associations of postmenopausal hormone therapy with metabolic syndrome among diabetic and non-diabetic women
    Ji-Eun Kim, Jaesung Choi, JooYong Park, Jong-koo Lee, Aesun Shin, Sang Min Park, Daehee Kang, Ji-Yeob Choi
    Maturitas.2019; 121: 76.     CrossRef
  • The changing epidemiology of herpes zoster over a decade in South Korea, 2006–2015
    Jae-Ki Choi, Sun Hee Park, Sanghyun Park, Sung-Yeon Cho, Hyo-Jin Lee, Si-Hyun Kim, Su-Mi Choi, Dong-Gun Lee, Jung-Hyun Choi, Jin-Hong Yoo
    Vaccine.2019; 37(36): 5153.     CrossRef
  • Prevalence of undiagnosed diabetes and pre-diabetes and its associated risk factors in Vietnam
    Van Dat Nguyen, Quang Mai Vien, Thai Hung Do, Cong Danh Phan, Huu Chau Nguyen, Van Tuyen Nguyen, Dinh Luong Nguyen, Won Seok Sir, Yun Chon
    Journal of Global Health Science.2019;[Epub]     CrossRef
  • Heterogeneous Trajectories of Cognitive Function in Older Adults with Diabetes: Findings from the Korean Longitudinal Study of Aging (KLoSA)
    Chanhee Kim, Min Jung Kim, Chang Gi Park
    Stress.2019; 27(1): 1.     CrossRef
  • The Effect of Coffee Consumption on the Prevalence of Diabetes Mellitus: The 2012–2016 Korea National Health and Nutrition Examination Survey
    Yejee Lim, Youngmi Park, Sun Kyu Choi, Soyeon Ahn, Jung Hun Ohn
    Nutrients.2019; 11(10): 2377.     CrossRef
  • Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study
    Yoo-Ri Chung, Kyoung Hwa Ha, Kihwang Lee, Dae Jung Kim, Ping-Hsun Wu
    PLOS ONE.2019; 14(10): e0224549.     CrossRef
  • Letter: Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90–6)
    Bo Kyung Koo
    Diabetes & Metabolism Journal.2019; 43(2): 242.     CrossRef
  • Changes of computed tomography‐based body composition after adrenalectomy in patients with endogenous hypercortisolism
    Namki Hong, Jooyeon Lee, Cheol Ryong Ku, Kichang Han, Cho Rok Lee, Sang Wook Kang, Yumie Rhee
    Clinical Endocrinology.2019; 90(2): 267.     CrossRef
  • Estimating Lifetime Duration of Diabetes by Age and Gender in the Korean Population Using a Markov Model
    Seung Woo Cho, Seon Ha Kim, Young-Eun Kim, Seok-Jun Yoon, Min-Woo Jo
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study
    Sang Youl Rhee, Suk Chon, Kyu Jeung Ahn, Jeong-Taek Woo
    Diabetes & Metabolism Journal.2019; 43(1): 49.     CrossRef
  • Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration
    Hun-Sung Kim, Dai-Jin Kim, Kun-Ho Yoon
    Endocrinology and Metabolism.2019; 34(4): 349.     CrossRef
  • Changes in secondhand smoke exposure levels and risk of type 2 diabetes in middle age: the Korean Genome and Epidemiology Study (KoGES)
    Jooeun Jeon, Keum Ji Jung, Heejin Kimm, Sun Ha Jee
    BMJ Open Diabetes Research & Care.2019; 7(1): e000859.     CrossRef
  • Implementation of the Chronic Disease Care System and its association with health care costs and continuity of care in Korean adults with type 2 diabetes mellitus
    Woorim Kim, Yoon Soo Choy, Sang Ah Lee, Eun-Cheol Park
    BMC Health Services Research.2018;[Epub]     CrossRef
  • Trends in diabetes prevalence among Korean adults based on Korean National Health and Nutrition Examination Surveys III–VI
    Jae-woo Lee, Hee-Taik Kang, Hyoung-Ji Lim, Byoungjin Park
    Diabetes Research and Clinical Practice.2018; 138: 57.     CrossRef
  • Insulin Resistance and the Risk of Diabetes and Dysglycemia in Korean General Adult Population
    Jong Ha Baek, Hosu Kim, Kyong Young Kim, Jaehoon Jung
    Diabetes & Metabolism Journal.2018; 42(4): 296.     CrossRef
  • Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes
    Jisook Yim, Gyuri Kim, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Jeong-Ho Kim, Jin Won Cho, Sang-Guk Lee, Yong-ho Lee
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study
    Soo Jin Yang, So-Young Kwak, Garam Jo, Tae-Jin Song, Min-Jeong Shin
    Scientific Reports.2018;[Epub]     CrossRef
  • Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009–2013)
    Seung Eun Lee, Kyungdo Han, Yu Mi Kang, Seon-Ok Kim, Yun Kyung Cho, Kyung Soo Ko, Joong-Yeol Park, Ki-Up Lee, Eun Hee Koh, Ying-Mei Feng
    PLOS ONE.2018; 13(3): e0194490.     CrossRef
  • Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults
    Su‐Min Jeong, Seulggie Choi, Kyuwoong Kim, Sung Min Kim, Gyeongsil Lee, Seong Yong Park, Yeon‐Yong Kim, Joung Sik Son, Jae‐Moon Yun, Sang Min Park
    Journal of the American Heart Association.2018;[Epub]     CrossRef
  • Age, sex, and the association of chronic kidney disease with all-cause mortality in Buddhist priests
    Hyo Jin Kim, Yunmi Kim, Sejoong Kim, Ho Jun Chin, Hajeong Lee, Jung Pyo Lee, Dong Ki Kim, Kook-Hwan Oh, Kwon Wook Joo, Yon Su Kim, Deuk-Young Nah, Sung Joon Shin, Kyung Soo Kim, Jae Yoon Park, Kyung Don Yoo
    Medicine.2018; 97(45): e13099.     CrossRef
  • Association of change in total cholesterol level with mortality: A population-based study
    Su-Min Jeong, Seulggie Choi, Kyuwoong Kim, Sung-Min Kim, Gyeongsil Lee, Joung Sik Son, Jae-Moon Yun, Sang Min Park, Katriina Aalto-Setala
    PLOS ONE.2018; 13(4): e0196030.     CrossRef
  • High hemoglobin levels are associated with decreased risk of diabetic retinopathy in Korean type 2 diabetes
    Min-Kyung Lee, Kyung-Do Han, Jae-Hyuk Lee, Seo-Young Sohn, Jee-Sun Jeong, Mee-Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
    Scientific Reports.2018;[Epub]     CrossRef
  • Impact of systemic inflammation on the relationship between insulin resistance and all-cause and cancer-related mortality
    Da Young Lee, Eun-Jung Rhee, Yoosoo Chang, Chong Il Sohn, Ho-Cheol Shin, Seungho Ryu, Won-Young Lee
    Metabolism.2018; 81: 52.     CrossRef
  • The two isoforms of matrix metalloproteinase- 2 have distinct renal spatial and temporal distributions in murine models of types 1 and 2 diabetes mellitus
    Il Young Kim, Sang Soo Kim, Hye Won Lee, Sun Sik Bae, Hong Koo Ha, Eun Soon Jung, Min Young Lee, Miyeun Han, Harin Rhee, Eun Young Seong, Dong Won Lee, Soo Bong Lee, David H. Lovett, Sang Heon Song
    BMC Nephrology.2018;[Epub]     CrossRef
  • The optimal cut-off of blood pressure related to left ventricular diastolic dysfunction and remodeling in Asian diabetic patients
    Ju Young Jung, Sung Keun Park, Jae-Hong Ryoo, Chang-Mo Oh, Jeong Gyu Kang, Kanghee Moon, Keum Ok Lee, Joong-Myung Choi
    Journal of Cardiology.2018; 71(1): 16.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Factors Associated with Smoking Cessation Intention among Current Smokers with Diabetes: Analysis of the 2013 Community Health Survey in Korea
    Young-Hoon Lee, Jum Suk Ko
    Korean Journal of Health Promotion.2017; 17(3): 184.     CrossRef
  • The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG‐CoA reductase inhibitors prescribed in Korean patients
    Tong Min Kim, Hyunah Kim, Yoo Jin Jeong, Sun Jung Baik, So Jung Yang, Seung‐Hwan Lee, Jae‐Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, In Young Choi, Kun‐Ho Yoon, Hun‐Sung Kim
    Pharmacoepidemiology and Drug Safety.2017; 26(10): 1156.     CrossRef
  • Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea
    Y. J. Jeong, H. Kim, S. J. Baik, T. M. Kim, S. J. Yang, S.-H. Lee, J.-H. Cho, H. Lee, H. W. Yim, I. Y. Choi, K.-H. Yoon, H.-S. Kim
    Journal of Clinical Pharmacy and Therapeutics.2017; 42(3): 292.     CrossRef
  • Associations of Dietary Antioxidants and Risk of Type 2 Diabetes: Data from the 2007–2012 Korea National Health and Nutrition Examination Survey
    Dan Quansah, Kyungho Ha, Shinyoung Jun, Seong-Ah Kim, Sangah Shin, Gyung-Ah Wie, Hyojee Joung
    Molecules.2017; 22(10): 1664.     CrossRef
  • Accuracy of Capillary Blood Glucose Test When Fasting in Diabetes Patients or General Population: Performance Evaluation of G300 Based on ISO 15197:2013 Standards
    Young-min Jee, Min-hee Seo, Byung-wook Yoo, Sung-ho Hong, Choo-yon Cho, Yong-jin Cho, Jung-eun Oh, Kyung-suk Shin
    Korean Journal of Health Promotion.2017; 17(4): 259.     CrossRef
  • Increased Vascular Disease Mortality Risk in Prediabetic Korean Adults Is Mainly Attributable to Ischemic Stroke
    Nam Hoon Kim, Tae Yeon Kwon, Sungwook Yu, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Yousung Park, Sin Gon Kim
    Stroke.2017; 48(4): 840.     CrossRef
Close layer
Obesity and Metabolism
Trends in the Diabetes Epidemic in Korea
Kyoung Hwa Ha, Dae Jung Kim
Endocrinol Metab. 2015;30(2):142-146.   Published online June 30, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.2.142
  • 8,967 View
  • 50 Download
  • 71 Web of Science
  • 83 Crossref
AbstractAbstract PDFPubReader   

Diabetes mellitus is a leading cause of mortality and increased disability-adjusted life years worldwide. In Korea, the prevalence of diabetes increased from 8.6% to 11.0% in 2001 to 2013 and the prevalence of adult obesity, which is the most important risk factor of diabetes, increased from 29.2% to 31.8% during the same period. There has been a dramatic increase in the number of obese Koreans with diabetes in recent decades and the prevalence of diabetes in people aged 40 years and older also increased in 2001 to 2013. Nevertheless, the mean age at the first diagnosis of diabetes was very similar for men in 2005 and 2013, while the mean age for women decreased slightly. There is an inverse linear relationship between body mass index and age at the diagnosis of diabetes among those who are newly diagnosed. Accordingly, the prevalence of diabetes is increasingly shifting to younger individuals and those who are obese. Therefore, public efforts should focus on healthy lifestyle changes, primary prevention measures, screening for the early detection of diabetes, and long-term management.

Citations

Citations to this article as recorded by  
  • Cluster analysis based on fasting and postprandial plasma glucose and insulin concentrations
    Miguel Altuve, Erika Severeyn
    International Journal of Diabetes in Developing Countries.2025; 45(1): 47.     CrossRef
  • Burden of type 2 diabetes and its relationship with human development index in Asian countries: Global Burden of Disease Study in 2019
    Seyed Ahmadreza Alinaghian, Shokoufeh Hamidzadeh, Afsaneh Badrizadeh, Zaher Khazaei, Amirhossein Souri, Victoria Momenabadi, Elham Goodarzi
    BMC Public Health.2025;[Epub]     CrossRef
  • Feasibility of a Structured Calorie-Restricted Dietary Intervention in Korean Adults with Early Type 2 Diabetes and Obesity: A Pilot Study
    Su-Jeong Park, Mee Kyung Kim, Jinyoung Kim, Ji-Yeon Choi, YoonJu Song, Hyuk-Sang Kwon
    Nutrients.2025; 17(9): 1530.     CrossRef
  • Genome-wide approach to study gene–nutrient intake interactions in type 2 diabetes mellitus in a large Korean cohort
    Jae-Min Park, Ja-Eun Choi, Youhyun Song, Yu-Jin Kwon, Ji-Won Lee, Kyung-Won Hong
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Trends and regional disparities in the diabetes burden across Asia, 1990–2021: Insights from the global burden of disease study
    Sufyan Shahid, Aya Abdulrahman Ajeel, Ali Dheyaa Marsool, Muneeb Saifullah, Hiba Mukhtar, Muhammad Umer Sattar, Anum Waseem, Zareen Shafqat, Zunaira Rehman, Raheel Ahmed, Dr. Muzammil Farhan
    Diabetes Epidemiology and Management.2025; 19-20: 100287.     CrossRef
  • Variations in health-related quality of life (EQ-5D) associated with cardiovascular health: a cross-sectional study of adults with diabetes in the Korean general population
    Hyejin Jung
    BMJ Open.2024; 14(5): e081789.     CrossRef
  • Smoking behavior change and the risk of pneumonia hospitalization among smokers with diabetes mellitus
    Dong-Woo Han, Wonyoung Jung, Kyu Na Lee, Kyungdo Han, Sei Won Lee, Dong Wook Shin
    Scientific Reports.2023;[Epub]     CrossRef
  • Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
    Ji Cheol Bae, Soo Heon Kwak, Hyun Jin Kim, Sang-Yong Kim, You-Cheol Hwang, Sunghwan Suh, Bok Jin Hyun, Ji Eun Cha, Jong Chul Won, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2022; 46(1): 81.     CrossRef
  • Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study
    Hyun Ho Choi, Giwoong Choi, Hojun Yoon, Kyoung Hwa Ha, Dae Jung Kim
    Diabetes & Metabolism Journal.2022; 46(5): 803.     CrossRef
  • Differences in health behavior and nutrient intake status between diabetes-aware and unaware Korean adults based on the Korea national health and nutrition examination survey 2016–18 data: A cross-sectional study
    Anshul Sharma, Chen Lulu, Kee-Ho Song, Hae-Jeung Lee
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort
    Byoungjin Park, Hye Sun Lee, Yong-Jae Lee
    Translational Research.2021; 228: 42.     CrossRef
  • Did Sejong the Great have ankylosing spondylitis? The oldest documented case of ankylosing spondylitis
    JiHwan Lee
    International Journal of Rheumatic Diseases.2021; 24(2): 203.     CrossRef
  • Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
    Chan-Hee Jung, Jang Won Son, Shinae Kang, Won Jun Kim, Hun-Sung Kim, Hae Soon Kim, Mihae Seo, Hye-Jung Shin, Seong-Su Lee, Su Jin Jeong, Yongin Cho, Seung Jin Han, Hyang Mi Jang, Mira Rho, Shinbi Lee, Mihyun Koo, Been Yoo, Jung-Wha Moon, Hye Young Lee, Ja
    Diabetes & Metabolism Journal.2021; 45(1): 1.     CrossRef
  • Association between living alone and incident type 2 diabetes among middle-aged individuals in Korea: a nationwide cohort study
    Ga Eun Nam, Wonsock Kim, Kyungdo Han, Jin-Hyung Jung, Byoungduck Han, Jinwook Kim, Nan Hee Kim, Kyung Mook Choi, Kyung Hwan Cho, Yong Gyu Park, Seon Mee Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • White Blood Cell Count as a Predictor of Incident Type 2 Diabetes Mellitus Among Non-Obese Adults: A Longitudinal 10-Year Analysis of the Korean Genome and Epidemiology Study
    Jae-Min Park, Hye Sun Lee, Ju-Young Park, Dong-Hyuk Jung, Ji-Won Lee
    Journal of Inflammation Research.2021; Volume 14: 1235.     CrossRef
  • A 9-Year Comparison of Dementia Prevalence in Korea: Results of NaSDEK 2008 and 2017
    Seung Wan Suh, You Joung Kim, Kyung Phil Kwak, Kiwon Kim, Moon-Doo Kim, Byung-Soo Kim, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Tae Hui Kim, Seok Woo Moon, Kyung Won Park, Jong-Il Park, Joon Hyuk Park, Jae Nam Bae, Jiyeong Seo, Su Jeong Seong, Sang Joo
    Journal of Alzheimer's Disease.2021; 81(2): 821.     CrossRef
  • Trends of Diabetes and Prediabetes Prevalence among Korean Adolescents From 2007 to 2018
    Ji Hyun Kim, Jung Sub Lim
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Breast Cancer Statistics in Korea, 2018
    Sang Yull Kang, Sae Byul Lee, Yoo Seok Kim, Zisun Kim, Hyun Yul Kim, Hee Jeong Kim, Sungmin Park, Soo Youn Bae, Kwanghyun Yoon, Se Kyung Lee, Kyu-Won Jung, Jaihong Han, Hyun Jo Youn
    Journal of Breast Cancer.2021; 24(2): 123.     CrossRef
  • Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmonary Fibrosis. A Nationwide Cohort Study
    Sung Woo Moon, Song Yee Kim, Man Pyo Chung, Hongseok Yoo, Sung Hwan Jeong, Dong Soon Kim, Jin Woo Song, Hong Lyeol Lee, Sun Mi Choi, Young Whan Kim, Yong Hyun Kim, Choon-Sik Park, Sung-Woo Park, Jong Sun Park, Yangjin Jegal, Jongmin Lee, Soo-Taek Uh, Tae-
    Annals of the American Thoracic Society.2021; 18(5): 780.     CrossRef
  • Association between Inflammatory Markers and Glycemic Control in Korean Diabetic Patients
    Min Kang, Seok-Joon Sohn
    Journal of Health Informatics and Statistics.2021; 46(3): 247.     CrossRef
  • Associations between obesity, weight change and decreased renal function in Korean type 2 diabetic patients: a longitudinal follow-up study
    Bo-Yeon Kim, Dug-Hyun Choi, Chan-Hee Jung, Ji-Oh Mok, Chul-Hee Kim
    BMC Endocrine Disorders.2021;[Epub]     CrossRef
  • Role of Estrogen in Type 1 and Type 2 Diabetes Mellitus: A Review of Clinical and Preclinical Data
    Monica De Paoli, Geoff H. Werstuck
    Canadian Journal of Diabetes.2020; 44(5): 448.     CrossRef
  • Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
    Suk Kyeong Kim, Ju-Young Jang, Dong-Lim Kim, Young A Rhyu, Suh Eun Lee, Seung-Hyun Ko, Kyungdo Han, Kee-Ho Song
    The Korean Journal of Internal Medicine.2020; 35(3): 641.     CrossRef
  • Alteration of Microbiome Profile by D-Allulose in Amelioration of High-Fat-Diet-Induced Obesity in Mice
    Youngji Han, Haryung Park, Bo-Ra Choi, Yosep Ji, Eun-Young Kwon, Myung-Sook Choi
    Nutrients.2020; 12(2): 352.     CrossRef
  • Type 2 diabetes: epidemiological changes at Instituto Mexicano del Seguro Social—associated with complications in Mexico
    Jessie N. Zurita-Cruz, Leticia Manuel-Apolinar, María Luisa Arellano-Flores, Alejandro Gutierrez-Gonzalez, Aleida de Jesús Rivera-Hernández, Rosa Angélica Carranza-Muleiro, Víctor Hugo Borja-Aburto, Nelly Cisneros-González
    International Journal of Diabetes in Developing Countries.2020; 40(2): 178.     CrossRef
  • Effects of Particulate Respirator Use on Cardiopulmonary Function in Elderly Women: a Quasi-Experimental Study
    Youn-Hee Lim, Woosung Kim, Yumi Choi, Hwan-Cheol Kim, Geunjoo Na, Hyoung-Ryoul Kim, Yun-Chul Hong
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • GLP‑1 receptor agonist on cardiovascular complications of diabetes mellitus
    Fengjun Liu, Yanhua Kong
    Experimental and Therapeutic Medicine.2020;[Epub]     CrossRef
  • Plasma sphingomyelins increase in pre-diabetic Korean men with abdominal obesity
    Seung-Soon Im, Hyeon Young Park, Jong Cheol Shon, In-Sung Chung, Ho Chan Cho, Kwang-Hyeon Liu, Dae-Kyu Song, Kyoung Heon Kim
    PLOS ONE.2019; 14(3): e0213285.     CrossRef
  • Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status
    Bo-Yeon Kim, Jong Chul Won, Jae Hyuk Lee, Hun-Sung Kim, Jung Hwan Park, Kyoung Hwa Ha, Kyu Chang Won, Dae Jung Kim, Kyong Soo Park
    Diabetes & Metabolism Journal.2019; 43(4): 487.     CrossRef
  • Analysis of diabetes quality assessment findings and future directions for the appropriate management of diabetes in Korea
    Yu Jin Kim, Suk Chon, Seungjoon Oh, Jeong-taek Woo, Sung Woon Kim, Sang Youl Rhee
    The Korean Journal of Internal Medicine.2019; 34(1): 125.     CrossRef
  • Diabetes and the Risk of Infection: A National Cohort Study
    Eun Jin Kim, Kyoung Hwa Ha, Dae Jung Kim, Young Hwa Choi
    Diabetes & Metabolism Journal.2019; 43(6): 804.     CrossRef
  • Age-specific diabetes risk by the number of metabolic syndrome components: a Korean nationwide cohort study
    Min-Kyung Lee, Kyungdo Han, Hyuk-Sang Kwon
    Diabetology & Metabolic Syndrome.2019;[Epub]     CrossRef
  • Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
    Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee
    PLOS ONE.2019; 14(10): e0223678.     CrossRef
  • Association between continuity of care and type 2 diabetes development among patients with thyroid disorder
    Sang Ah Lee, Dong-Woo Choi, Junhyun Kwon, Doo Woong Lee, Eun-Cheol Park
    Medicine.2019; 98(52): e18537.     CrossRef
  • Association of C-Reactive Protein with Risk of Developing Type 2 Diabetes Mellitus, and Role of Obesity and Hypertension: A Large Population-Based Korean Cohort Study
    Suganya Kanmani, Minji Kwon, Moon-Kyung Shin, Mi Kyung Kim
    Scientific Reports.2019;[Epub]     CrossRef
  • Egg consumption is associated with a lower risk of type 2 diabetes in middle-aged and older men
    Jieul Lee, Jihye Kim
    Nutrition Research and Practice.2018; 12(5): 396.     CrossRef
  • Diabetes, Frequency of Exercise, and Mortality Over 12 Years: Analysis of the National Health Insurance Service-Health Screening (NHIS-HEALS) Database
    Woo Young Shin, Taehee Lee, Da-Hye Jeon, Hyeon Chang Kim
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Epidemiology of liver cancer in South Korea
    Bo Hyun Kim, Joong-Won Park
    Clinical and Molecular Hepatology.2018; 24(1): 1.     CrossRef
  • Letter: Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index (Diabetes Metab J 2018;42:137-46)
    Ah Reum Khang
    Diabetes & Metabolism Journal.2018; 42(3): 249.     CrossRef
  • Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial
    Han Seok Choi, Sunmi Kim, Min Jung Kim, Myung-Sunny Kim, Juewon Kim, Chan-Woong Park, Daebang Seo, Song Seok Shin, Sang Woo Oh
    Journal of Ginseng Research.2018; 42(1): 90.     CrossRef
  • Response: Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index (Diabetes Metab J2018;42:137-46)
    Kyoung Hwa Ha, Dae Jung Kim, Sungrae Kim
    Diabetes & Metabolism Journal.2018; 42(3): 251.     CrossRef
  • Prediction of Type 2 Diabetes Remission after Bariatric or Metabolic Surgery
    Ji Yeon Park
    Journal of Obesity & Metabolic Syndrome.2018; 27(4): 213.     CrossRef
  • Waist‐to‐calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes
    Eun Yeong Choe, Yong‐ho Lee, Young Ju Choi, Byung Wook Huh, Byung‐Wan Lee, Soo‐Kyung Kim, Eun Seok Kang, Bong‐Soo Cha, Eun Jig Lee, Kap Bum Huh, Zobair M Younossi
    Journal of Gastroenterology and Hepatology.2018; 33(5): 1082.     CrossRef
  • Prevalence of Comorbidities among Patients with Diabetes
    Suyoung Kim, Eun-Hee Nah, Seon Cho
    Journal of Health Informatics and Statistics.2018; 43(3): 237.     CrossRef
  • Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort
    Sang-Eun Lee, Ji Min Sung, In-Jeong Cho, Hyeon Chang Kim, Hyuk-Jae Chang, Lamberto Manzoli
    PLOS ONE.2018; 13(4): e0195459.     CrossRef
  • Outcomes of living donor kidney transplantation in diabetic patients: age and sex matched comparison with non-diabetic patients
    Chung Hee Baek, Hyosang Kim, Seung Don Baek, Mun Jang, Wonhak Kim, Won Seok Yang, Duck Jong Han, Su-Kil Park
    The Korean Journal of Internal Medicine.2018; 33(2): 356.     CrossRef
  • An Analysis of The Morbidity and Mortality of Diabetes Mellitus in a Forensic Context
    Chong Zhou, Roger W. Byard
    Journal of Forensic Sciences.2018; 63(4): 1149.     CrossRef
  • Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-pancreatic cancer
    Seo Young Sohn, Eun Kyung Lee, Sung-Sik Han, You Jin Lee, Yul Hwangbo, Young Hwa Kang, Seung Duk Lee, Seong Hoon Kim, Sang Myung Woo, Woo Jin Lee, Eun Kyung Hong, Sang-Jae Park
    Medicine.2018; 97(18): e0590.     CrossRef
  • Comparison of Open and Laparoscopic Gastrectomy in Elderly Patients
    Su Mi Kim, Ho Geun Youn, Ji Yeong An, Yoon Young Choi, Sung Hoon Noh, Seung Jong Oh, Tae Sung Sohn, Sung Kim
    Journal of Gastrointestinal Surgery.2018; 22(5): 785.     CrossRef
  • Development and Validation of the Korean Diabetes Risk Score: A 10-Year National Cohort Study
    Kyoung Hwa Ha, Yong-ho Lee, Sun Ok Song, Jae-woo Lee, Dong Wook Kim, Kyung-hee Cho, Dae Jung Kim
    Diabetes & Metabolism Journal.2018; 42(5): 402.     CrossRef
  • Trends in diabetes prevalence among Korean adults based on Korean National Health and Nutrition Examination Surveys III–VI
    Jae-woo Lee, Hee-Taik Kang, Hyoung-Ji Lim, Byoungjin Park
    Diabetes Research and Clinical Practice.2018; 138: 57.     CrossRef
  • Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
    Kyoung Hwa Ha, Cheol Young Park, In Kyung Jeong, Hyun Jin Kim, Sang-Yong Kim, Won Jun Kim, Ji Sung Yoon, In Joo Kim, Dae Jung Kim, Sungrae Kim
    Diabetes & Metabolism Journal.2018; 42(2): 137.     CrossRef
  • Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area
    Chang Hwi Yoon, Young-Joo Jin, Jin Woo Lee
    European Journal of Gastroenterology & Hepatology.2018; 30(9): 1090.     CrossRef
  • Prediction of Diabetes Remission after Bariatric or Metabolic Surgery
    Ji Yeon Park
    Journal of Metabolic and Bariatric Surgery.2018; 7(1): 22.     CrossRef
  • Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study
    Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Kwan Woo Lee, Nam H. Cho
    Diabetes Research and Clinical Practice.2017; 123: 173.     CrossRef
  • Glycated Hemoglobin and All-Cause Mortality in Korean Type 2 Diabetes
    Mi Suk An, Sun A Kim, Jun-Ho Lee, Seong-Woo Choi, Min-Ho Shin
    Chonnam Medical Journal.2017; 53(3): 223.     CrossRef
  • Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea
    Y. J. Jeong, H. Kim, S. J. Baik, T. M. Kim, S. J. Yang, S.-H. Lee, J.-H. Cho, H. Lee, H. W. Yim, I. Y. Choi, K.-H. Yoon, H.-S. Kim
    Journal of Clinical Pharmacy and Therapeutics.2017; 42(3): 292.     CrossRef
  • Governmental or Social Support of Bariatric Surgery in the Asia-Pacific Region
    Jisun Lim, Young Hye Cho, Hiroshi Yamamoto, Alvin Eng, Tania Markovic, Kyoung Kon Kim
    Journal of Obesity & Metabolic Syndrome.2017; 26(1): 10.     CrossRef
  • Application of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012
    Young Shin Song, Tae Jung Oh, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang, Kyong Soo Park, Soo Lim
    Diabetes & Metabolism Journal.2017; 41(1): 38.     CrossRef
  • The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG‐CoA reductase inhibitors prescribed in Korean patients
    Tong Min Kim, Hyunah Kim, Yoo Jin Jeong, Sun Jung Baik, So Jung Yang, Seung‐Hwan Lee, Jae‐Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, In Young Choi, Kun‐Ho Yoon, Hun‐Sung Kim
    Pharmacoepidemiology and Drug Safety.2017; 26(10): 1156.     CrossRef
  • The Effect and Safety of Dapagliflozin in Patients with Type 2 Diabetes: A Single-Institution Pharmacovigilance Review
    Hyung Woo Lee, Sun Joon Moon, Hee Sim Han, Eun Jeong Shin, Jin Hee Baek, Hyun-Joo Han, Young Min Cho, Kwi Suk Kim
    The Journal of Korean Diabetes.2017; 18(4): 275.     CrossRef
  • Optimal glycemic target level for colon cancer patients with diabetes
    Shin Jun Lee, Jae Hyun Kim, Seun Ja Park, So Young Ock, Su Kyoung Kwon, Young Sik Choi, Bu Kyung Kim
    Diabetes Research and Clinical Practice.2017; 124: 66.     CrossRef
  • Physician-Directed Diabetes Education without a Medication Change and Associated Patient Outcomes
    Hun-Sung Kim, Hyunah Kim, Hae-Kyung Yang, Eun Young Lee, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung-Hwan Lee, Jae Hyoung Cho, In Young Choi, Hyeon Woo Yim, Bong-Yun Cha
    Diabetes & Metabolism Journal.2017; 41(3): 187.     CrossRef
  • Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?
    Ki Dong Ko, Kyoung Kon Kim, Kyu Rae Lee
    Journal of Obesity & Metabolic Syndrome.2017; 26(2): 102.     CrossRef
  • Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF)
    Sang Eun Lee, Hae-Young Lee, Hyun-Jai Cho, Won-Seok Choe, Hokon Kim, Jin Oh Choi, Eun-Seok Jeon, Min-Seok Kim, Jae-Joong Kim, Kyung-Kuk Hwang, Shung Chull Chae, Sang Hong Baek, Seok-Min Kang, Dong-Ju Choi, Byung-Su Yoo, Kye Hun Kim, Hyun-Young Park, Myeon
    Korean Circulation Journal.2017; 47(3): 341.     CrossRef
  • Factors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysis
    Véronique Thibault, Mathieu Bélanger, Emilie LeBlanc, Lise Babin, Stuart Halpine, Beverly Greene, Michelina Mancuso
    Diabetology & Metabolic Syndrome.2016;[Epub]     CrossRef
  • Association of Waist-Height Ratio with Diabetes Risk: A 4-Year Longitudinal Retrospective Study
    Yoon Jeong Son, Jihyun Kim, Hye-Jeong Park, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
    Endocrinology and Metabolism.2016; 31(1): 127.     CrossRef
  • Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in Korea
    Hun-Sung Kim, Yoo Jeong, Sun Baik, So Yang, Tong Kim, Hyunah Kim, Hyunyong Lee, Seung-Hwan Lee, Jae Cho, In-Young Choi, Kun-Ho Yoon
    Applied Clinical Informatics.2016; 07(03): 899.     CrossRef
  • Relative and combined effects of socioeconomic status and diabetes on mortality
    Nam Hoon Kim, Tae Joon Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Yousung Park, Sin Gon Kim
    Medicine.2016; 95(30): e4403.     CrossRef
  • Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy
    Jong Chul Won, Tae Sun Park
    Endocrinology and Metabolism.2016; 31(2): 230.     CrossRef
  • Patterns of Diagnosis and Risk Factors for Type 2 Diabetes in Women with a History of Gestational Diabetes Mellitus
    Mi Jin Choi, Chae Weon Chung
    Perspectives in Nursing Science.2016; 13(1): 17.     CrossRef
  • Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013
    Yu Mi Kang, Ye-Jee Kim, Joong-Yeol Park, Woo Je Lee, Chang Hee Jung
    Cardiovascular Diabetology.2016;[Epub]     CrossRef
  • Health Performance and Challenges in Korea: a Review of the Global Burden of Disease Study 2013
    Yo Han Lee, Seok-Jun Yoon, Arim Kim, Hyeyoung Seo, Seulki Ko
    Journal of Korean Medical Science.2016; 31(Suppl 2): S114.     CrossRef
  • Pharmacological Management of Obesity in Patients with Type 2 Diabetes: An Update
    Eun Ju Lee, Tae Nyun Kim
    The Korean Journal of Obesity.2016; 25(3): 121.     CrossRef
  • Current status of managing diabetes mellitus in Korea
    Kyoung Hwa Ha, Dae Jung Kim
    The Korean Journal of Internal Medicine.2016; 31(5): 845.     CrossRef
  • Hyperglycemia at presentation is associated with in hospital mortality in non-diabetic patient with organophosphate poisoning
    Jeong Mi Moon, Byeong Jo Chun, Yong Soo Cho
    Clinical Toxicology.2016; 54(3): 252.     CrossRef
  • Effectiveness of Web-Based Interventions for Managing Diabetes in Korea
    Jee Young Joo
    CIN: Computers, Informatics, Nursing.2016; 34(12): 587.     CrossRef
  • Hypoglycemia and Health Costs
    Yong-ho Lee, Gyuri Kim, Eun Seok Kang
    The Journal of Korean Diabetes.2016; 17(1): 11.     CrossRef
  • Letter: Characterization of Patients with Type 2 Diabetes according to Body Mass Index: Korea National Health and Nutrition Examination Survey from 2007 to 2011 (Endocrinol Metab 2015;30:514-21, Dong-Hwa Lee et al.)
    Eun-Hee Cho
    Endocrinology and Metabolism.2016; 31(2): 345.     CrossRef
  • Gender-Specific Associations between Socioeconomic Status and Psychological Factors and Metabolic Syndrome in the Korean Population: Findings from the 2013 Korean National Health and Nutrition Examination Survey
    Kyoung Im Cho, Bo Hyun Kim, Hyung Gon Je, Jae Sik Jang, Yong Hyun Park
    BioMed Research International.2016; 2016: 1.     CrossRef
  • Need for Diabetes Prevention Study
    Ja Young Jeon, Dae Jung Kim
    The Journal of Korean Diabetes.2015; 16(3): 161.     CrossRef
  • Diabetes in Asians
    Eun-Jung Rhee
    Endocrinology and Metabolism.2015; 30(3): 263.     CrossRef
  • Epidemiologic Characteristics of Dyslipidemia in Korea
    Kyoung Hwa Ha, Hyuk-Sang Kwon, Dae Jung Kim
    Journal of Lipid and Atherosclerosis.2015; 4(2): 93.     CrossRef
Close layer
Mineral, Bone & Muscle
Epidemiology of Osteoporosis and Osteoporotic Fractures in South Korea
Young-Kyun Lee, Byung-Ho Yoon, Kyung-Hoi Koo
Endocrinol Metab. 2013;28(2):90-93.   Published online June 18, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.2.90
  • 9,069 View
  • 71 Download
  • 52 Web of Science
  • 56 Crossref
AbstractAbstract PDFPubReader   

Several epidemiologic studies suggested that osteoporosis and osteoporotic fractures are not uncommon in South Korea. However, these previous cohort studies had limitations that may have influenced their results and the generalizability of the study conclusions, including small sample sizes, inclusion of only women, enrollment of participants from specific areas, and nonrandom selection of participants. Recently, epidemiologic studies using a nationwide claim register have been performed to overcome these limitations through collaboration between the Korean Society of Bone and Mineral Research and Health Insurance Review Assessments. Our review of the Korean Nationwide-database Osteoporosis Study could be helpful to obtain accurate incidence and prevalence estimations of osteoporosis and osteoporosis-related fractures in Korea.

Citations

Citations to this article as recorded by  
  • Oral phosphate binders and incident osteoporotic fracture in patients on dialysis
    Ji Eun Kim, Jina Park, Yunyoung Jang, Eunjeong Kang, Yong Chul Kim, Dong Ki Kim, Kwon Wook Joo, Yon Su Kim, Hajeong Lee
    Nephrology Dialysis Transplantation.2025; 40(2): 329.     CrossRef
  • Clinical Significance of Incident Osteoporotic Fractures After Kidney Transplantation: A National Korean Cohort Study
    Yunyoung Jang, Ji Eun Kim, Jina Park, Jeongin Song, Sehoon Park, Yong Chul Kim, Dong Ki Kim, Kwon Wook Joo, Yon Su Kim, Minsu Park, Hajeong Lee, Eunjeong Kang
    American Journal of Kidney Diseases.2025; 85(4): 409.     CrossRef
  • Factors Associated With Compliance and Persistence With Pharmacotherapy in Patients With Osteoporosis: A Nationwide Cohort Study in Korea
    Seong Hee Ahn, So Young Park, Mi Kyung Kwak, Yong-Chan Ha, Tae-Young Kim, Ha Young Kim
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • A predictive nomogram for selective screening of asymptomatic vertebral fractures: The Vietnam Osteoporosis Study
    Hoa T. Nguyen, Bao T. Nguyen, An V. Tran, Tan T. Nguyen, Long H. Ngo, Tam Vo, Thi H. Nhung Thai, Linh D. Mai, Thach S. Tran, Tuan V. Nguyen, Lan T. Ho-Pham
    Osteoporosis and Sarcopenia.2025; 11(1): 9.     CrossRef
  • Association between osteoporosis and mortality in Parkinson's disease with mediating effect of hip fractures: a Korean nationwide population-based study
    Yeonju Jin, Bo Kyu Choi, Jong Woo Lee, Jin Yong Hong, Ickpyo Hong, Min Seok Baek
    Frontiers in Aging Neuroscience.2025;[Epub]     CrossRef
  • Menopause and Osteoporosis: An Approach to Gynecologists—A Literature Review
    Mohsen MA Abdelhafez, Karim AM Ahmed, Fairrul MA Kadir, DG Marshitah PG Baharuddin, Nornazirah Azizan, Doreen Sumpat, Aya AM Eldiastey, Mohd NM Daud, Mohamad S Jeffree, Win W Than, Mohd F Hayati, Mohd F Amri, Mohd Y Ibrahim, Zhen Z Lo, Nashwa Ahmed, Mohd
    Journal of South Asian Federation of Obstetrics and Gynaecology.2025; 17(S1): S115.     CrossRef
  • Comparison of Type 2 Diabetes Risk in Osteoporosis Patients Treated with Denosumab or Alendronate: A Nationwide Cohort Study
    Kyoung Jin Kim, Seol A. Jang, Su Jin Kwon, Gi Hyeon Seo, Kyoung Min Kim
    Calcified Tissue International.2025;[Epub]     CrossRef
  • Risk of fragility fracture of pelvis in endometrial cancer survivors : A national claim database study
    Ki-Tae Park, Jung-Wee Park, Dong-Hoon Lee, Ye Jhin Jeon, Jean Kyung Bak, Bit-Na Yoo, Youn Kyung Chung, Byung-Ho Yoon, Young-Kyun Lee
    Archives of Osteoporosis.2025;[Epub]     CrossRef
  • Risk of Pelvic Insufficiency Fractures in Cervical Cancer Survivors: Using the National Claim Database
    Ki-Tae Park, Jung-Wee Park, Ye Jin Jeon, Jean Kyung Bak, Bit-Na Yoo, Youn Kyung Chung, Byung-Ho Yoon, Young-Kyun Lee
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • Assessing the burden of osteoporosis and clinical fragility fractures in the French general population: insights from linked healthcare claims and health interview survey data used for surveillance
    Joël Coste, Laurence Mandereau-Bruno, Panayotis Constantinou, Tatjana T. Makovski, Laure Carcaillon-Bentata, Francis Guillemin
    Archives of Osteoporosis.2025;[Epub]     CrossRef
  • The 2024 Guidelines for Osteoporosis - Korean Society of Menopause
    Dong Ock Lee, Yeon Hee Hong, Moon Kyoung Cho, Young Sik Choi, Sungwook Chun, Youn-Jee Chung, Seung Hwa Hong, Kyu Ri Hwang, Jinju Kim, Hoon Kim, Dong-Yun Lee, Sa Ra Lee, Hyun-Tae Park, Seok Kyo Seo, Jung-Ho Shin, Jae Yen Song, Kyong Wook Yi, Haerin Paik, J
    Journal of Menopausal Medicine.2024; 30(1): 1.     CrossRef
  • Tuberculosis and osteoporotic fracture risk: development of individualized fracture risk estimation prediction model using a nationwide cohort study
    Hayoung Choi, Jungeun Shin, Jin-Hyung Jung, Kyungdo Han, Wonsuk Choi, Han Rim Lee, Jung Eun Yoo, Yohwan Yeo, Hyun Lee, Dong Wook Shin
    Frontiers in Public Health.2024;[Epub]     CrossRef
  • Automated Opportunistic Osteoporosis Screening Using Low-Dose Chest CT among Individuals Undergoing Lung Cancer Screening in a Korean Population
    Woo Young Kang, Zepa Yang, Heejun Park, Jemyoung Lee, Suk-Joo Hong, Euddeum Shim, Ok Hee Woo
    Diagnostics.2024; 14(16): 1789.     CrossRef
  • Osteoporosis incidence and its associated factors in the older Korean population: findings from a population-based cohort study
    Tanmoy Das, Md Abdullah Al Jubayer Biswas, Prosanta Mondal, Sabuj Sarker, Hyun J.“June” Lim
    Archives of Osteoporosis.2024;[Epub]     CrossRef
  • Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific region: a systematic review
    Manju Chandran, Katherine Brind’Amour, Saeko Fujiwara, Yong-Chan Ha, Hai Tang, Jawl-Shan Hwang, James Tinker, John A. Eisman
    Osteoporosis International.2023; 34(6): 1037.     CrossRef
  • Effects of Bazedoxifene/Vitamin D Combination Therapy on Serum Vitamin D Levels and Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial
    Chaiho Jeong, Jeonghoon Ha, Jun-Il Yoo, Young-Kyun Lee, Jung Hee Kim, Yong-Chan Ha, Yong-Ki Min, Dong-Won Byun, Ki-Hyun Baek, Ho Yeon Chung
    Journal of Bone Metabolism.2023; 30(2): 189.     CrossRef
  • Risk of Fractures in Thyroid Cancer Patients With Postoperative Hypoparathyroidism: A Nationwide Cohort Study in Korea
    Seong Hee Ahn, You Jin Lee, Seongbin Hong, Jung Wee Park, Ye Jhin Jeon, Bit‐Na Yoo, Yong‐Chan Ha, Jean Kyung Bak, Ha Young Kim, Young‐Kyun Lee
    Journal of Bone and Mineral Research.2023; 38(9): 1268.     CrossRef
  • Impact of changes in physical activity and incident fracture after acute ischemic stroke
    Dae young Cheon, Kyung-Do Han, Jeen Hwa Lee, Kyung-Ho Yu, Bo Young Choi, Minwoo Lee
    Scientific Reports.2023;[Epub]     CrossRef
  • Associations between Long-Term Air Pollution Exposure and Risk of Osteoporosis-Related Fracture in a Nationwide Cohort Study in South Korea
    Seulkee Heo, Honghyok Kim, Sera Kim, Seung-Ah Choe, Garam Byun, Jong-Tae Lee, Michelle L. Bell
    International Journal of Environmental Research and Public Health.2022; 19(4): 2404.     CrossRef
  • Significance of Measuring Lumbar Spine 3-Dimensional Computed Tomography Hounsfield Units to Predict Screw Loosening
    Kyeong Hwan Kim, Tae-Hwan Kim, Seok Woo Kim, Ji Hee Kim, Heui Seung Lee, In Bok Chang, Joon Ho Song, Yong-Kil Hong, Jae Keun Oh
    World Neurosurgery.2022; 165: e555.     CrossRef
  • Risk of osteoporotic fracture in older patients under antihypertensive treatment
    Oh Kyung Kwon, Sun-Hwa Kim, Si-Hyuck Kang, Young-Kyun Lee, Chang-Hwan Yoon, Hae-Young Lee, Tae-Jin Youn, In-Ho Chae, Cheol-Ho Kim
    European Journal of Preventive Cardiology.2021; 28(11): e12.     CrossRef
  • Risk factors for subsequent vertebral fractures following a previous hip fracture
    Sang-Min Park, Sung Jun Go, Heesoo Han, Jung Wee Park, Young-Kyun Lee, Ho-Joong Kim, Jin S. Yeom, Kyung-Hoi Koo
    Journal of Bone and Mineral Metabolism.2021; 39(2): 193.     CrossRef
  • Characteristics of Osteoporosis & Osteoporotic Fractures in Korea Based on Health Insurance Review and Assessment (HIRA) Database: 2009–2017
    Ho-Seok Oh, Sung-Kyu Kim, Hyoung-Yeon Seo
    Healthcare.2021; 9(3): 324.     CrossRef
  • Association between Irritable Bowel Syndrome and Risk of Osteoporosis in Korean Premenopausal Women
    Sang-Yeoup Lee, Hye-Rim Hwang, Yu-Hyeon Yi, Jin-Mi Kim, Yun-Jin Kim, Jeong-Gyu Lee, Young-Hye Cho, Young-Jin Tak, Seung Hun Lee, Eun Ju Park, Youngin Lee
    Medical Principles and Practice.2021; 30(6): 527.     CrossRef
  • Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease
    Dae Yeon Won, Seong Jun Byun, Jin Sook Jeong, Ju-Young Shin
    Journal of the American Medical Directors Association.2020; 21(8): 1128.     CrossRef
  • High Circulating Sphingosine 1-Phosphate is a Risk Factor for Osteoporotic Fracture Independent of Fracture Risk Assessment Tool
    Seung Hun Lee, Jee Yang Lee, Kyeong-Hye Lim, Young-Sun Lee, Seong-Hee Kim, Sooyoung Choi, Seong-Hwan Cho, Jung-Min Koh
    Calcified Tissue International.2020; 107(4): 362.     CrossRef
  • Osteoporosis and Osteoporotic Fracture Fact Sheet in Korea
    Seong Hee Ahn, Sang-Min Park, So Young Park, Jun-Il Yoo, Hyoung-Seok Jung, Jae-Hwi Nho, Se Hwa Kim, Young-Kyun Lee, Yong-Chan Ha, Sunmee Jang, Tae-Young Kim, Ha Young Kim
    Journal of Bone Metabolism.2020; 27(4): 281.     CrossRef
  • Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older
    Ja Seo Koo, Seong Hwan Moon, Hankil Lee, Sohee Park, Yun Mi Yu, Hye-Young Kang, Robert Daniel Blank
    PLOS ONE.2020; 15(12): e0244759.     CrossRef
  • The Epidemiology of Fracture in Patients with Acute Ischemic Stroke in Korea
    Kyung Bok Lee, Jung-Gon Lee, Beom Joon Kim, Jun Yup Kim, Keon-Joo Lee, Moon-Ku Han, Jong-Moo Park, Kyusik Kang, Yong-Jin Cho, Hong-Kyun Park, Keun-Sik Hong, Tai Hwan Park, Soo Joo Lee, Mi-Sun Oh, Kyung-Ho Yu, Byung-Chul Lee, Jae-Kwan Cha, Dae-Hyun Kim, Jo
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Osteoporosis detection in panoramic radiographs using a deep convolutional neural network-based computer-assisted diagnosis system: a preliminary study
    Jae-Seo Lee, Shyam Adhikari, Liu Liu, Ho-Gul Jeong, Hyongsuk Kim, Suk-Ja Yoon
    Dentomaxillofacial Radiology.2019; 48(1): 20170344.     CrossRef
  • Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration
    Hun-Sung Kim, Dai-Jin Kim, Kun-Ho Yoon
    Endocrinology and Metabolism.2019; 34(4): 349.     CrossRef
  • Adherence to a Mediterranean Diet and Bone Mineral Density in Spanish Premenopausal Women
    Jesús Pérez-Rey, Raúl Roncero-Martín, Sergio Rico-Martín, Purificación Rey-Sánchez, Juan D. Pedrera-Zamorano, María Pedrera-Canal, Fidel López-Espuela, Jesús M. Lavado-García
    Nutrients.2019; 11(3): 555.     CrossRef
  • Effect of Training and Testing Condition of Convolutional Neural Network on evaluating Osteoporosis
    Jae-Yun Kim, Jae-Seo Lee, Byung-Cheol Kang, Hyongsuk Kim, Shyam Adhikari, Liu Liu, Suk-Ja Yoon
    The Korean Journal of Oral and Maxillofacial Pathology.2019; 43(3): 73.     CrossRef
  • Comparison of intraoperative radiation exposure with and without use of distal targeting device: a randomized control study
    Jun-Il Yoo, Hojin Jeong, Jaeboem Na, Sang-Youn Song, Jung-Taek Kim, Yong-Han Cha, Chan Ho Park
    Archives of Orthopaedic and Trauma Surgery.2019; 139(11): 1579.     CrossRef
  • Anemia and Risk of Fractures in Older Korean Adults: A Nationwide Population-Based Study
    Eun Ae Lee, Dong Wook Shin, Jun Hyun Yoo, Hyeon Young Ko, Su Min Jeong
    Journal of Bone and Mineral Research.2019; 34(6): 1049.     CrossRef
  • Elevated ceramides 18:0 and 24:1 with aging are associated with hip fracture risk through increased bone resorption
    Beom-Jun Kim, Jin Young Lee, So Jeong Park, Seung Hum Lee, Su Jung Kim, Hyun Ju Yoo, Sarah I. Rivera De Pena, Meghan McGee-Lawrence, Carlos M. Isales, Jung-Min Koh, Mark W. Hamrick
    Aging.2019; 11(21): 9388.     CrossRef
  • Effect of improved medication adherence on health care costs in osteoporosis patients
    Hyemin Cho, Ji-Hye Byun, Inmyung Song, Ha Y. Kim, Yong-Chan Ha, Tae-Young Kim, Young-Kyun Lee, Sunmee Jang
    Medicine.2018; 97(30): e11470.     CrossRef
  • Osteoporosis and fracture after gastrectomy for stomach cancer
    Gi Hyeon Seo, Hae Yeon Kang, Eun Kyung Choe
    Medicine.2018; 97(17): e0532.     CrossRef
  • Inflammation inhibitory effect of water extract from pumpkin’s tendril
    Ha-Na Jeong, Ju-Hee Choi, Ha-Nul Lee, So-Hyeon Lee, Soon-Chang Cho, Jong-Hwan Park, Young-Min Kim
    Korean Journal of Food Preservation.2017; 24(8): 1122.     CrossRef
  • Strong familial association of bone mineral density between parents and offspring: KNHANES 2008–2011
    H. S. Choi, J. H. Park, S. H. Kim, S. Shin, M. J. Park
    Osteoporosis International.2017; 28(3): 955.     CrossRef
  • Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment
    Y. W. Kim, J. H. Kim, S. H. Yoon, J. H. Lee, C.-H. Lee, C. S. Shin, Y. S. Park
    Osteoporosis International.2017; 28(1): 329.     CrossRef
  • Factors Affecting Bone Mineral Density Measurement after Fracture in South Korea
    Jin-Woo Kim, Yong-Chan Ha, Young-Kyun Lee
    Journal of Bone Metabolism.2017; 24(4): 217.     CrossRef
  • Femoral geometry, bone mineral density, and the risk of hip fracture in premenopausal women: a case control study
    Dong-Hwa Lee, Kyong Yeun Jung, A Ram Hong, Jung Hee Kim, Kyoung Min Kim, Chan Soo Shin, Seong Yeon Kim, Sang Wan Kim
    BMC Musculoskeletal Disorders.2016;[Epub]     CrossRef
  • The Association of Higher Plasma Macrophage Migration Inhibitory Factor Levels with Lower Bone Mineral Density and Higher Bone Turnover Rate in Postmenopausal Women
    Hyeonmok Kim, Seong Hee Ahn, Chaeho Shin, Seung Hun Lee, Beom-Jun Kim, Jung-Min Koh
    Endocrinology and Metabolism.2016; 31(3): 454.     CrossRef
  • Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea
    Sun-Young Jung, Hyun Soon Sohn, Eun-Ja Park, Hae Sun Suh, Ji-Won Park, Jin-Won Kwon, Chi-Ling Chen
    PLOS ONE.2016; 11(3): e0150531.     CrossRef
  • The effects of body mass index on the hereditary influences that determine peak bone mass in mother–daughter pairs (KNHANES V)
    K. M. Kim, Y. J. Kim, S. H. Choi, S. Lim, J. H. Moon, J. H. Kim, S. W. Kim, H. C. Jang, C. S. Shin
    Osteoporosis International.2016; 27(6): 2057.     CrossRef
  • Low Bone Mineral Density Is Associated with Tooth Loss in Postmenopausal Women: A Nationwide Representative Study in Korea
    Soyeon Ji, Young Jin Tak, Dong Hun Han, Yun Jin Kim, Sang Yeoup Lee, Jeong Gyu Lee, Dong Wook Jeong, Min Ji Kim
    Journal of Women's Health.2016; 25(11): 1159.     CrossRef
  • The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study
    S. J. Bae, S. H. Lee, S. H. Ahn, H.-M. Kim, B.-J. Kim, J.-M. Koh
    Osteoporosis International.2016; 27(8): 2533.     CrossRef
  • Is central skeleton bone quality a predictor of the severity of proximal humeral fractures?
    Seung Yeol Lee, Soon-Sun Kwon, Tae Hoon Kim, Sang-Jin Shin
    Injury.2016; 47(12): 2777.     CrossRef
  • Association of the TREML2 and HTR1E Genetic Polymorphisms with Osteoporosis
    Dongju Jung, Hyun-Seok Jin
    Biomedical Science Letters.2015; 21(4): 181.     CrossRef
  • A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis
    J.-W. Kwon, E.-J. Park, S.-Y. Jung, H.S. Sohn, H. Ryu, H.S. Suh
    Journal of Dental Research.2015; 94(9_suppl): 212S.     CrossRef
  • Reliability and validity of lower extremity computed tomography as a screening tool for osteoporosis
    S. Y. Lee, S.-S. Kwon, H. S. Kim, J. H. Yoo, J. Kim, J. Y. Kim, B. C. Min, S. J. Moon, K. H. Sung
    Osteoporosis International.2015; 26(4): 1387.     CrossRef
  • Osteoporosis in Healthy South Indian Males and the Influence of Life Style Factors and Vitamin D Status on Bone Mineral Density
    Sahana Shetty, Nitin Kapoor, Dukhabandhu Naik, Hesarghatta Shyamasunder Asha, Suresh Prabu, Nihal Thomas, Mandalam Subramaniam Seshadri, Thomas Vizhalil Paul
    Journal of Osteoporosis.2014; 2014: 1.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • Association of osteoporosis susceptibility genes with bone mineral density and bone metabolism related markers in Koreans: The Chungju Metabolic Disease Cohort (CMC) study
    Se Eun Park, Ki Won Oh, Won Young Lee, Ki Hyun Baek, Kun Ho Yoon, Ho Young Son, Won Chul Lee, Moo Il Kang
    Endocrine Journal.2014; 61(11): 1069.     CrossRef
  • Management of Osteoporosis: Who to Treat, What to Use, and for How Long?
    Sang Wan Kim
    Korean Journal of Medicine.2013; 85(4): 364.     CrossRef
Close layer
Original Articles
Multi-country Study on the Prevalence and Clinical Features of Peripheral Arterial Disease in Type 2 Diabetic Patients Who are at High Risk for Atherosclerosis.
Sang Youl Rhee, Seungjoon Oh, Young Kil Choi, Doo Man Kim, Bong Yun Cha, Hyun Chul Lee, Seung Woo Ha, In Kyu Lee, Tae Sun Park, Min Young Chung, In Joo Kim, Moon Kyu Lee, Sung Soo Koong, Kyung Soo Park, Kyung Wan Min, Young Seol Kim
J Korean Endocr Soc. 2006;21(4):290-301.   Published online August 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.4.290
  • 2,710 View
  • 32 Download
AbstractAbstract PDF
BACKGROUND
PAD-SEARCH (Peripheral Arterial Disease-Screening and Evaluation of diabetic patients in Asian Regions Characterized by High risk factors) is the first international study to investigate the prevalence of peripheral arterial disease (PAD) in Asian type 2 diabetic patients and to demonstrate the relationships between the putative risk factors and PAD in this population. METHODS: A total of 6,625 type 2 diabetic patients (2,873 males and 3,752 females aged 50 and older) were enrolled in PAD-SEARCH in Korea, China, Taiwan, Hong Kong, Indonesia, Thailand and Philippines from October 2003 to March 2004. The Fukuda vascular profile VS-1000(TM) was used to determine the ankle-brachial index (ABI) and the brachial-ankle pulse wave velocity (baPWV). RESULTS: The mean patient age was 63.7 +/- 8.2 years and the mean duration of diabetes was 10.3 +/- 8.0 years. 1,172 (17.7%) subjects were diagnosed as PAD by the ABI (< or = 0.9). Subjects with PAD had a significantly longer duration of diabetes or hypertension, a higher HbA1c level and a significantly lower mean BMI than did the non-PAD subjects. In terms of the lipid profiles, triglyceride was the only significant variable. Notably, the mean ABI and baPWV in the females were significantly poorer than the age matched males for the in subjects with a normal ABI. However, the mean ABI and baPWV in males were significantly poorer than those of the age matched females for the subjects with PAD. On the multivariate analysis, gender, age, BMI, smoking status, duration of diabetes and a previous history of cerebrovascular disease were identified as the independent risk factors of PAD. CONCLUSION: These findings suggest that PAD is a common complication in Asian type 2 diabetic patients. Therefore, PAD screening and treatment should be emphasized for Asian diabetic patients with high risk factors.
Close layer
The Incidence and Clinical Characteristics of Cushing's Syndrome in Korea.
J Korean Endocr Soc. 2000;15(1):31-45.   Published online January 1, 2001
  • 1,774 View
  • 37 Download
AbstractAbstract PDF
BACKGROUND
Cushing's syndrome is a relatively well understood syndrome. In Korea, there was no large scaled epidemiological report for etiology, clinical manifestation and results of treatment for Cushing's syndrome so far. This study was undertaken to elucidate the clinical characteristics of Cushing's syndrome in Korea by the survey committee for endocrine disease in Korean society of endocrinology. METHODS: For the case collection, we developed the case analysis protocol and computer program. And then we sent those form and program to 51 hospitals lacated in all over the country except Jeju-Do. Finally we collected 180 cases of Cushing's syndrome newly diagnosed from Jan. 1st, 1988 to Dec. 31st, 1993 from 28 hospitals. In this study, we excluded the patients with iatrogenic Cushing's syndrome. RESULTS: 1. If we collected all the cases in Korea, 0.84 new cases/million was diagnosed annually. The incidence was 3.5 times greater in women than in men, and the most frequent age of onset was the fourth decade. 2. Pituitary microadenoma and adrenal adenoma were the major causes (43.3%, 41.7% respectively). The ectopic Cushing's syndrome had very low incidence (0.6%) then other western countries. 3. Liddle's low dose dexamethasone suppression test, 24hr urine free cortisol level and 1mg overnight dexamethasone suppression test as a screening tests showed good sensitivity (98.1%, 94.3%, 96.3% respectively). 4. Both of 8 mg overnight dexamethasone suppression test and basal plasma ACTH level as differential test of Cushing's disease from adrenal Cushing's syndromes showed good specificity (90.6%, 100% respectively) but relatively low sensitivity (60.7%, 26.3% respectively). 5. Combination of both 8 mg overnight dexamethasone suppression test and basal plasma ACTH level improved the sensitivity (75.0%) and specificity (94.7%) as differential tests. 6. Treatments depended on the etiology. Surgery was the best choice when it could be performed. Radiotherapy and medical treatments were performed as isolated or combined modality but results were poor. CONCLUSION: Cushing's syndrome in Korea were not significantly different from western cases except that adrenal adenomas were more frequent. Ectopic Cushing's syndrome and Cushing's disease must be attentioned for diagnosis and proper management. Early and exact diagnosis process will improve the morbidity, mortality and life quality of patients.
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP